▁1- ami no in dan ▁is ▁an ▁active ▁major ▁metabol ite ▁and ▁it ▁is ▁not ▁a ▁ma o - b ▁inhibi tor ▁ .
▁co - administration ▁of ▁te no fo vir ▁di so prox il ▁fumar ate ▁and ▁di dano sine ▁is ▁not ▁recommended ▁ .
▁before ▁you ▁take ▁para reg
▁pan t ecta ▁control ▁20 ▁mg ▁gastro - re si stant ▁tablets ▁panto pra zole
▁renal ▁ex cre tion ▁of ▁the ▁un change d ▁vil dag lip tin ▁account ed ▁for ▁23 ▁% ▁of ▁the ▁dose ▁after ▁oral ▁administration ▁ .
▁sil den a fil ▁teva ▁25 ▁mg ▁film - co ated ▁tablets ▁sil den a fil ▁teva ▁50 ▁mg ▁film - co ated ▁tablets ▁sil den a fil ▁teva ▁100 ▁mg ▁film - co ated ▁tablets
▁media n ▁overall ▁survival ▁was ▁15. 9 ▁months ▁( ▁95 ▁% ▁ci ▁: ▁11. 6 ▁ , ▁18. 3 ▁) ▁ .
▁september -2010 ▁ , ▁presente d ▁in ▁module ▁1. 8.2 . ▁of ▁the ▁marketing ▁author isation ▁and ▁any ▁subsequent ▁updates ▁of ▁the ▁r mp ▁agreed ▁by ▁the ▁ch mp ▁ .
▁these ▁receptor ▁sub type s ▁are ▁express ed ▁in ▁different ▁tissu es ▁under ▁normal ▁physio logic al ▁conditions ▁ .
▁since ▁these ▁patients ▁are ▁amen or r ho e ic ▁and ▁have ▁low ▁end ogen ous ▁o est rogen ▁secret ion ▁ , ▁treatment ▁can ▁commence ▁at ▁any ▁time ▁ .
▁ci s ▁bio ▁international ▁ , ▁na ncy ▁ , ▁franc e
▁more ▁patients ▁responde d ▁to ▁treatment ▁with ▁dia com it ▁than ▁to ▁place bo ▁ .
▁in ▁a ▁pre - ▁/ ▁post na tal ▁development ▁study ▁perform ed ▁in ▁rat s ▁si tag lip tin ▁showed ▁no ▁advers e ▁effects ▁ .
▁interaction ▁with ▁other ▁medicinal ▁products ▁and ▁other ▁form s ▁of ▁interaction
▁the ▁most ▁common ▁side ▁effects ▁with ▁met hyl thi oni nium ▁chlor ide ▁are ▁na use a ▁( ▁feeling ▁sick ▁) ▁ , ▁abdominal ▁and ▁che st ▁pain ▁ , ▁head ache ▁ , ▁di zzi ness ▁ , ▁trem ors ▁ , ▁anxiety ▁ , ▁confusion al ▁state ▁ , ▁dys p no e a ▁( ▁difficult y ▁breath ing ▁) ▁ , ▁ta chy car dia ▁( ▁rapid ▁heart beat ▁) ▁ , ▁hyper tension ▁( ▁high ▁blood ▁pressure ▁) ▁ , ▁hyper hid rosi s ▁( ▁excessive ▁sweat ing ▁) ▁ , ▁pain ▁at ▁the ▁site ▁of ▁inject ion ▁or ▁in ▁a ▁li mb ▁ , ▁and ▁the ▁formation ▁of ▁met ha emo glob ina emia ▁ .
▁clo pido gre l ▁my lan ▁is ▁un like ly ▁to ▁affect ▁your ▁ability ▁to ▁drive ▁or ▁to ▁use ▁machines ▁ .
▁en ta ca pone ▁bind s ▁to ▁human ▁album in ▁ binding ▁site ▁i i ▁which ▁also ▁bind s ▁several ▁other ▁medicinal ▁products ▁ , ▁including ▁dia zep am ▁and ▁ibu profe n ▁ .
▁activity ▁measure ments ▁using ▁an ▁ion isation ▁cha mber ▁are ▁very ▁sensitive ▁to ▁geometri c ▁factors ▁and ▁ , ▁therefore ▁ , ▁should ▁be ▁perform ed ▁only ▁under ▁geometri c ▁conditions ▁which ▁have ▁been ▁appropriate ly ▁valida ted ▁ .
▁sub mission ▁of ▁study ▁protocol ▁within ▁1 ▁month ▁of ▁author isation
▁di so dium ▁ phos pha te ▁ , ▁an hydro us ▁so dium ▁di hydro gen ▁ phos pha te ▁di hydrat e ▁suc rose
▁the ▁european ▁commission ▁gran ted ▁a ▁marketing ▁author isation ▁valid ▁throughout ▁the ▁european ▁union ▁for ▁fa bra zy me ▁on ▁3 ▁august ▁2001 ▁ .
▁capsule ▁ shell ▁: ▁gelatin e ▁ , ▁so dium ▁la ur ils ul fa te ▁ , ▁yellow ▁ir on ▁oxid e ▁( ▁e 172 ▁) ▁ , ▁titan ium ▁ dioxid e ▁( ▁e 171 ▁) ▁ , ▁si li con ▁ dioxid e ▁( ▁e 551 ▁)
▁you ▁must ▁follow ▁carefully ▁the ▁instructions ▁on ▁prevent ing ▁skin ▁burn s ▁ .
▁what ▁is ▁le flu nom ide ▁win thro p ▁used ▁for ▁?
▁no ▁data ▁are ▁available ▁ . ▁( ▁see ▁section ▁5.1 ▁and ▁section ▁5.2 ▁) ▁ .
▁de pending ▁on ▁the ▁sign s ▁and ▁symptoms ▁of ▁your ▁disease ▁ , ▁your ▁doctor ▁will ▁decide ▁when ▁you ▁should ▁receive ▁more ▁mab ther a ▁ .
▁the ▁active ▁substance ▁is ▁temo zo lom ide ▁ .
▁this ▁medicine ▁is ▁pre scribe d ▁for ▁the ▁treatment ▁of ▁ac ti nic ▁kera tos is ▁in ▁adults ▁ .
▁intel ence ▁works ▁by ▁ reducing ▁the ▁amount ▁of ▁hi v ▁in ▁your ▁body ▁ .
▁once ▁bro ach ed ▁use ▁immediately ▁ .
▁ pharma co therapeut ic ▁group ▁: ▁other ▁respirator y ▁system ▁products ▁ , ▁at c ▁code ▁r 07 ax 01 ▁ .
▁in ▁meta static ▁renal ▁cell ▁car cino ma ▁ , ▁patients ▁taking ▁su tent ▁lived ▁for ▁an ▁average ▁of ▁4 7.3 ▁weeks ▁without ▁their ▁disease ▁worse ning ▁ , ▁compared ▁with ▁2 2.0 ▁weeks ▁in ▁the ▁patients ▁receiving ▁inter fer on ▁alfa ▁ .
▁ve nous ▁ thro mbo e mbol ism ▁was ▁seen ▁to ▁a ▁les ser ▁extent ▁with ▁le nali domi de ▁in ▁combination ▁with ▁mel phal an ▁and ▁pred nis one ▁in ▁new ly ▁diagnose d ▁multiple ▁mye loma ▁and ▁with ▁mono therapy ▁in ▁mye lo dys plast ic ▁syndrome s ▁ .
▁what ▁is ▁a x ura ▁used ▁for
▁it ▁is ▁recommended ▁to ▁observe ▁the ▁treated ▁dog ▁up ▁to ▁24 ▁hours ▁post - administration ▁of ▁the ▁product ▁for ▁possible ▁advers e ▁reaction s ▁( ▁see ▁section ▁ 4.6 ▁) ▁ .
▁patients ▁who ▁have ▁all ▁three ▁risk ▁factors ▁for ▁pm l ▁( ▁i . e . ▁ , ▁are ▁anti - j c v ▁anti body ▁positive ▁and ▁have ▁received ▁more ▁than ▁2 ▁years ▁of ▁tys abri ▁ therapy ▁ , ▁and ▁have ▁received ▁prior ▁immun os up press ant ▁ therapy ▁) ▁have ▁a ▁significantly ▁higher ▁risk ▁of ▁pm l ▁ .
▁verte bral ▁fra c tures ▁ , ▁non - verte bral ▁fra c tures ▁ .
▁un com mon ▁side ▁effects ▁with ▁the ▁combination ▁of ▁pe ga sys ▁and ▁riba vir in ▁( ▁may ▁affect ▁up ▁to ▁1 ▁in ▁100 ▁people ▁) ▁are ▁:
▁remove ▁the ▁following ▁items ▁from ▁the ▁cim zia ▁pack ▁and ▁set ▁them ▁up ▁on ▁a ▁clean ▁flat ▁surface ▁:
▁please ▁tell ▁your ▁doctor ▁if ▁you ▁are ▁taking ▁any ▁of ▁the ▁medicine s ▁above ▁ , ▁since ▁your ▁doctor ▁needs ▁to ▁know ▁if ▁you ▁already ▁are ▁at ▁risk ▁for ▁se iz ure ▁ .
▁the ▁owner ▁is ▁advise d ▁to ▁have ▁gluco se ▁contain ing ▁products ▁( ▁e . g . ▁honey ▁ , ▁de xt rose ▁gel ▁) ▁in ▁the ▁household ▁ .
▁sax ag lip tin ▁and ▁met form in ▁have ▁a ▁negli gi ble ▁influence ▁on ▁the ▁ability ▁to ▁drive ▁and ▁use ▁machines ▁ .
▁to ▁a ▁minor ▁extent ▁it ▁also ▁inhibi ts ▁collage n - indu ced ▁ thro mbo cy te ▁ aggregat ion ▁ .
▁p vc ▁/ ▁p vd c ▁/ ▁alu ▁bli sters ▁ , ▁seal ed ▁with ▁aluminium ▁foi l ▁ , ▁each ▁contain ing ▁30 ▁film - co ated ▁tablets ▁ .
▁ring ing ▁/ ▁sound ▁in ▁the ▁ear s ▁( ▁tin ni tus ▁)
▁clo pido gre l ▁should ▁therefore ▁be ▁used ▁with ▁cau tion ▁in ▁this ▁population ▁( ▁see ▁section ▁4.2 ▁) ▁ .
▁if ▁the ▁need le ▁is ▁not ▁kept ▁straight ▁while ▁you ▁att ach ▁it ▁ , ▁it ▁can ▁damage ▁the ▁rub ber ▁seal ▁and ▁cause ▁le ak age ▁ , ▁or ▁break ▁the ▁need le ▁ .
▁these ▁reaction s ▁have ▁usually ▁been ▁mild ▁and ▁usually ▁did ▁not ▁result ▁in ▁dis continu ation ▁of ▁immediate - release ▁ex en ati de ▁ .
▁fil gra s tim ▁ratio ph arm ▁and ▁che mo therapy
▁mir cera ▁250 ▁micro gram s ▁/ ▁0.3 ▁ml ▁solution ▁for ▁inject ion ▁in ▁pre - fill ed ▁sy ringe ▁met h oxy ▁poly e thy lene ▁gly col - e po etin ▁beta
▁no ▁dose ▁adjust ment ▁is ▁necessary ▁for ▁any ▁of ▁these ▁medicinal ▁products ▁ .
▁the ▁vaccin e ▁is ▁able ▁to ▁induc e ▁anti bo dies ▁in ▁a ▁wide ▁range ▁of ▁bir ds ▁ .
▁this ▁le a flet ▁was ▁approved ▁in ▁{ ▁month ▁y yy y ▁} ▁ .
▁the ▁ex cre tion ▁of ▁mil be my cin ▁o xim e ▁in ▁la cta ting ▁dog s ▁( ▁bit ches ▁) ▁has ▁not ▁been ▁test ed ▁and ▁the ▁safety ▁for ▁suc kling ▁pup pies ▁has ▁not ▁been ▁established ▁ .
▁what ▁is ▁dia com it ▁used ▁for ▁?
▁most ▁of ▁the ▁cases ▁were ▁related ▁to ▁handling ▁error s ▁or ▁pump ▁system ▁failure ▁ .
▁what ▁sus tiva ▁looks ▁like ▁and ▁content s ▁of ▁the ▁pack
▁bli ster ▁pack ▁( ▁14 ▁ , ▁56 ▁or ▁100 ▁) ▁and ▁perfor ated ▁unit ▁dose ▁bli ster ▁pack ▁( ▁100 ▁) ▁for ▁75 ▁mg ▁hard ▁capsule s
▁if ▁the ▁hair ▁is ▁long ▁ , ▁a ▁small ▁area ▁may ▁be ▁clip ped ▁ , ▁if ▁required ▁ .
▁2 ▁ml ▁of ▁solution ▁in ▁a ▁cart ridge ▁( ▁type ▁i ▁glass ▁) ▁closed ▁with ▁a ▁stopper ▁( ▁but yl ▁rub ber ▁) ▁and ▁a ▁seal ▁( ▁rub ber ▁) ▁ .
▁ab normal ▁blood ▁clo tting ▁ , ▁ clu mping ▁of ▁cell s ▁ , ▁ab normal ▁clo tting ▁factor ▁ , ▁re duction ▁in ▁red ▁blood ▁cell s ▁which ▁can ▁make ▁the ▁skin ▁pale ▁and ▁cause ▁we ak ness ▁or ▁breath less ness ▁ , ▁low ▁level ▁of ▁lymph o cy tes ▁a ▁specific ▁type ▁of ▁white ▁blood ▁cell s ▁( ▁lymph op enia ▁) ▁ , ▁feeling ▁your ▁heart beat
▁if ▁you ▁have ▁a ▁diabet ic ▁pre - com a
▁the ▁proportion ▁of ▁patients ▁a chie ving ▁b cr - a bl ▁ratio ▁of ▁ ≤ ▁ 0.01 ▁% ▁( ▁4- log ▁re duction ▁) ▁at ▁any ▁time ▁was ▁higher ▁in ▁the ▁spr y cel ▁group ▁compared ▁to ▁the ▁imati ni b ▁group ▁( ▁5 4.1 ▁% ▁versus ▁45 ▁% ▁) ▁ .
▁skin ▁changes ▁in ▁the ▁form ▁of ▁cru st s ▁ , ▁hyper kera tos is ▁ , ▁or ▁er y thema ▁were ▁observe d ▁in ▁ toxic ity ▁studies ▁in ▁cyn om ol gus ▁mon key s ▁ .
▁i asi bon ▁is ▁a ▁' ▁generic ▁medicine ▁' ▁ .
▁the ▁optimal ▁du ration ▁of ▁treatment ▁is ▁un know n ▁ .
▁read ▁all ▁of ▁this ▁le a flet ▁carefully ▁before ▁you ▁start ▁using ▁this ▁medicine ▁because ▁it ▁contain s ▁important ▁information ▁for ▁you ▁ .
▁grade ▁3 ▁ toxic ity ▁ , ▁at ▁any ▁time ▁during ▁the ▁treatment ▁cycle ▁ , ▁de lay ▁treatment ▁until ▁resolve d ▁to ▁grade ▁ 0-1 ▁and ▁then ▁resume ▁treatment ▁with ▁doce ta xel ▁55 ▁mg ▁/ ▁m ▁2 ▁ .
▁following ▁single ▁oral ▁administration ▁of ▁[ ▁14 c ▁] ▁fin go li mod ▁ , ▁the ▁major ▁fin go li mod - related ▁component s ▁in ▁blood ▁ , ▁as ▁judge d ▁from ▁their ▁contribution ▁to ▁the ▁au c ▁up ▁to ▁34 ▁days ▁post ▁dose ▁of ▁total ▁radio label led ▁component s ▁ , ▁are ▁fin go li mod ▁itself ▁( ▁23 ▁% ▁) ▁ , ▁fin go li mod ▁ phos pha te ▁( ▁10 ▁% ▁) ▁ , ▁and ▁in active ▁metabol ites ▁( ▁m 3 ▁carb oxy lic ▁acid ▁metabol ite ▁( ▁8 ▁% ▁) ▁ , ▁m 29 ▁cer ami de ▁metabol ite ▁( ▁9 ▁% ▁) ▁and ▁m 30 ▁cer ami de ▁metabol ite ▁( ▁7 ▁% ▁) ▁) ▁ .
▁what ▁are ▁the ▁benefit ▁and ▁risk ▁of ▁clo pido gre l ▁1 a ▁ pharma ▁?
▁no ▁post - marketing ▁sur ve illa nce ▁data ▁are ▁available ▁following ▁a flu nov ▁administration ▁ .
▁therefore ▁ , ▁res ection ▁of ▁fluor esc ing ▁tissu e ▁should ▁be ▁we ighed ▁up ▁carefully ▁against ▁the ▁neurologi cal ▁function ▁of ▁fluor esc ing ▁tissu e ▁ .
▁pra mi pe xo le ▁has ▁been ▁associated ▁with ▁som nol ence ▁and ▁episode s ▁of ▁sud den ▁sleep ▁ons et ▁ , ▁particularly ▁in ▁patients ▁with ▁par kin son ▁' s ▁disease ▁ .
▁if ▁you ▁have ▁any ▁questions ▁about ▁your ▁treatment ▁schedule ▁ , ▁ask ▁your ▁doctor ▁or ▁nurse ▁ .
▁thy mana x ▁has ▁no ▁abuse ▁potential ▁as ▁measure d ▁in ▁healthy ▁volunteer ▁studies ▁on ▁a ▁specific ▁visual ▁analog ue ▁scale ▁or ▁the ▁addiction ▁research ▁center ▁invent ory ▁( ▁ar ci ▁) ▁49 ▁check - list ▁ .
▁of ▁the ▁14 ▁patients ▁whose ▁c yan ide ▁exposure ▁was ▁due ▁to ▁something ▁other ▁than ▁smo ke ▁in hal ation ▁ , ▁10 ▁survive d ▁ , ▁including ▁seven ▁patients ▁with ▁' ▁le thal ▁' ▁levels ▁of ▁c yan ide ▁in ▁the ▁blood ▁ .
▁stabilit y ▁has ▁been ▁demonstrat ed ▁for ▁21 ▁days ▁at ▁room ▁temperature ▁in ▁the ▁ca dd - micro ▁pump ▁ .
▁e rious ▁infection s ▁( ▁including ▁blood ▁pois o ning ▁and ▁influenza ▁) ▁;
▁do ▁not ▁throw ▁away ▁any ▁medicine s ▁via ▁was te water ▁or ▁household ▁was te ▁ .
▁visual ▁acu ity ▁reduce d ▁ , ▁vision ▁blu r red ▁ , ▁lac rim ation ▁increased
▁pick ▁up ▁the ▁sy ringe ▁and ▁remove ▁the ▁need le ▁cover
▁the ▁main ▁measure ▁of ▁effective ness ▁was ▁the ▁number ▁of ▁patients ▁who ▁responde d ▁to ▁treatment ▁ , ▁based ▁on ▁the ▁number ▁and ▁sever ity ▁of ▁symptoms ▁ .
▁the ▁active ▁substance ▁is ▁hydro xo co bala min ▁ .
▁if ▁the ▁liquid ▁is ▁colour ed ▁or ▁you ▁can ▁see ▁parti cles ▁flo ating ▁in ▁it ▁ ,
▁read ▁the ▁package ▁le a flet ▁before ▁use ▁for ▁intra ven ous ▁use ▁only
▁the ▁european ▁commission ▁gran ted ▁a ▁marketing ▁author isation ▁valid ▁throughout ▁the ▁european ▁union ▁for ▁ tec fi dera ▁on ▁30 ▁januar y ▁2014 ▁ .
▁if ▁you ▁have ▁forgotten ▁to ▁take ▁white ▁active ▁tablets ▁in ▁a ▁bli ster ▁ , ▁and ▁you ▁do ▁not ▁have ▁the ▁expected ▁monthly ▁period ▁while ▁taking ▁the ▁yellow ▁place bo ▁tablets ▁from ▁the ▁same ▁bli ster ▁ , ▁you ▁may ▁be ▁pregnant ▁ .
▁accident al ▁in gestion ▁can ▁be ▁le thal ▁for ▁children ▁ .
▁a ▁dose ▁re duction ▁of ▁ra ne xa ▁may ▁be ▁needed ▁in ▁combination ▁with ▁:
▁since ▁ zia gen ▁contain s ▁a baca vir ▁some ▁patients ▁taking ▁ zia gen ▁may ▁develop ▁a ▁hyper sensitiv ity ▁reaction ▁( ▁serious ▁allergi c ▁reaction ▁) ▁which ▁can ▁be ▁life - th rea te ning ▁if ▁treatment ▁with ▁ zia gen ▁is ▁continued ▁ .
▁gly cer ol ▁( ▁e 4 22 ▁) ▁mal ti tol ▁liquid ▁( ▁e 965 ▁)
▁always ▁carry ▁an ▁extra ▁pen ▁and ▁new ▁need les ▁with ▁you ▁ , ▁in ▁case ▁of ▁loss ▁or ▁damage ▁ .
▁considerable ▁inter - ▁and ▁intra - individu al ▁variabil ity ▁was ▁observe d ▁in ▁the ▁ pharma cok ine tics ▁of ▁ra lte grav ir ▁ .
▁difficult y ▁in ▁breath ing ▁ , ▁short ness ▁of ▁breath ▁or ▁w hee zing
▁no ▁effects ▁on ▁male ▁fertil ity ▁were ▁observe d ▁in ▁rat s ▁( ▁see ▁section ▁5.3 ▁) ▁ .
▁in ▁the ▁second ▁study ▁ , ▁edu rant ▁was ▁compared ▁with ▁efa vir enz ▁ , ▁when ▁both ▁medicine s ▁were ▁given ▁in ▁combination ▁with ▁a ▁fixed ▁regime n ▁of ▁anti vir al ▁medicine s ▁consist ing ▁of ▁te no fo vir ▁di so prox il ▁and ▁em trici ta bine ▁or ▁two ▁other ▁nucleo side ▁or ▁nucleo ti de ▁rever se ▁tran script ase ▁inhibi tors ▁ .
▁the ▁maximum ▁recommended ▁dose ▁is ▁one ▁tablet ▁80 ▁mg ▁tel mis ar tan ▁/ ▁10 ▁mg ▁am lo di pine ▁per ▁day ▁ .
▁your ▁doctor ▁will ▁show ▁you ▁in ▁which ▁area ▁of ▁the ▁skin ▁you ▁should ▁inject ▁your ▁insulin ▁ .
▁the ▁risk ▁for ▁a baca vir ▁h s r ▁to ▁occur ▁is ▁high ▁for ▁patients ▁who ▁test ▁positive ▁for ▁the ▁ hla - b ▁* ▁5 701 ▁alle le ▁ .
▁the ▁solution ▁in ▁the ▁ste lara ▁vi al ▁should ▁not ▁be ▁shake n ▁ .
▁your ▁doctor ▁or ▁radio logist ▁will ▁consider ▁this ▁with ▁you ▁ .
▁the ▁prin ting ▁in k ▁is ▁compose d ▁of ▁ shell ac ▁ , ▁ir on ▁oxid e ▁black ▁( ▁e 172 ▁) ▁ , ▁n - but yl ▁alcohol ▁ , ▁pur ified ▁water ▁ , ▁ propyl ene ▁gly col ▁and ▁ammo nium ▁hydro xi de ▁ .
▁the ▁ pharma cok ine tics ▁of ▁t m z ▁were ▁comparable ▁in ▁patients ▁with ▁normal ▁he pati c ▁function ▁and ▁in ▁those ▁with ▁mild ▁or ▁moderat e ▁he pati c ▁im pair ment ▁ .
▁receptor s ▁for ▁som at osta tin ▁can ▁be ▁found ▁in ▁high ▁amount s ▁on ▁tum our ▁cell s ▁ , ▁including ▁tu mo urs ▁of ▁the ▁pit uit ary ▁g land ▁which ▁cause ▁cu shing ▁' s ▁disease ▁and ▁a cro mega ly ▁ .
▁280 ▁tablets ▁( ▁20 x 14 ▁ , ▁p vc ▁/ ▁pct fe ▁bli sters ▁)
▁hold ▁the ▁applica tor ▁in ▁one ▁hand ▁and ▁pull ▁the ▁safety ▁tab ▁straight ▁off ▁the ▁applica tor ▁ .
▁decrease ▁in ▁the ▁number ▁of ▁plate let s ▁in ▁the ▁blood ▁( ▁ thro mbo cy top enia ▁) ▁ ,
▁from ▁a ▁micro bi ological ▁point ▁of ▁view ▁ , ▁the ▁solution ▁should ▁be ▁used ▁immediately ▁ .
▁the ▁full ▁e par ▁for ▁kry ste xx a ▁can ▁be ▁found ▁on ▁the ▁agency ▁' s ▁website ▁: ▁ema . europa . eu ▁/ ▁find ▁medicine ▁/ ▁human ▁medicine s ▁/ ▁european ▁public ▁assessment ▁reports ▁ .
▁optim ark ▁is ▁contra indica ted ▁in ▁patients ▁with ▁severe ▁renal ▁im pair ment ▁( ▁g fr ▁< ▁30 ▁ml ▁/ ▁min ▁/ ▁1. 73 ▁m ▁2 ▁) ▁and ▁/ ▁or ▁a cute ▁renal ▁injury ▁and ▁in ▁patients ▁who ▁have ▁had ▁ liver ▁transplant ation ▁or ▁in ▁patients ▁in ▁the ▁per i operativ e ▁ liver ▁transplant ation ▁period ▁ .
▁an ▁appropriate ▁dose ▁for ▁children ▁under ▁6 ▁years ▁of ▁age ▁and ▁we igh ing ▁less ▁than ▁25 ▁kg ▁cannot ▁be ▁achieve d ▁with ▁ka ly de co ▁tablets ▁ .
▁the ▁withdraw al ▁period ▁for ▁por cili s ▁co lic los ▁is ▁zero ▁days ▁for ▁pig ▁me at ▁ .
▁in ▁the ▁example ▁above ▁ , ▁the ▁dose ▁number ▁shows ▁there ▁are ▁13 ▁inject ions ▁left ▁ .
▁dos es ▁higher ▁than ▁100 ▁mg ▁are ▁not ▁recommended ▁ .
▁based ▁on ▁this ▁plan ▁ , ▁safety ▁information ▁has ▁been ▁included ▁in ▁the ▁summary ▁of ▁product ▁character istic s ▁and ▁the ▁package ▁le a flet ▁for ▁leve ti race tam ▁ho spira ▁ , ▁including ▁the ▁appropriate ▁precau tions ▁to ▁be ▁followed ▁by ▁health care ▁professionals ▁and ▁patients ▁ .
▁tell ▁your ▁doctor ▁if ▁you ▁have ▁ever ▁been ▁diagnose d ▁with ▁lymph oma ▁( ▁a ▁type ▁of ▁blood ▁cancer ▁) ▁or ▁any ▁other ▁cancer ▁before ▁you ▁use ▁si mpon i ▁ .
▁always ▁keep ▁enough ▁ty bost ▁so ▁you ▁don ▁' t ▁run ▁out ▁ .
▁cm l ▁is ▁a ▁cancer ▁of ▁the ▁blood ▁which ▁makes ▁the ▁body ▁produce ▁too ▁many ▁ab normal ▁white ▁blood ▁cell s ▁ .
▁the ▁ pharma cok ine tics ▁of ▁a ▁20 ▁mg ▁single - dos e ▁of ▁baze do xi fen e ▁were ▁evaluat ed ▁in ▁a ▁study ▁in ▁26 ▁healthy ▁post meno paus al ▁women ▁ .
▁the ▁required ▁dose ▁is ▁calcula ted ▁from ▁the ▁weight ▁of ▁the ▁patient ▁ , ▁using ▁the ▁minimum ▁number ▁of ▁sac hets ▁possible ▁ .
▁educational ▁material ▁for ▁health care ▁professionals
▁irre ver sible ▁ , ▁select ive ▁ma o - b ▁inhibi tor ▁( ▁se legi line ▁ , ▁rasa gi line ▁)
▁the ▁size ▁of ▁the ▁seal ant ▁matri x ▁depend s ▁on ▁the ▁size ▁of ▁the ▁wo und ▁ .
▁overall ▁ , ▁the ▁ef fica cy ▁and ▁safety ▁profile ▁of ▁kin eret ▁is ▁comparable ▁in ▁adult ▁and ▁pa e dia tric ▁cap s ▁patients ▁ .
▁the ▁most ▁common ▁side ▁effect ▁with ▁ratio gra s tim ▁( ▁seen ▁in ▁more ▁than ▁1 ▁patient ▁in ▁10 ▁) ▁is ▁mus culos kelet al ▁pain ▁( ▁pain ▁in ▁the ▁muscle s ▁and ▁bone s ▁) ▁ .
▁following ▁an ▁oral ▁dose ▁ , ▁the ▁apparent ▁terminal ▁elimina tion ▁half - life ▁is ▁approximately ▁6.5 ▁h ▁ .
▁+ ▁45 ▁44 ▁20 ▁11 ▁00
▁your ▁doctor ▁will ▁decide ▁how ▁long ▁you ▁must ▁continue ▁treatment ▁for ▁ .
▁after ▁a ▁dos age ▁of ▁2 ▁mg ▁/ ▁kg ▁a ▁t max ▁of ▁1 ▁h ▁( ▁cat s ▁and ▁dog s ▁) ▁ , ▁a ▁c max ▁of ▁1,4 64 ▁ng ▁/ ▁ml ▁( ▁cat s ▁) ▁and ▁6 15 ▁ng ▁/ ▁ml ▁( ▁dog s ▁) ▁ , ▁and ▁an ▁au c ▁of ▁3 , 128 ▁ng ▁· ▁h ▁/ ▁ml ▁( ▁cat s ▁) ▁and ▁2 , 180 ▁ng ▁· ▁h ▁/ ▁ml ▁( ▁dog s ▁) ▁is ▁obtain ed ▁ .
▁you ▁should ▁take ▁clo pido gre l ▁ratio ph arm ▁g m bh ▁for ▁as ▁long ▁as ▁your ▁doctor ▁continues ▁to ▁pre scribe ▁it ▁ .
▁following ▁intra ven ous ▁bol us ▁administration ▁of ▁30 ▁mg ▁te nec te plas e ▁in ▁patients ▁with ▁a cute ▁my o card ial ▁in far ction ▁ , ▁the ▁initial ly ▁estima ted ▁te nec te plas e ▁plasma ▁concentration ▁was ▁6. 45 ▁ ± ▁3. 60 ▁μ g ▁/ ▁ml ▁( ▁mean ▁ ± ▁s d ▁) ▁ .
▁use ▁the ▁blue ▁triple ▁pack ▁4 ▁contain ing ▁3 ▁sy ring es ▁with ▁a ▁0.2 5 ▁; ▁0.5 ▁; ▁0 . 75 ▁and ▁1.0 - ml ▁mark ing ▁ , ▁for ▁treatment ▁days ▁19 ▁ , ▁21 ▁and ▁23 ▁ .
▁type ▁i ▁glass ▁pre - fill ed ▁sy ringe ▁ .
▁protein ▁ binding ▁of ▁ce fti o fur ▁and ▁its ▁major ▁metabol ite ▁is ▁high ▁ , ▁approximately ▁70 ▁% ▁- ▁90 ▁% ▁ .
▁severe ▁( ▁grade ▁3 ▁or ▁4 ▁) ▁fatigue ▁and ▁as th enia ▁incide nce ▁was ▁3 ▁and ▁3 ▁% ▁respective ly ▁ .
▁the ▁main ▁measure ▁of ▁effective ness ▁was ▁the ▁production ▁of ▁anti body ▁levels ▁known ▁to ▁be ▁protect ive ▁against ▁those ▁disease s ▁ .
▁no ▁dose ▁adjust ment ▁is ▁necessary ▁for ▁patients ▁with ▁renal ▁im pair ment ▁or ▁for ▁patients ▁with ▁end ▁stage ▁renal ▁disease ▁under go ing ▁ha e modi al ysis ▁( ▁see ▁section ▁5.2 ▁) ▁ .
▁immediate ▁and ▁de lay ed ▁hyper sensitiv ity ▁reaction s ▁ , ▁e . g . ▁ex an thema ▁ , ▁ur tica ria ▁ , ▁pru ritu s ▁ , ▁dermatit is ▁ , ▁ang io ede ma ▁and ▁ana phy la ctic ▁reaction
▁ex ace rb ations ▁of ▁hepatitis ▁after ▁dis continu ation ▁of ▁treatment
▁bone ▁ab normal ities ▁( ▁in fre quen t ly ▁contribu ting ▁to ▁fra c tures ▁) ▁may ▁be ▁associated ▁with ▁proxima l ▁renal ▁tu bulo pathy ▁( ▁see ▁section ▁4. 8 ▁) ▁ .
▁due ▁to ▁the ▁structura l ▁similar ity ▁of ▁ful vest rant ▁and ▁est radio l ▁ , ▁ful vest rant ▁may ▁interfere ▁with ▁anti body ▁based - est radio l ▁as say s ▁and ▁may ▁result ▁in ▁false ly ▁increased ▁levels ▁of ▁est radio l ▁ .
▁increased ▁ liver ▁trans ami nas es ▁in ▁your ▁blood
▁however ▁ , ▁side ▁effects ▁such ▁as ▁di zzi ness ▁and ▁visual ▁disturb ances ▁may ▁un com mon ly ▁occur ▁( ▁see ▁section ▁4 ▁) ▁ .
▁your ▁doctor ▁will ▁ask ▁you ▁to ▁have ▁blood ▁tests ▁period ically ▁during ▁treatment ▁with ▁pi og lita zone ▁act avis ▁ .
▁a ▁heart ▁attack ▁within ▁the ▁last ▁six ▁months ▁ ,
▁do ▁not ▁mix ▁ne ore cor mon ▁with ▁other ▁inject ions ▁or ▁in fusion ▁solutions ▁ .
▁the ▁european ▁commission ▁gran ted ▁a ▁marketing ▁author isation ▁valid ▁throughout ▁the ▁european ▁union ▁for ▁je nta du eto ▁on ▁20 ▁jul y ▁2012 ▁ .
▁for ▁the ▁full ▁list ▁of ▁all ▁side ▁effects ▁reported ▁with ▁ri va stig mine ▁he xal ▁ , ▁see ▁the ▁package ▁le a flet ▁ .
▁ex cip ient s ▁with ▁known ▁effect
▁a ▁lower ▁starting ▁dose ▁of ▁olan za pine ▁should ▁be ▁considered ▁in ▁patients ▁who ▁are ▁using ▁flu vo xa mine ▁or ▁any ▁other ▁cy p 1 a 2 ▁inhibi tors ▁ , ▁such ▁as ▁ci pro flo xa cin ▁ .
▁the ▁active ▁substance ▁in ▁ze rit ▁ , ▁stavu dine ▁ , ▁is ▁a ▁nucleo side ▁rever se ▁tran script ase ▁inhibi tor ▁( ▁nr ti ▁) ▁ .
▁death ▁ , ▁or ▁hospital isation ▁for ▁worse ning ▁pah ▁ ,
▁some ▁patients ▁may ▁even ▁still ▁feel ▁further ▁improvement s ▁after ▁4 ▁to ▁6 ▁months ▁of ▁ therapy ▁ .
▁you ▁have ▁ki dne y ▁problems ▁( ▁protein ▁in ▁the ▁urin e ▁) ▁ , ▁since ▁your ▁doctor ▁will ▁monitor ▁your ▁ki dne y ▁function ▁and ▁may ▁need ▁to ▁adjust ▁your ▁dose ▁of ▁zal trap ▁ .
▁other ▁information ▁about ▁nem da tine
▁g 3 ▁/ ▁4 ▁alt ▁increased ▁( ▁< ▁1 ▁% ▁)
▁the ▁ pharma cok ine tics ▁of ▁novom ix ▁70 ▁have ▁not ▁been ▁investiga ted ▁in ▁pa e dia tric s ▁ , ▁older ▁patients ▁or ▁in ▁patients ▁with ▁renal ▁or ▁he pati c ▁im pair ment ▁ .
▁such ▁reaction s ▁are ▁usually ▁responsive ▁to ▁anal ges ics ▁ .
▁system ic ▁vas cular ▁resist ance ▁( ▁-2 76 ▁dy nes ▁* ▁sec ▁/ ▁cm 5 ▁( ▁16 ▁% ▁) ▁) ▁was ▁improve d ▁after ▁12 ▁weeks ▁of ▁treatment ▁ .
▁for ▁treatment ▁of ▁bi ting ▁lice ▁a ▁single ▁dose ▁should ▁be ▁ sufficient ▁ .
▁oral ▁use ▁ , ▁15 ▁mg ▁per ▁kg ▁body weight ▁once ▁daily ▁ .
▁in ▁these ▁studies ▁ , ▁mon key s ▁exhibi ted ▁greater ▁ sensitiv ity ▁to ▁po mali domi de ▁effects ▁than ▁rat s ▁ .
▁consideration ▁should ▁be ▁given ▁to ▁the ▁sever ity ▁of ▁the ▁hyper cal ca emia ▁as ▁well ▁as ▁the ▁tum our ▁type ▁ .
▁clinic ally ▁significant ▁hyper sensitiv ity ▁reaction s ▁associated ▁with ▁to cili zum ab ▁and ▁requiri ng ▁treatment ▁dis continu ation ▁were ▁reported ▁in ▁a ▁total ▁of ▁56 ▁out ▁of ▁4 , 009 ▁patients ▁( ▁1.4 ▁% ▁) ▁treated ▁with ▁to cili zum ab ▁during ▁the ▁control led ▁and ▁open ▁label ▁clinic al ▁studies ▁ .
▁significant ▁improvement ▁in ▁health ▁related ▁quality ▁of ▁life ▁was ▁also ▁demonstrat ed ▁with ▁significant ▁improvement ▁in ▁both ▁the ▁physical ▁health ▁score ▁( ▁ph s ▁) ▁and ▁mental ▁health ▁score ▁( ▁mh s ▁) ▁of ▁the ▁sf -36 ▁ .
▁all ▁studies ▁used ▁statistic al ▁methods ▁to ▁control ▁for ▁con found ing ▁factors ▁ , ▁including ▁prefer ential ▁pre scribi ng ▁of ▁varen ic line ▁to ▁health ier ▁patients ▁ , ▁although ▁there ▁is ▁the ▁possibility ▁of ▁residu al ▁con found ing ▁ .
▁these ▁symptoms ▁var y ▁from ▁patient ▁to ▁patient ▁but ▁usually ▁involve ▁:
▁there ▁are ▁no ▁data ▁in ▁pregnant ▁women ▁ .
▁the ▁potential ▁risk ▁with ▁the ▁combination ▁of ▁aza ▁or ▁6- mp ▁and ▁re mica de ▁should ▁be ▁carefully ▁considered ▁ .
▁the ▁effect ▁was ▁seen ▁both ▁in ▁patients ▁a ged ▁between ▁50 ▁and ▁59 ▁years ▁and ▁in ▁those ▁a ged ▁60 ▁years ▁and ▁older ▁ .
▁the ▁level ▁of ▁activity ▁in ▁the ▁bone ▁was ▁in ▁the ▁range ▁of ▁44 ▁% ▁to ▁77 ▁% ▁at ▁4 ▁hours ▁post ▁inject ion ▁ .
▁some ▁medicine ▁may ▁interact ▁with ▁ra xon e ▁ .
▁pack ▁size s ▁are ▁available ▁in ▁30 ▁ , ▁60 ▁and ▁120 ▁capsule s ▁ .
▁los ing ▁weight ▁and ▁maintain ing ▁weight ▁loss ▁ , ▁for ▁example ▁by ▁improving ▁your ▁die t ▁and ▁increasing ▁your ▁physical ▁activity ▁ , ▁can ▁help ▁reduce ▁the ▁risk ▁of ▁serious ▁health ▁problems ▁and ▁help ▁improve ▁your ▁health ▁ .
▁nature ▁and ▁composition ▁of ▁immediate ▁packaging
▁although ▁kio vig ▁does ▁not ▁contain ▁sugar ▁ , ▁it ▁may ▁be ▁dilu ted ▁with ▁a ▁special ▁sugar ▁solution ▁( ▁5 ▁% ▁gluco se ▁) ▁ , ▁which ▁could ▁affect ▁your ▁blood ▁sugar ▁level ▁ .
▁the ▁pre scribe d ▁dose ▁for ▁the ▁patient ▁is ▁given ▁in ▁mg ▁/ ▁kg ▁ .
▁a ▁single ▁dose ▁of ▁the ▁product ▁should ▁be ▁ad minister ed ▁ .
▁other ▁medicine s ▁and ▁heli xa te ▁ne x gen ▁3000 ▁iu
▁have ▁severe ▁osteo ar thri tis ▁of ▁the ▁k ne e ▁( ▁disease ▁of ▁the ▁joint s ▁with ▁pain ▁and ▁swe lling ▁)
▁pro quad ▁should ▁not ▁be ▁given ▁to ▁pregnant ▁women ▁ .
▁before ▁starting ▁treatment ▁with ▁liber tek ▁ , ▁inform ▁your ▁doctor ▁if ▁you ▁are ▁suffering ▁from ▁any ▁symptoms ▁of ▁this ▁kind ▁and ▁of ▁any ▁additional ▁medicine s ▁you ▁may ▁take ▁since ▁some ▁of ▁those ▁could ▁increase ▁the ▁probabil ity ▁of ▁these ▁side ▁effects ▁ .
▁when ▁changing ▁back ▁to ▁a ▁twice ▁daily ▁regime n ▁ , ▁patients ▁should ▁take ▁the ▁recommended ▁twice ▁daily ▁dose ▁approximately ▁24 ▁hours ▁after ▁the ▁last ▁once ▁daily ▁dose ▁ .
▁neuro blo c ▁is ▁a ▁neuro mus cular ▁block ing ▁agent ▁ .
▁if ▁you ▁have ▁not ▁been ▁expose d ▁to ▁e b v ▁prior ▁to ▁your ▁transplant
▁only ▁the ▁suppli ed ▁solve nt ▁must ▁be ▁used ▁for ▁recon stitu tion ▁; ▁it ▁contain s ▁calci um ▁which ▁is ▁required ▁for ▁the ▁activity ▁of ▁xi ap ex ▁ .
▁fos avance ▁70 ▁mg ▁/ ▁5 , 600 ▁iu ▁tablets ▁are ▁available ▁as ▁modifi ed ▁recta ng le - sha ped ▁ , ▁white ▁to ▁off - white ▁tablets ▁marked ▁with ▁an ▁out line ▁of ▁a ▁bone ▁image ▁on ▁one ▁side ▁and ▁' ▁270 ▁' ▁on ▁the ▁other ▁ .
▁treat ▁certain ▁psychiatr ic ▁disorder s ▁such ▁as ▁severe ▁anxiety ▁or ▁schi zo ph r enia ▁( ▁e . g . ▁dia zep am ▁ , ▁mida zola m ▁ , ▁hal o peri dol ▁)
▁di zzi ness ▁ , ▁including ▁di zzi ness ▁when ▁standing ▁up ▁ , ▁and ▁occasion ally ▁fa in ting ▁ , ▁may ▁occur ▁ .
▁o laza x ▁di sper zi ▁10 ▁mg ▁oro dis per sible ▁tablets ▁olan za pine
▁eu ▁/ ▁1 ▁/ ▁06 ▁/ ▁ 356 ▁/ ▁0 14 ▁30 ▁film - co ated ▁tablets
▁this ▁medicine ▁does ▁not ▁require ▁any ▁special ▁storage ▁conditions ▁ .
▁in ▁addition ▁ , ▁no ▁changes ▁in ▁ta dala fil ▁concentration s ▁were ▁seen ▁3 ▁hours ▁after ▁co - administration ▁with ▁alcohol ▁ .
▁ware ▁ , ▁her t ford shire ▁sg 12 ▁0 d j ▁unit ed ▁king dom ▁ .
▁ ica ndra ▁combine s ▁two ▁anti hy per gly ca e mic ▁agents ▁with ▁compliment ary ▁mechanism s ▁of ▁action ▁to ▁improve ▁gly ca e mic ▁control ▁in ▁patients ▁with ▁type ▁2 ▁diabetes ▁: ▁vil dag lip tin ▁ , ▁a ▁member ▁of ▁the ▁is let ▁enhance r ▁class ▁ , ▁and ▁met form in ▁hydro ch lor ide ▁ , ▁a ▁member ▁of ▁the ▁bi guan ide ▁class ▁ .
▁each ▁pen ▁contain s ▁3 ▁ml ▁of ▁solution ▁for ▁inject ion ▁ , ▁equivalent ▁to ▁300 ▁unit s ▁ .
▁h 2- anta gon ists ▁or ▁other ▁medicinal ▁products ▁that ▁increase ▁gas tric ▁ph ▁ .
▁if ▁exposure ▁has ▁been ▁greater ▁than ▁24 ▁hours ▁or ▁f rozen ▁more ▁than ▁once ▁ , ▁then ▁ni vesti m ▁should ▁not ▁be ▁used ▁ .
▁the ▁ pharma cok ine tic ▁behaviour ▁of ▁ma ci ▁is ▁related ▁to ▁the ▁resor p tion ▁of ▁the ▁collage n ▁membran e ▁ , ▁a ▁prote oly tic ▁process ▁perform ed ▁by ▁cell s ▁in ▁the ▁vicini ty ▁of ▁the ▁defect s ▁ .
▁phar yn gola ryn ge al ▁pain ▁tons il lar ▁disorder
▁in ▁part ▁2 ▁ , ▁all ▁patients ▁received ▁i vac af tor ▁as ▁indicate d ▁in ▁part ▁1 ▁for ▁16 ▁additional ▁weeks ▁ .
▁each ▁olan za pine ▁teva ▁20 ▁mg ▁film - co ated ▁tablet ▁contain s ▁20 ▁mg ▁of ▁the ▁active ▁substance ▁ .
▁from ▁a ▁micro bi ological ▁point ▁of ▁view ▁ , ▁immediate ▁use ▁is ▁recommended ▁ .
▁there ▁have ▁also ▁been ▁reports ▁of ▁per i pher al ▁oed ema ▁ , ▁increase ▁in ▁blood ▁creati nine ▁and ▁severe ▁cu tane ous ▁advers e ▁reaction s ▁( ▁scar s ▁) ▁including ▁ toxic ▁epi der mal ▁nec rol ysis ▁( ▁ten ▁) ▁and ▁oral ▁mu co sal ▁reaction s ▁ .
▁to ▁calcula te ▁the ▁dose ▁of ▁ve drop ▁to ▁be ▁ad minister ed ▁ , ▁divide ▁the ▁pre scribe d ▁dose ▁of ▁d - al pha - to co pher ol ▁( ▁in ▁mg ▁) ▁by ▁50 ▁ .
▁if ▁you ▁are ▁taking ▁any ▁of ▁these ▁ , ▁ask ▁your ▁doctor ▁for ▁advice ▁ .
▁experimental ▁studies ▁of ▁the ▁ex cip ient ▁l - pro line ▁carried ▁out ▁in ▁animals ▁found ▁no ▁direct ▁or ▁indirect ▁ toxic ity ▁affect ing ▁pre gna ncy ▁ , ▁em bry onal ▁or ▁fo e tal ▁development ▁ .
▁plasma ▁h c v - rna ▁is ▁measure d ▁with ▁a ▁research - based ▁quantitat ive ▁poly mera se ▁chain ▁reaction ▁as say ▁by ▁a ▁central ▁laborator y
▁olan za pine ▁is ▁not ▁recommended ▁for ▁use ▁in ▁patients ▁with ▁dem entia - related ▁psycho sis ▁and ▁/ ▁or ▁behaviour al ▁disturb ances ▁because ▁of ▁an ▁increase ▁in ▁mortal ity ▁and ▁the ▁risk ▁of ▁cerebro vas cular ▁accident ▁ .
▁by ▁block ing ▁their ▁re - up take ▁ , ▁du lo xe tine ▁increase s ▁the ▁amount ▁of ▁these ▁neuro trans mit ters ▁in ▁the ▁space s ▁between ▁these ▁nerv e ▁cell s ▁ , ▁increasing ▁the ▁level ▁of ▁communication ▁between ▁the ▁cell s ▁ .
▁if ▁you ▁take ▁more ▁lo ju xta ▁than ▁you ▁should
▁for ▁further ▁details ▁ , ▁see ▁the ▁package ▁le a flet ▁ .
▁broken ▁bone s ▁can ▁happen ▁during ▁normal ▁ , ▁everyday ▁activity ▁ , ▁such ▁as ▁ lifting ▁ , ▁or ▁from ▁minor ▁injury ▁that ▁would ▁not ▁generally ▁break ▁normal ▁bone ▁ .
▁detailed ▁information ▁on ▁this ▁veterinar y ▁medicinal ▁product ▁is ▁available ▁on ▁the ▁website ▁of ▁the ▁european ▁medicine s ▁agency ▁http ▁: ▁/ ▁/ ▁www . ema . europa . eu
▁2 ▁vi als ▁of ▁cin ry ze ▁500 ▁unit s ▁powder ▁for ▁solution ▁for ▁inject ion ▁2 ▁vi als ▁of ▁water ▁for ▁inject ions ▁( ▁5 ▁ml ▁each ▁)
▁in ▁patients ▁previously ▁un tre ated ▁with ▁che mo therapy ▁ , ▁t m z ▁is ▁ad minister ed ▁oral ly ▁at ▁a ▁dose ▁of ▁200 ▁mg ▁/ ▁m 2 ▁once ▁daily ▁for ▁the ▁first ▁5 ▁days ▁followed ▁by ▁a ▁23 ▁day ▁treatment ▁interrupt ion ▁( ▁total ▁of ▁28 ▁days ▁) ▁ .
▁any ▁person ▁inte nding ▁to ▁manufacture ▁ , ▁import ▁ , ▁possess ▁ , ▁sell ▁ , ▁supply ▁and ▁/ ▁or ▁use ▁suv ax yn ▁cs f ▁marker ▁vaccin e ▁must ▁consult ▁the ▁relevant ▁member ▁state ▁' s ▁ competent ▁authority ▁on ▁the ▁current ▁vaccin ation ▁policies ▁prior ▁to ▁the ▁manufacture ▁ , ▁import ▁ , ▁possession ▁ , ▁sale ▁ , ▁supply ▁and ▁/ ▁or ▁use ▁ .
▁patients ▁in ▁the ▁study ▁were ▁given ▁del ty ba ▁or ▁place bo ▁( ▁a ▁dum my ▁treatment ▁) ▁for ▁2 ▁months ▁in ▁addition ▁to ▁their ▁other ▁treatment s ▁ .
▁what ▁benefit ▁has ▁previ co x ▁shown ▁during ▁the ▁studies ▁?
▁feeling ▁your ▁heart beat ▁( ▁palp it ations ▁)
▁if ▁you ▁have ▁ki dne y ▁or ▁ liver ▁disease
▁specific ▁precau tions ▁for ▁the ▁disposa l ▁of ▁un used ▁products ▁or ▁was te ▁materials ▁ , ▁if ▁any
▁difficult y ▁control ling ▁your ▁bo wel ▁movement s
▁age ▁( ▁weeks ▁) ▁ , ▁media n ▁[ ▁range ▁]
▁recu vy ra ▁should ▁only ▁be ▁used ▁for ▁major ▁surgery ▁that ▁requires ▁op iate ▁anal gesi a ▁for ▁a ▁du ration ▁of ▁at ▁least ▁4 ▁days ▁ .
▁this ▁is ▁especially ▁important ▁if ▁you ▁take ▁medicine s ▁to ▁treat ▁heart ▁problems ▁or ▁if ▁you ▁are ▁taking ▁any ▁medicine ▁which ▁can ▁cause ▁an ▁ab normal ity ▁on ▁the ▁ec g ▁( ▁electro card i ogram ▁) ▁called ▁increased ▁pr ▁interval ▁including ▁carb amaz e pine ▁ , ▁la mo tri gine ▁ , ▁pre gabal in ▁( ▁medicine s ▁used ▁to ▁treat ▁epi le psy ▁) ▁and ▁medicine s ▁used ▁to ▁treat ▁certain ▁types ▁of ▁irregular ▁heart ▁beat ▁or ▁heart ▁failure ▁ .
▁a ▁24- week ▁study ▁was ▁conduct ed ▁to ▁evaluat e ▁the ▁ef fica cy ▁and ▁safety ▁of ▁sax ag lip tin ▁5 ▁mg ▁in ▁combination ▁with ▁met form in ▁as ▁initial ▁combination ▁ therapy ▁in ▁treatment - na ï ve ▁patients ▁with ▁in adequa te ▁gly ca e mic ▁control ▁( ▁h ba 1 c ▁8 -12 ▁% ▁) ▁ .
▁veg f ▁levels ▁are ▁eleva ted ▁in ▁response ▁causing ▁the ▁le ak age ▁of ▁fluid ▁into ▁the ▁retin a ▁and ▁there by ▁causing ▁ma cular ▁oed ema ▁ .
▁cy top enia s ▁ , ▁including ▁rare ▁severe ▁neutro p enia ▁and ▁ thro mbo cy top enia ▁ , ▁have ▁been ▁observe d ▁in ▁patients ▁treated ▁with ▁ple grid y ▁ .
▁must ▁be ▁ad minister ed ▁by ▁author ised ▁personnel ▁only ▁ .
▁control oc ▁control ▁is ▁not ▁recommended ▁for ▁use ▁in ▁children ▁and ▁adolescents ▁below ▁18 ▁years ▁of ▁age ▁due ▁to ▁in sufficient ▁data ▁on ▁safety ▁and ▁ef fica cy ▁ .
▁marketing ▁author isation ▁holder ▁: ▁vir bac ▁s . a ▁ .
▁the ▁factor ▁vii i ▁/ ▁von ▁will e brand ▁factor ▁( ▁v w f ▁) ▁complex ▁consist s ▁of ▁two ▁mole cules ▁( ▁factor ▁vii i ▁and ▁v w f ▁) ▁with ▁different ▁physio logic al ▁function s ▁ .
▁what ▁rasi lam lo ▁is ▁and ▁what ▁it ▁is ▁used ▁for
▁do ▁not ▁a im ▁the ▁stream ▁at ▁the ▁white ▁powder ▁at ▁the ▁bottom ▁of ▁the ▁vi al ▁ .
▁warm ▁the ▁solve nt ▁vi al ▁to ▁room ▁temperature ▁by ▁gent ly ▁roll ing ▁it ▁between ▁your ▁hands ▁ .
▁line zo lid ▁( ▁a ▁medicine ▁to ▁treat ▁bacteria l ▁infection s ▁) ▁ .
▁cla dri bine ▁is ▁a ▁cy to toxic ▁medicinal ▁product ▁ , ▁which ▁is ▁mu tage nic ▁to ▁culture d ▁mamma lian ▁cell s ▁ .
▁it ▁is ▁recommended ▁that ▁the ▁last ▁dose ▁be ▁given ▁to ▁the ▁child ▁by ▁the ▁age ▁of ▁20 ▁to ▁22 ▁weeks ▁ .
▁common ▁: ▁allergi c ▁reaction s ▁have ▁been ▁reported ▁in ▁the ▁same ▁proportion ▁( ▁1.6 ▁% ▁) ▁of ▁patients ▁treated ▁with ▁des ir udin ▁( ▁n ▁= ▁2 , 367 ▁) ▁or ▁with ▁un fraction ated ▁hep arin ▁( ▁n ▁= ▁1,1 ▁34 ▁) ▁in ▁clinic al ▁trial s ▁ , ▁regardless ▁of ▁causa li ty ▁ .
▁it ▁may ▁har m ▁them ▁ , ▁even ▁if ▁their ▁sign ▁of ▁illness ▁are ▁the ▁same ▁as ▁your s ▁ .
▁to ▁avoid ▁potential ▁incompatibil ities ▁iba ndro nic ▁acid ▁concentrat e ▁for ▁solution ▁for ▁in fusion ▁should ▁only ▁be ▁dilu ted ▁with ▁is oto nic ▁so dium ▁chlor ide ▁solution ▁or ▁5 ▁% ▁gluco se ▁solution ▁ .
▁with ▁a ▁long ▁history ▁of ▁diabetes ▁ ,
▁recovery ▁of ▁the ▁total ▁radio activ ity ▁range d ▁from ▁88 - 94 ▁% ▁of ▁the ▁ad minister ed ▁dose ▁by ▁168 ▁hours ▁post ▁dose ▁ .
▁hyper tension ▁ , ▁or tho static ▁hypo tension ▁ , ▁hypo tension
▁patients ▁should ▁be ▁advise d ▁to ▁take ▁precau tions ▁to ▁avoid ▁hypo gly ca emia ▁while ▁driving ▁ .
▁for ▁the ▁pro phy la xis ▁of ▁shock ▁ , ▁patients ▁should ▁always ▁be ▁maximal ly ▁hydrat ed ▁prior ▁to ▁ , ▁during ▁and ▁after ▁the ▁per fusion ▁procedure ▁ .
▁industrial ▁area ▁a radi ppo u ▁ , ▁7 100 ▁ , ▁ larna ca ▁ , ▁pob ▁40 26 1 ▁ , ▁630 2 ▁ , ▁ larna ca ▁ ,
▁patients ▁being ▁treated ▁with ▁en ta ca pone ▁in ▁association ▁with ▁levo do pa ▁and ▁present ing ▁with ▁som nol ence ▁and ▁/ ▁or ▁sud den ▁sleep ▁ons et ▁episode s ▁must ▁be ▁instru cted ▁to ▁ref rain ▁from ▁driving ▁or ▁enga ging ▁in ▁activities ▁where ▁im pair ed ▁alert ness ▁may ▁put ▁themselves ▁or ▁others ▁at ▁risk ▁of ▁serious ▁injury ▁or ▁death ▁( ▁e . g . ▁operating ▁machines ▁) ▁until ▁such ▁re current ▁episode s ▁have ▁resolve d ▁( ▁see ▁also ▁section ▁4.4 ▁) ▁ .
▁the ▁dose ▁se lector ▁changes ▁the ▁number ▁of ▁unit s ▁ .
▁in ▁psa ▁study ▁2 ▁there ▁was ▁a ▁significant ▁improvement ▁in ▁functional ▁assessment ▁of ▁chronic ▁illness ▁ therapy - fati gue ▁( ▁facit - f ▁) ▁score s ▁in ▁the ▁uste kin um ab ▁groups ▁when ▁compared ▁with ▁place bo ▁at ▁week ▁24 ▁ .
▁then ▁breath e ▁out ▁gent ly ▁( ▁do ▁not ▁breath e ▁out ▁through ▁the ▁in hal er ▁) ▁ .
▁before ▁use ▁ , ▁leave ▁the ▁sy ringe ▁to ▁stand ▁until ▁it ▁reach es ▁room ▁temperature ▁ .
▁il d - like ▁advers e ▁reaction s ▁were ▁reported ▁in ▁ 0.7 ▁% ▁of ▁patients ▁treated ▁with ▁gi ot rif ▁across ▁all ▁clinic al ▁trial s ▁( ▁including ▁0.5 ▁% ▁of ▁patients ▁with ▁ct ca e ▁grade ▁ ≥ ▁3 ▁il d - like ▁advers e ▁reaction s ▁) ▁ .
▁severe ▁cu tane ous ▁and ▁hyper sensitiv ity ▁reaction s
▁the ▁european ▁commission ▁gran ted ▁a ▁marketing ▁author isation ▁valid ▁throughout ▁the ▁european ▁union ▁for ▁vist ide ▁on ▁23 ▁april ▁1997 ▁ .
▁after ▁recon stitu tion ▁ , ▁each ▁vi al ▁contain s ▁5 ▁mg ▁of ▁te du glut ide ▁in ▁0.5 ▁ml ▁of ▁solution ▁ , ▁correspond ing ▁to ▁a ▁concentration ▁of ▁10 ▁mg ▁/ ▁ml ▁ .
▁the ▁active ▁substance ▁is ▁pi og lita zone ▁ .
▁insulin ▁does ▁cross ▁the ▁place n tal ▁barrier ▁ , ▁although ▁not ▁in ▁clinic ally ▁significant ▁amount ▁ .
▁the ▁significa nce ▁of ▁this ▁finding ▁is ▁being ▁further ▁monitor ed ▁ .
▁content s ▁of ▁the ▁pack ▁and ▁other ▁information ▁what ▁epi vir ▁contain s
▁therefore ▁the ▁data ▁indicate ▁that ▁a flu nov ▁may ▁be ▁co - ad minister ed ▁with ▁non - ad ju vante d ▁season al ▁influenza ▁vaccin es ▁( ▁with ▁inject ions ▁made ▁into ▁opposite ▁lim bs ▁) ▁ .
▁method ▁and ▁route ▁( ▁s ▁) ▁of ▁administration
▁flu ra lan er ▁is ▁an ▁a cari cide ▁and ▁insect ici de ▁ .
▁what ▁measure s ▁are ▁being ▁taken ▁to ▁ensure ▁the ▁safe ▁and ▁effective ▁use ▁of ▁bo su lif ▁?
▁tel ▁: ▁+ ▁31- ▁( ▁0 ▁) ▁ 297 -28 ▁06 ▁66
▁single ▁dose ▁studies ▁demonstrat e ▁linear ity ▁of ▁ pharma cok ine tics ▁in ▁the ▁ therapeut ic ▁dose ▁range ▁ .
▁the ▁combination ▁of ▁inf lec tra ▁and ▁a bata cept ▁is ▁not ▁recommended ▁ .
▁like ▁all ▁medicine s ▁ , ▁clo pido gre l ▁sand oz ▁can ▁cause ▁side ▁effects ▁ , ▁although ▁not ▁everybody ▁gets ▁them ▁ .
▁ac tel sar ▁h ct ▁is ▁a ▁combination ▁of ▁two ▁active ▁substance s ▁ , ▁tel mis ar tan ▁and ▁hydro ch lor o thi azi de ▁in ▁one ▁tablet ▁ .
▁hy cam tin ▁capsule s ▁should ▁only ▁be ▁pre scribe d ▁and ▁ therapy ▁super vis ed ▁by ▁a ▁physician ▁experienced ▁in ▁the ▁use ▁of ▁che mo therapeut ic ▁agents ▁ .
▁other ▁information ▁about ▁a pti vus ▁:
▁on ▁its ▁own ▁ , ▁in ▁patients ▁who ▁are ▁not ▁satisfac tori ly ▁control led ▁on ▁die t ▁and ▁exercise ▁and ▁in ▁whom ▁met form in ▁( ▁a ▁diabetes ▁medicine ▁) ▁is ▁not ▁suitable ▁; ▁in ▁combination ▁with ▁met form in ▁or ▁a ▁ ppar - gam ma ▁ago nist ▁( ▁a ▁type ▁of ▁diabetes ▁medicine ▁) ▁such ▁as ▁a ▁thi azo li dine dio ne ▁ , ▁in ▁patients ▁who ▁are ▁not ▁satisfac tori ly ▁control led ▁on ▁met form in ▁or ▁the ▁ ppar - ▁gamma ▁ago nist ▁used ▁on ▁its ▁own ▁;
▁as ▁in ▁adult ▁patients ▁ , ▁children ▁and ▁adolescents ▁also ▁experienced ▁other ▁psychiatr ic ▁advers e ▁events ▁( ▁e . g . ▁ , ▁depression ▁ , ▁emotional ▁la bility ▁ , ▁and ▁som nol ence ▁) ▁( ▁see ▁section ▁4.4 ▁) ▁ .
▁in van z ▁is ▁used ▁when ▁the ▁bacteria ▁that ▁cause ▁the ▁infection ▁are ▁likely ▁to ▁be ▁killed ▁by ▁the ▁antibiotic ▁ .
▁it ▁may ▁be ▁needed ▁that ▁your ▁baby ▁' s ▁doctor ▁decide s ▁to ▁check ▁the ▁levels ▁of ▁ca ffe ine ▁in ▁a ▁blood ▁test ▁period ically ▁throughout ▁treatment ▁to ▁avoid ▁ toxic ity ▁ .
▁each ▁carton ▁contain s ▁one ▁sa chet ▁ .
▁the ▁ch mp ▁also ▁considered ▁the ▁use ▁of ▁gal vus ▁on ▁its ▁own ▁and ▁conclude d ▁that ▁it ▁was ▁effective ▁in ▁ reducing ▁blood ▁gluco se ▁but ▁less ▁so ▁than ▁met form in ▁ .
▁fa tty ▁tissu e ▁under ▁the ▁skin ▁may ▁sh rink ▁( ▁lipo a trop hy ▁) ▁or ▁get ▁thi cker ▁( ▁lipo hy per trop hy ▁) ▁ .
▁treatment ▁of ▁over dos e ▁with ▁el vite grav ir ▁consist s ▁of ▁general ▁support ive ▁measure s ▁including ▁monitoring ▁of ▁vital ▁sign s ▁as ▁well ▁as ▁observation ▁of ▁the ▁clinic al ▁status ▁of ▁the ▁patient ▁ .
▁clo fara bine ▁is ▁one ▁of ▁a ▁family ▁of ▁medicine s ▁called ▁anti cancer ▁medicine s ▁ .
▁further ▁information ▁concern ing ▁the ▁effect ▁on ▁fertil ity ▁of ▁the ▁use ▁of ▁64 cu - label led ▁medicinal ▁products ▁is ▁specifi ed ▁in ▁the ▁summary ▁of ▁product ▁character istic s ▁of ▁the ▁medicinal ▁product ▁to ▁be ▁radio label led ▁ .
▁if ▁you ▁are ▁un certa in ▁whether ▁any ▁of ▁the ▁conditions ▁above ▁apply ▁to ▁you ▁ , ▁talk ▁to ▁your ▁doctor ▁ , ▁ pharma ci st ▁or ▁nurse ▁before ▁taking ▁im no vid ▁ .
▁in ▁case ▁of ▁the ▁accident al ▁in gestion ▁by ▁a ▁dog ▁of ▁many ▁card alis ▁che w able ▁tablets ▁ , ▁there ▁is ▁no ▁specific ▁anti do te ▁or ▁treatment ▁ .
▁mer ck le ▁g m bh ▁ , ▁lud wig - mer ck le - stra sse ▁3 ▁ , ▁89 143 ▁blau be uren ▁ , ▁german y ▁teva ▁ pharma ▁b . v . ▁ , ▁s wens weg ▁5 ▁ , ▁20 31 ▁ga ▁haar lem ▁ , ▁the ▁ne ther lands
▁in ▁another ▁long - term ▁26- week ▁control led ▁trial ▁ , ▁the ▁incide nce ▁of ▁e ps ▁was ▁14. 8 ▁% ▁for ▁ar ipi pra zole - tre ated ▁patients ▁and ▁15. 1 ▁% ▁for ▁olan za pine - tre ated ▁patients ▁ .
▁orang e ▁marked ▁" ▁p fiz er ▁" ▁on ▁the ▁cap ▁and ▁" ▁p g n ▁100 ▁" ▁on ▁the ▁body ▁with ▁black ▁in k ▁ .
▁total ▁fixed ▁ flex ion ▁contract ure ▁and ▁range ▁of ▁motion ▁following ▁administration ▁of ▁two ▁concurrent ▁inject ions ▁of ▁xi ap ex ▁0.5 8 ▁mg ▁in ▁the ▁same ▁hand ▁ , ▁mitt ▁population ▁ , ▁study ▁aux - ▁ cc - 867 ▁( ▁first ▁treatment ▁cycle ▁)
▁one ▁pre - fill ed ▁sy ringe ▁contain s ▁75 ▁micro gram s ▁of ▁met h oxy ▁poly e thy lene ▁gly col - e po etin ▁beta ▁* ▁at ▁a ▁concentration ▁of ▁250 ▁micro gram s ▁/ ▁ml ▁ .
▁in ▁rat s ▁ , ▁minimal ▁to ▁mild ▁decrease s ▁in ▁er y thro cy te ▁parameter s ▁were ▁ac com pani ed ▁by ▁bone ▁mar row ▁changes ▁; ▁similar ▁changes ▁occur red ▁in ▁mon key s ▁at ▁a ▁lower ▁incide nce ▁ .
▁store ▁and ▁transport ▁refrigera ted ▁( ▁2 ▁° ▁c ▁- ▁8 ▁° ▁c ▁) ▁ .
▁bra vec to ▁11 2.5 ▁mg ▁spot - on ▁solution ▁for ▁very ▁small ▁dog s ▁( ▁2- 4.5 ▁kg ▁) ▁bra vec to ▁250 ▁mg ▁spot - on ▁solution ▁for ▁small ▁dog s ▁( ▁> ▁4.5 ▁- ▁10 ▁kg ▁) ▁bra vec to ▁500 ▁mg ▁spot - on ▁solution ▁for ▁medium - s ized ▁dog s ▁( ▁> ▁10 ▁- ▁20 ▁kg ▁) ▁bra vec to ▁1000 ▁mg ▁spot - on ▁solution ▁for ▁large ▁dog s ▁( ▁> ▁20 ▁- ▁40 ▁kg ▁) ▁bra vec to ▁1400 ▁mg ▁spot - on ▁solution ▁for ▁very ▁large ▁dog s ▁( ▁> ▁40 ▁- ▁56 ▁kg ▁) ▁flu ra lan er
▁the ▁media n ▁exposure ▁to ▁the ▁treatment ▁up ▁to ▁the ▁cut - off ▁date ▁of ▁the ▁primary ▁ef fica cy ▁and ▁safety ▁analysis ▁was ▁10. 37 ▁months ▁( ▁0.0 3-3 7.8 ▁) ▁ , ▁with ▁66 . 0 ▁% ▁of ▁patients ▁having ▁at ▁least ▁six ▁months ▁' ▁exposure ▁ .
▁severe ▁renal ▁and ▁/ ▁or ▁he pati c ▁im pair ment ▁ .
▁some ▁cases ▁of ▁spl en ic ▁rup ture ▁were ▁fatal ▁ .
▁p b pc ▁mobil isation ▁should ▁be ▁considered ▁only ▁in ▁donor s ▁who ▁meet ▁normal ▁clinic al ▁and ▁laborator y ▁e ligi bility ▁criteri a ▁for ▁stem ▁cell ▁donation ▁with ▁special ▁attention ▁to ▁ha e mat ological ▁values ▁and ▁infect i ous ▁disease ▁ .
▁in ▁a ▁recent ▁clinic al ▁study ▁with ▁a ▁prevale nce ▁of ▁malign an cy ▁of ▁49 ▁% ▁ , ▁the ▁positive ▁predict ive ▁value ▁for ▁neo spec t ▁in ▁association ▁with ▁ct ▁/ ▁che st ▁x - ray ▁was ▁84 ▁% ▁( ▁ci ▁6 3.1 - 94 . 7 ▁% ▁) ▁for ▁all ▁sp ns ▁and ▁8 1.8 ▁% ▁for ▁les ions ▁equal ▁to ▁or ▁less ▁than ▁3 cm ▁ .
▁e can sya ▁500 ▁mg ▁tablets ▁cap e cita bine
▁if ▁you ▁are ▁already ▁taking ▁rif abu tin ▁ , ▁you ▁will ▁need ▁a ▁blood ▁test ▁and ▁you ▁will ▁need ▁to ▁look ▁out ▁for ▁some ▁possible ▁side ▁effects ▁of ▁rif abu tin ▁ .
▁the ▁levels ▁of ▁si rol imus ▁in ▁the ▁patient ▁' s ▁blood ▁should ▁be ▁monitor ed ▁ , ▁and ▁the ▁dose ▁of ▁rap am une ▁should ▁be ▁adjust ed ▁to ▁obtain ▁the ▁appropriate ▁levels ▁of ▁si rol imus ▁( ▁4 ▁to
▁single - pack s ▁( ▁perfor ated ▁unit ▁dose ▁bli ster ▁) ▁contain ing ▁56 ▁x ▁1 ▁tablets ▁ .
▁60 ▁x ▁1 ▁capsule s
▁if ▁a ▁patient ▁wish es ▁to ▁become ▁pregnant ▁ , ▁or ▁pre gna ncy ▁occur s ▁ , ▁treatment ▁with ▁vi cto za ▁should ▁be ▁dis continu ed ▁ .
▁flu enz ▁is ▁not ▁recommended ▁for ▁women ▁who ▁are ▁pregnant ▁or ▁are ▁breast - feed ing ▁ .
▁rota rix ▁should ▁never ▁be ▁inject ed ▁under ▁any ▁circumstances ▁ .
▁because ▁these ▁reaction s ▁were ▁deri ved ▁from ▁spontane ous ▁reports ▁ , ▁the ▁fre que ncies ▁could ▁not ▁be ▁determine d ▁and ▁are ▁thu s ▁considered ▁as ▁not ▁known ▁ .
▁because ▁v izar sin ▁is ▁a ▁generic ▁medicine ▁ , ▁studies ▁in ▁patients ▁have ▁been ▁limited ▁to ▁tests ▁to ▁determine ▁that ▁it ▁is ▁bio e qui valent ▁to ▁the ▁reference ▁medicine ▁ , ▁viagra ▁ .
▁uc b ▁ pharma ▁( ▁produtos ▁farma cê u ticos ▁) ▁ , ▁l da ▁tel ▁: ▁+ ▁ 351 -21 ▁302 ▁5 300
▁female ▁rat s ▁receiving ▁du lo xe tine ▁before ▁and ▁during ▁ma ting ▁and ▁early ▁pre gna ncy ▁had ▁a ▁decrease ▁in ▁matern al ▁food ▁consum p tion ▁and ▁body ▁weight ▁ , ▁o estro us ▁cycle ▁disrupt ion ▁ , ▁decrease d ▁live ▁birth ▁indice s ▁and ▁pro gen y ▁survival ▁ , ▁and ▁pro gen y ▁growth ▁retard ation ▁at ▁system ic ▁exposure ▁levels ▁estima ted ▁to ▁be ▁at ▁the ▁most ▁at ▁maximum ▁clinic al ▁exposure ▁( ▁au c ▁) ▁ .
▁dose ▁modification s ▁were ▁required ▁in ▁30 ▁% ▁of ▁patients ▁ , ▁most ▁common ly ▁for ▁ana emia ▁and ▁neutro p enia ▁ .
▁ra lte grav ir ▁at ▁concentration s ▁of ▁31 ▁20 ▁n m ▁result ed ▁in ▁95 ▁% ▁inhibi tion ▁( ▁ ic 95 ▁) ▁of ▁hi v -1 ▁re plication ▁( ▁relative ▁to ▁an ▁un tre ated ▁virus - infect ed ▁culture ▁) ▁in ▁human ▁t - ly m pho id ▁cell ▁culture s ▁infect ed ▁with ▁the ▁cell - line ▁adapt ed ▁hi v -1 ▁variant ▁h 9 ii ib ▁ .
▁when ▁the ▁sub mission ▁of ▁a ▁p sur ▁and ▁the ▁update ▁of ▁a ▁r mp ▁coincid e ▁ , ▁they ▁should ▁be ▁submitted ▁at ▁the ▁same ▁time ▁ .
▁if ▁the ▁vi als ▁are ▁store d ▁under ▁refrigera tion ▁ , ▁allow ▁the ▁required ▁number ▁of ▁box es ▁of ▁tax o tere ▁concentrat e ▁for ▁solution ▁for ▁in fusion ▁to ▁stand ▁below ▁25 ▁° ▁c ▁for ▁5 ▁minutes ▁before ▁use ▁ .
▁in ▁the ▁additional ▁study ▁ , ▁radio label led ▁ze val in ▁brought ▁about ▁a ▁response ▁in ▁about ▁half ▁of ▁the ▁patients ▁ .
▁the ▁suspens ion ▁should ▁be ▁given ▁using ▁the ▁me as uring ▁sy ringe ▁provided ▁in ▁the ▁package ▁ .
▁geno type ▁1 ▁l vl ▁with ▁r vr ▁*
▁hormonal ▁contra cep tives ▁cannot ▁be ▁the ▁sole ▁method ▁of ▁contra ception ▁during ▁treatment ▁with ▁stay ve er
▁all ▁patients ▁achieve d ▁complete ▁ha e mat ological ▁response ▁ , ▁cy to gene tic ▁response ▁and ▁/ ▁or ▁clinic al ▁response ▁ .
▁other ▁medicine s ▁and ▁in fan rix ▁he xa
▁remove ▁the ▁protect ive ▁she ath ▁from ▁the ▁other ▁end ▁of ▁the ▁transfer ▁need le ▁ .
▁this ▁usually ▁requires ▁mix ing ▁the ▁powder ▁and ▁the ▁gel ▁for ▁1 ▁to ▁2 ▁minutes ▁ .
▁c . ▁after ▁the ▁second ▁" ▁click ▁" ▁( ▁or ▁count ▁of ▁15 ▁) ▁lift ▁pre - fill ed ▁pen ▁from ▁the ▁inject ion ▁site ▁ .
▁then ▁hold ▁the ▁sy ringe ▁vertical ly ▁and ▁the ▁need le ▁up ward s ▁ , ▁and ▁gent ly ▁push ▁the ▁plu nger ▁up ward s ▁ .
▁wollen ▁g lands ▁in ▁the ▁ne ck ▁ , ▁arm pit ▁or ▁gro in ▁( ▁lymph ade no pathy ▁) ▁flu - like ▁symptoms ▁ , ▁such ▁as ▁high ▁temperature ▁ , ▁sore ▁ thro at ▁ , ▁run ny ▁nos e ▁ , ▁co ugh ▁and ▁chill s
▁each ▁capsule ▁contain s ▁2 ▁mg ▁niti sin one ▁each ▁capsule ▁contain s ▁5 ▁mg ▁niti sin one ▁each ▁capsule ▁contain s ▁10 ▁mg ▁niti sin one ▁each ▁capsule ▁contain s ▁20 ▁mg ▁niti sin one
▁do ▁not ▁stop ▁taking ▁prezi sta ▁without ▁talking ▁to ▁your ▁doctor ▁first
▁you ▁should ▁not ▁eat ▁anything ▁for ▁at ▁least ▁2 ▁hours ▁before ▁taking ▁come t riq ▁and ▁for ▁1 ▁hour ▁after ▁taking ▁the ▁medicine ▁ .
▁do ▁not ▁filter ▁the ▁suspens ion ▁after ▁recon stitu tion ▁since ▁this ▁could ▁remove ▁the ▁active ▁substance ▁ .
▁oy ▁eli ▁li lly ▁finland ▁ab ▁puh ▁/ ▁tel ▁: ▁+ ▁ 358 ▁( ▁0 ▁) ▁9 ▁85 45 250
▁clinic al ▁sign s ▁including ▁vom i ting ▁on ▁first ▁administration ▁ , ▁excess ▁sa liv ation ▁and ▁water y ▁fa e ces ▁have ▁been ▁observe d ▁when ▁the ▁product ▁has ▁been ▁ad minister ed ▁at ▁dos es ▁in ▁excess ▁of ▁20 ▁mg ▁/ ▁kg ▁ .
▁in ▁two ▁further ▁studies ▁ , ▁three ▁different ▁dos es ▁of ▁revi nty ▁el lip ta ▁were ▁compared ▁with ▁vil ante rol ▁on ▁its ▁own ▁; ▁the ▁main ▁measure ▁of ▁effective ness ▁was ▁the ▁re duction ▁in ▁the ▁number ▁of ▁moderat e ▁and ▁severe ▁fl are - ups ▁cop d ▁patients ▁experienced ▁during ▁52 ▁weeks ▁( ▁one ▁year ▁) ▁of ▁treatment ▁ .
▁in ▁clinic al ▁trial s ▁ , ▁the ▁most ▁common ▁advers e ▁reaction s ▁were ▁blu r red ▁vision ▁ , ▁eye ▁irrita tion ▁and ▁eye ▁pain ▁ , ▁occur ring ▁in ▁approximately ▁2 ▁% ▁to ▁7 ▁% ▁patients ▁ .
▁imi qui mod ▁has ▁not ▁been ▁evaluat ed ▁for ▁the ▁treatment ▁of ▁bas al ▁cell ▁car cino ma ▁within ▁1 ▁cm ▁of ▁the ▁eye lid s ▁ , ▁nos e ▁ , ▁lips ▁or ▁hair line ▁ .
▁this ▁helps ▁prevent ▁contamina tion ▁and ▁/ ▁or ▁infection ▁ , ▁entry ▁of ▁air ▁into ▁the ▁insulin ▁reserv oir ▁and ▁le ak age ▁of ▁insulin ▁ .
▁reduc tions ▁in ▁ha emo glob in ▁ , ▁white ▁blood ▁cell ▁count ▁ , ▁absolute ▁neutro phil s ▁and ▁plate let s ▁have ▁been ▁observe d ▁in ▁clinic al ▁trial s ▁investiga ting ▁the ▁use ▁of ▁imi qui mod ▁5 ▁% ▁cream ▁ .
▁clo pido gre l ▁a cino ▁contain s ▁clo pido gre l ▁and ▁be long s ▁to ▁a ▁group ▁of ▁medicine s ▁called ▁anti plate let ▁medicinal ▁products ▁ .
▁what ▁is ▁kar ve a ▁used ▁for ▁?
▁supr elor in ▁4. 7 ▁mg ▁implant ▁for ▁dog s
▁en dos co pic ▁studies ▁of ▁intestinal ▁mu cosa ▁have ▁shown ▁evidence ▁of ▁mu co sal ▁hea ling ▁in ▁in flix ima b - tre ated ▁patients ▁ .
▁this ▁summary ▁was ▁last ▁updated ▁in ▁december ▁2013 ▁ .
▁do ▁not ▁store ▁recon stitu ted ▁novos even ▁in ▁plastic ▁sy ring es ▁ .
▁card board ▁box ▁with ▁1 ▁colour less ▁ , ▁type ▁i ▁glass ▁inject ion ▁vi al ▁of ▁50 ▁ml ▁ , ▁100 ▁ml ▁and ▁250 ▁ml ▁closed ▁with ▁a ▁bro mo but yl ▁rub ber ▁stopper ▁and ▁seal ed ▁with ▁an ▁aluminium ▁cap ▁ .
▁very ▁common ▁reaction s ▁( ▁may ▁affect ▁more ▁than ▁1 ▁in ▁10 ▁people ▁)
▁thu s ▁ , ▁free ▁( ▁un bound ▁) ▁pi og lita zone ▁concentration ▁is ▁un change d ▁( ▁see ▁section ▁4.2 ▁) ▁ .
▁multi dos e ▁presentation s ▁must ▁be ▁for ▁individual ▁patient ▁use ▁only ▁ .
▁it ▁is ▁also ▁not ▁recommended ▁for ▁people ▁under ▁18 ▁years ▁with ▁low ▁plate let ▁count s ▁due ▁to ▁hepatitis ▁c ▁or ▁severe ▁a plast ic ▁ana emia ▁ .
▁syn co pe ▁ , ▁convuls ion ▁ , ▁age usia ▁ , ▁sleep ▁phase ▁ rhythm ▁disturb ance
▁animal ▁studies ▁do ▁not ▁indicate ▁direct ▁or ▁indirect ▁har m ful ▁effects ▁with ▁respect ▁to ▁pre gna ncy ▁ , ▁em bry onal ▁/ ▁fo e tal ▁development ▁ , ▁part uri tion ▁or ▁post na tal ▁development ▁( ▁see ▁section ▁5.3 ▁) ▁ .
▁following ▁oral ▁ab sor p tion ▁ , ▁pe ak ▁plasma ▁concentration s ▁of ▁ali ski ren ▁are ▁reached ▁after ▁1-3 ▁hours ▁ .
▁patients ▁should ▁inform ▁physician s ▁and ▁dentist s ▁that ▁they ▁are ▁taking ▁clo pido gre l ▁/ ▁a ce tyl sali cy lic ▁acid ▁zen tiva ▁before ▁any ▁surgery ▁is ▁schedule d ▁and ▁before ▁any ▁new ▁medicinal ▁product ▁is ▁taken ▁ .
▁insu man ▁rapid ▁is ▁suppli ed ▁in ▁cart ridge s ▁contain ing ▁3 ▁ml ▁solution ▁( ▁300 ▁iu ▁) ▁ .
▁common ▁side ▁effects ▁( ▁may ▁affect ▁up ▁to ▁1 ▁in ▁10 ▁people ▁) ▁:
▁it ▁can ▁be ▁given ▁once ▁or ▁twice ▁a ▁day ▁ , ▁with ▁or ▁without ▁a ▁fast - ac ting ▁insulin ▁( ▁given ▁at ▁meal ▁times ▁) ▁ , ▁according ▁to ▁the ▁doctor ▁' s ▁recommend ation ▁ .
▁it ▁is ▁recommended ▁to ▁res us pen d ▁the ▁insulin ▁as ▁instru cted ▁every ▁time ▁you ▁use ▁a ▁new ▁novom ix ▁50 ▁pen fill ▁ .
▁the ▁use ▁of ▁medicinal ▁products ▁called ▁aman ta dine ▁( ▁for ▁the ▁treatment ▁of ▁par kin son ▁' s ▁disease ▁) ▁ , ▁ke tamine ▁( ▁a ▁substance ▁generally ▁used ▁as ▁an ▁ana e sthetic ▁) ▁ , ▁de x tro met hor phan ▁( ▁generally ▁used ▁to ▁treat ▁co ugh ▁) ▁and ▁other ▁n mda - anta gon ists ▁at ▁the ▁same ▁time ▁should ▁be ▁avoid ed ▁ .
▁the ▁surge on ▁will ▁also ▁use ▁a ▁machine ▁that ▁find s ▁the ▁99 m t c ▁part ▁of ▁the ▁medicine ▁ .
▁if ▁you ▁have ▁been ▁told ▁by ▁your ▁doctor ▁that ▁the ▁child ▁being ▁vaccin ated ▁has ▁an ▁in tolerance ▁to ▁some ▁sugar s ▁ , ▁contact ▁your ▁doctor ▁before ▁receiving ▁this ▁vaccin e ▁ .
▁store ▁in ▁a ▁refrigera tor ▁ .
▁hospital isation ▁is ▁advise d ▁and ▁general ▁support ive ▁measure s ▁should ▁be ▁ employed ▁with ▁immediate ▁gas tric ▁lava ge ▁and ▁repeat ed ▁dos es ▁of ▁char co al ▁over ▁time ▁ .
▁duk oral ▁is ▁a ▁vaccin e ▁that ▁is ▁given ▁by ▁mouth ▁ .
▁other ▁medicine s ▁and ▁e vice l
▁children ▁a ged ▁2 ▁to ▁5 ▁years ▁should ▁receive ▁one ▁inject ion ▁ .
▁you ▁may ▁notice ▁a ▁small ▁air ▁bu bble ▁in ▁the ▁pre - fill ed ▁sy ringe ▁ .
▁ef fica cy ▁of ▁prote los ▁to ▁reduce ▁the ▁risk ▁of ▁new ▁verte bral ▁fra c ture ▁was ▁confirm ed ▁in ▁the ▁trop os ▁study ▁ , ▁including ▁for ▁osteo poro tic ▁patients ▁without ▁fragil ity ▁fra c ture ▁at ▁base line ▁ .
▁decrease d ▁renal ▁function ▁in ▁el der ly ▁patients ▁is ▁frequent ▁and ▁as ym pto matic ▁ .
▁this ▁le a flet ▁was ▁last ▁revi sed ▁in ▁{ ▁month ▁y yy y ▁} ▁ .
▁compared ▁with ▁patients ▁who ▁did ▁not ▁develop ▁anti bo dies ▁ , ▁no ▁relationship ▁between ▁the ▁presence ▁of ▁anti - pani tum um ab ▁anti bo dies ▁and ▁ pharma cok ine tics ▁ , ▁ef fica cy ▁and ▁safety ▁has ▁been ▁observe d ▁ .
▁it ▁is ▁recommended ▁that ▁the ▁patient ▁sit ▁or ▁stand ▁in ▁up right ▁position ▁when ▁administrat ing ▁instan yl ▁ .
▁the ▁tablet ▁film ▁coa ting ▁contain s ▁: ▁poly ▁( ▁vinyl ▁alcohol ▁) ▁ , ▁macro gol ▁3 350 ▁ , ▁tal c ▁( ▁e 553 b ▁) ▁ , ▁titan ium ▁ dioxid e ▁( ▁e 171 ▁) ▁ , ▁red ▁ir on ▁oxid e ▁( ▁e 172 ▁) ▁ , ▁and ▁yellow ▁ir on ▁oxid e ▁( ▁e 172 ▁) ▁ .
▁based ▁on ▁the ore tical ▁consideration s ▁ , ▁co - administration ▁of ▁tip rana vir ▁with ▁low ▁dose ▁rito na vir ▁and ▁al fuz os in ▁results ▁in ▁increased ▁al fuz os in ▁concentration s ▁and ▁may ▁result ▁in ▁hypo tension ▁ .
▁con bri za ▁has ▁minor ▁influence ▁on ▁the ▁ability ▁to ▁drive ▁and ▁use ▁machines ▁ .
▁exe lon ▁6. 0 ▁mg ▁hard ▁capsule s
▁using ▁a ▁sy ringe ▁fitte d ▁with ▁a ▁need le ▁ , ▁a sept ically ▁withdraw ▁1.5 ▁ml ▁of ▁steril e ▁water ▁for ▁inject ion ▁ .
▁table ▁1 ▁: ▁unde sir able ▁effects ▁reported ▁with ▁intra ven ous ▁her cept in ▁mono therapy ▁or ▁in ▁combination ▁with ▁che mo therapy ▁in ▁pivo tal ▁clinic al ▁trial s ▁( ▁n ▁= ▁8 386 ▁) ▁and ▁in ▁post - marketing
▁ toxic ity ▁studies ▁in ▁young ▁animals ▁ , ▁treated ▁from ▁four ▁days ▁of ▁age ▁ , ▁result ed ▁in ▁high ▁mortal ity ▁in ▁both ▁the ▁control ▁animals ▁and ▁those ▁receiving ▁amp rena vir ▁ .
▁each ▁xe pli on ▁100 ▁mg ▁pre - fill ed ▁sy ringe ▁contain s ▁156 ▁mg ▁pali peri done ▁palm itate ▁ .
▁increased ▁plasma ▁ben zo dia ze pine ▁levels ▁may ▁occur ▁via ▁decrease d ▁he pati c ▁metabolism ▁leading ▁to ▁excessive ▁sed ation ▁ .
▁rapid ▁squirt ing ▁into ▁the ▁mouth ▁may ▁cause ▁cho king ▁ .
▁figure ▁3 ▁: ▁ka plan - me ier ▁cur ves ▁of ▁overall ▁survival
▁in ▁the ▁body ▁ , ▁f sh ▁stimula tes ▁the ▁production ▁of ▁egg s ▁ , ▁and ▁l h ▁stimula tes ▁their ▁release ▁ .
▁tell ▁your ▁doctor ▁immediately ▁if ▁you ▁are ▁pregnant ▁or ▁if ▁you ▁are ▁breast - feed ing ▁ .
▁ nl -36 41 ▁ rt ▁mij d recht ▁tel ▁: ▁+ ▁31 ▁ 297 ▁280 ▁ 666
▁have ▁been ▁treated ▁in ▁the ▁past ▁with ▁che mo therapie s ▁or ▁general ▁medication s ▁that ▁have ▁a ▁high ▁risk ▁of ▁causing ▁heart ▁damage ▁ , ▁your ▁doctor ▁may ▁wish ▁to ▁monitor ▁your ▁cardiac ▁function ▁( ▁ec g ▁ , ▁heart ▁rate ▁ , ▁body ▁weight ▁) ▁while ▁receiving ▁mab camp ath ▁ .
▁following ▁a ▁suspect ed ▁recent ▁over dos e ▁ , ▁empty ing ▁the ▁stomach ▁by ▁gas tric ▁lava ge ▁or ▁by ▁in duction ▁of ▁e mesi s ▁may ▁be ▁indicate d ▁with ▁the ▁usual ▁precau tions ▁to ▁protect ▁the ▁air way ▁ .
▁animal ▁studies ▁do ▁not ▁indicate ▁har m ful ▁effects ▁with ▁respect ▁to ▁fo e tal ▁development ▁ .
▁each ▁tablet ▁contain s ▁75 ▁mg ▁of ▁clo pido gre l ▁( ▁as ▁hydro gen ▁sul pha te ▁) ▁ .
▁ex cip ient ▁with ▁known ▁effect ▁: ▁a ▁600 ▁mg ▁dose ▁( ▁30 ▁ml ▁) ▁of ▁oral ▁solution ▁contain s ▁approximately ▁47 ▁mg ▁so dium ▁ .
▁although ▁no ▁interaction ▁during ▁con com i tant ▁administration ▁of ▁ phen pro cou mon ▁or ▁war far in ▁has ▁been ▁observe d ▁in ▁clinic al ▁ pharma cok ine tic ▁studies ▁ , ▁a ▁few ▁isola ted ▁cases ▁of ▁changes ▁in ▁international
▁using ▁the ▁oral ▁sy ringe ▁ , ▁first ▁withdraw ▁5 ▁ml ▁and ▁empty ▁content s ▁of ▁sy ringe ▁directly ▁into ▁the ▁mouth ▁ , ▁then ▁re fill ▁the ▁oral ▁sy ringe ▁with ▁2.5 ▁ml ▁and ▁empty ▁the ▁remain ing ▁content s ▁into ▁the ▁mouth ▁ . ▁]
▁bre e lib ▁is ▁a ▁small ▁hand held ▁ , ▁battery - power ed ▁ , ▁breath ▁activa ted ▁ , ▁vibra ting ▁me sh ▁technology ▁system ▁ .
▁ste ven s - joh n son ▁syndrome 6 ▁ang io - ne uro tic ▁oed ema 6
▁the ▁ pharma cok ine tic ▁parameter s ▁of ▁the ▁prote ase ▁inhibi tors ▁presente d ▁in ▁table ▁2 ▁were ▁assess ed ▁in ▁the ▁presence ▁of ▁rito na vir ▁ .
▁har m less ▁redd ish - brow n ▁disco lou ration ▁of ▁urin e
▁gli me piri de ▁has ▁been ▁available ▁in ▁the ▁eu ▁since ▁1995 ▁ .
▁eu ▁/ ▁1 ▁/ ▁97 ▁/ ▁04 9 ▁/ ▁0 26 ▁- ▁14 ▁tablets
▁this ▁is ▁based ▁on ▁your ▁size ▁( ▁height ▁and ▁weight ▁) ▁and ▁if ▁you ▁have ▁a ▁re current ▁tum our ▁and ▁have ▁had ▁che mo therapy ▁treatment ▁in ▁the ▁past ▁ .
▁significant ▁improvement ▁of ▁the ▁skin ▁condition ▁was ▁demonstrat ed ▁in ▁several ▁studies ▁under ▁control led ▁conditions ▁ , ▁where as ▁significant ▁re duction ▁of ▁it ching ▁was ▁demonstrat ed ▁in ▁only ▁one ▁of ▁these ▁laborator y ▁studies ▁in ▁which ▁the ▁dog s ▁received ▁treatment ▁against ▁external ▁parasites ▁at ▁the ▁same ▁time ▁ .
▁what ▁no xa fil ▁is ▁and ▁what ▁it ▁is ▁used ▁for
▁detailed ▁information ▁on ▁this ▁product ▁is ▁available ▁on ▁the ▁website ▁of ▁the ▁european ▁medicine s ▁agency ▁( ▁http ▁: ▁/ ▁/ ▁www . ema . europa . eu ▁) ▁ .
▁the ▁dose ▁of ▁this ▁medicinal ▁product ▁should ▁provide ▁sax ag lip tin ▁2.5 ▁mg ▁twice ▁daily ▁( ▁5 ▁mg ▁total ▁daily ▁dose ▁) ▁and ▁a ▁dose ▁of ▁met form in ▁similar ▁to ▁the ▁dose ▁already ▁being ▁taken ▁ .
▁as ▁part ▁of ▁the ▁inclusi on ▁criteri a ▁ , ▁patients ▁were ▁required ▁to ▁have ▁an ▁eco g ▁performance ▁status ▁of ▁0-2 ▁and ▁intermedi ate - ▁or ▁poor - risk ▁cy to gene tic ▁ab normal ities ▁ .
▁there ▁are ▁currently ▁no ▁clinic al ▁safety ▁data ▁for ▁hy q via ▁on ▁fertil ity ▁available ▁ .
▁v te ▁or ▁v te - related ▁death
▁patients ▁with ▁and ▁without ▁cardiovascular ▁risk ▁factors ▁ , ▁including ▁patients ▁age ▁50 ▁years ▁or ▁young er ▁ , ▁experienced ▁these ▁events ▁ .
▁the ▁50 ▁% ▁inhibi tory ▁concentration ▁( ▁ ic 50 ▁) ▁of ▁amp rena vir ▁range d ▁from ▁0.0 12 ▁to ▁0.0 8 ▁m ▁in ▁acu tely ▁infect ed ▁cell s ▁and ▁was ▁0 . 41 ▁m ▁in ▁chronic ally ▁infect ed ▁cell s ▁( ▁1 ▁m ▁= ▁0 . 50 ▁g ▁/ ▁ml ▁) ▁ .
▁met form in ▁increase s ▁the ▁transport ▁capacity ▁of ▁specific ▁types ▁of ▁membran e ▁gluco se ▁transporter s ▁( ▁glut -1 ▁and ▁glut -4 ▁) ▁ .
▁the ▁powder ▁is ▁white ▁to ▁almost ▁white ▁; ▁the ▁solve nt ▁is ▁a ▁clear ▁liquid ▁ .
▁ergo t ▁al kalo ids ▁( ▁for ▁example ▁ , ▁ergo tamine ▁ , ▁di hydro er go tamine ▁ , ▁er gon ovine ▁ , ▁and ▁met hy ler gon ovine ▁) ▁( ▁used ▁to ▁treat ▁migra ine ▁and ▁cluster ▁head ach es ▁)
▁gla xo ▁group ▁l t d ▁ 980 ▁great ▁west ▁road ▁bre nt ford
▁more ▁than ▁97 ▁% ▁of ▁melo xi cam ▁is ▁ bound ▁to ▁plasma ▁protein s ▁ .
▁in ▁the ▁same ▁study ▁ , ▁a ▁statistic ally ▁significant ▁increase ▁was ▁reported ▁in ▁the ▁incide nce ▁of ▁pulmonar y ▁e mbol ism ▁( ▁ 0.7 ▁% ▁in ▁the ▁place bo ▁group ▁versus ▁1.1 ▁% ▁in ▁the ▁feno fi bra te ▁group ▁; ▁p ▁= ▁0.0 22 ▁) ▁and ▁a ▁statistic ally ▁non - signif i cant ▁increase ▁in ▁deep ▁ve in ▁ thro mbo ses ▁( ▁place bo ▁: ▁1.0 ▁% ▁[ ▁48 ▁/ ▁4 , 900 ▁patients ▁] ▁versus ▁feno fi bra te ▁1.4 ▁% ▁[ ▁67 ▁/ ▁4 , 895 ▁patients ▁] ▁; ▁p ▁= ▁0.0 74 ▁) ▁ .
▁how ▁is ▁i firma sta ▁used ▁?
▁so dium ▁di hydro gen ▁ phos pha te ▁mono hydrat e ▁ed etate ▁di so dium
▁the ▁inject ion ▁button ▁colour ▁will ▁var y ▁based ▁on ▁the ▁formula tion ▁of ▁insu man ▁insulin ▁used ▁ .
▁your ▁child ▁must ▁not ▁stop ▁taking ▁a pti vus ▁unless ▁your ▁child ▁' s ▁doctor ▁in struct s ▁to ▁do ▁so ▁ .
▁if ▁such ▁inhibi tors ▁occur ▁ , ▁the ▁condition ▁will ▁manifest ▁itself ▁as ▁an ▁in sufficient ▁clinic al ▁response ▁ .
▁eu ▁/ ▁1 ▁/ ▁11 ▁/ ▁70 6 ▁/ ▁ 001 ▁10 ▁film - co ated ▁tablets ▁eu ▁/ ▁1 ▁/ ▁11 ▁/ ▁70 6 ▁/ ▁ 002 ▁30 ▁film - co ated ▁tablets ▁eu ▁/ ▁1 ▁/ ▁11 ▁/ ▁70 6 ▁/ ▁ 003 ▁100 ▁film - co ated ▁tablets ▁eu ▁/ ▁1 ▁/ ▁11 ▁/ ▁70 6 ▁/ ▁ 004 ▁130 ▁film - co ated ▁tablets ▁eu ▁/ ▁1 ▁/ ▁11 ▁/ ▁70 6 ▁/ ▁ 005 ▁175 ▁film - co ated ▁tablets ▁eu ▁/ ▁1 ▁/ ▁11 ▁/ ▁70 6 ▁/ ▁ 006 ▁250 ▁film - co ated ▁tablets
▁limited ▁immun ogen i city ▁data ▁obtain ed ▁three ▁weeks ▁after ▁administration ▁of ▁a ▁single ▁dose ▁of ▁0.2 5 ▁ml ▁or ▁0.5 ▁ml ▁to ▁healthy ▁children ▁a ged ▁10 -17 ▁years ▁ .
▁kin zal mono ▁block s ▁the ▁effect ▁of ▁ang io ten sin ▁i i ▁so ▁that ▁the ▁blood ▁ves sels ▁relax ▁ , ▁and ▁your ▁blood ▁pressure ▁is ▁lower ed ▁ .
▁> ▁3 ▁and ▁ ≤ ▁5 ▁x ▁ul n ▁: ▁confirm ▁by ▁another ▁ liver ▁test ▁; ▁if ▁confirm ed ▁ , ▁a ▁decision ▁should ▁be ▁made ▁on ▁an ▁individual ▁basis ▁to ▁continue ▁or ▁to ▁stop ▁the lin ▁administration ▁ .
▁0.5 ▁mg ▁ , ▁or ▁1 ▁mg ▁pra mi pe xo le ▁di hydro ch lor ide ▁mono hydrat e ▁ , ▁respective ly ▁ .
▁he pato cel lular ▁car cino ma ▁( ▁11 ▁april ▁2006 ▁)
▁vi al ▁b ▁: ▁multi dos e ▁vi al ▁contain ing ▁the ▁ad ju vant ▁( ▁em ul sion ▁) ▁ .
▁very ▁rare ▁( ▁affect s ▁less ▁than ▁1 ▁user ▁in ▁10,000 ▁)
▁plastic ▁l d pe ▁bottle ▁of ▁30 ▁ml ▁( ▁1,000 ▁dos es ▁) ▁with ▁but yl ▁rub ber ▁stopper ▁and ▁seal ed ▁with ▁an ▁aluminium ▁cap ▁ .
▁in ▁vi tro ▁assessment ▁of ▁interaction s
▁soon ▁after ▁dos ing ▁ , ▁p th ▁begin s ▁to ▁decrease ▁until ▁a ▁na dir ▁at ▁approximately ▁2 ▁to ▁6 ▁hours ▁post dos e ▁ , ▁correspond ing ▁with ▁ cina cal cet ▁c max ▁ .
▁titan ium ▁ dioxid e ▁( ▁e 171 ▁) ▁red ▁ir on ▁oxid e ▁( ▁e 172 ▁) ▁black ▁ir on ▁oxid e ▁( ▁e 172 ▁)
▁this ▁is ▁a ▁summary ▁of ▁the ▁european ▁public ▁assessment ▁report ▁( ▁e par ▁) ▁for ▁kio vig ▁ .
▁severe ▁he pati c ▁function ▁disorder ▁ .
▁un com mon ▁( ▁more ▁than ▁1 ▁but ▁less ▁than ▁10 ▁animals ▁in ▁1,000 ▁animals ▁) ▁ ,
▁each ▁pre - fill ed ▁pen ▁contain s ▁60 ▁micro gram s ▁of ▁darbe po etin ▁alfa ▁in ▁0.3 ▁ml ▁( ▁200 ▁μ g ▁/ ▁ml ▁) ▁ .
▁if ▁you ▁become ▁pregnant ▁while ▁taking ▁clo pido gre l ▁b gr ▁ , ▁consult ▁your ▁doctor ▁immediately ▁as ▁it ▁is ▁recommended ▁not ▁to ▁take ▁clo pido gre l ▁while ▁you ▁are ▁pregnant ▁ .
▁brin a ves s ▁has ▁a ▁minor ▁to ▁moderat e ▁influence ▁on ▁the ▁ability ▁to ▁drive ▁and ▁use ▁machines ▁ .
▁light ▁blue ▁to ▁blue ▁ , ▁capsule ▁shape d ▁tablet ▁ , ▁de bos sed ▁with ▁" ▁93 ▁" ▁on ▁one ▁side ▁and ▁" ▁210 ▁" ▁on ▁the ▁other ▁side ▁ .
▁do ▁not ▁use ▁the ▁suspens ion ▁if ▁you ▁notice ▁that ▁the ▁appearance ▁or ▁smell ▁of ▁your ▁medicine ▁has ▁changed ▁ .
▁the ▁fa b ▁' ▁fragment ▁compris es ▁protein ▁compound s ▁and ▁is ▁expected ▁to ▁be ▁de grad ed ▁to ▁pe pti des ▁and ▁amino ▁acid s ▁by ▁prote ol ysis ▁ .
▁their ▁presence ▁in ▁the ▁heart ▁raise s ▁the ▁possibility ▁that ▁even ▁highly ▁select ive ▁beta 2- ad r energi c ▁ago nist s ▁may ▁have ▁cardiac ▁effects ▁ .
▁close ▁monitoring ▁of ▁gly ca e mic ▁control ▁should ▁be ▁considered ▁( ▁see ▁section ▁4.4 ▁) ▁ .
▁his t ological ▁evidence ▁of ▁he pati c ▁effects ▁was ▁seen ▁in ▁dog s ▁following ▁a cute ▁administration ▁of ▁high ▁dos es ▁ , ▁but ▁was ▁also ▁not ▁ac com pani ed ▁by ▁changes ▁in ▁se rum ▁che mist ry ▁ .
▁it ▁is ▁not ▁known ▁whether ▁taso ner min ▁is ▁ex cre ted ▁in ▁human ▁milk ▁ .
▁use ▁water proof ▁glo ves ▁ , ▁effective ▁radi ation ▁ shield ing ▁ , ▁and ▁appropriate ▁safety ▁measure s ▁when ▁handling ▁lymph ose ek ▁to ▁avoid ▁un ne cess ary ▁radi ation ▁exposure ▁to ▁the ▁patient ▁ , ▁occupa tional ▁workers ▁ , ▁clinic al ▁personnel ▁ , ▁and ▁other ▁person s ▁ .
▁for ▁storage ▁conditions ▁after ▁constitution ▁ , ▁see ▁section ▁6.3 . ▁keep ▁the ▁container ▁tight ly ▁closed ▁ .
▁inspect ▁the ▁sy ringe ▁for ▁obvious ▁f law s ▁ , ▁but ▁don ▁' t ▁remove ▁the ▁need le ▁cover ▁ .
▁an ▁initial ▁dose ▁of ▁6 ▁mg ▁contain s ▁up ▁to ▁150 ▁mg ▁of ▁alcohol ▁which ▁ise qui valent ▁to ▁3 ▁ml ▁beer ▁or ▁1. 25 ▁ml ▁wine ▁ .
▁no ▁studies ▁on ▁the ▁effects ▁of ▁mab ther a ▁on ▁the ▁ability ▁to ▁drive ▁and ▁use ▁machines ▁have ▁been ▁perform ed ▁ , ▁although ▁the ▁ pharma c ological ▁activity ▁and ▁advers e ▁reaction s ▁reported ▁to ▁date ▁suggest ▁that ▁mab ther a ▁would ▁have ▁no ▁or ▁negli gi ble ▁influence ▁on ▁the ▁ability ▁to ▁drive ▁and ▁use ▁machines ▁ .
▁you ▁will ▁need ▁to ▁give ▁yourself ▁an ▁inject ion ▁into ▁the ▁tissu e ▁under ▁the ▁skin ▁ , ▁known ▁as ▁a ▁sub cuta ne ous ▁inject ion ▁ .
▁fer ta vid ▁solution ▁for ▁inject ion ▁in ▁cart ridge s ▁150 ▁iu ▁/ ▁0 . 18 ▁ml ▁ , ▁300 ▁iu ▁/ ▁0.3 6 ▁ml ▁ , ▁600 ▁iu ▁/ ▁0 . 72 ▁ml ▁ , ▁900 ▁iu ▁/ ▁1. 08 ▁ml ▁:
▁the ▁full ▁e par ▁for ▁rap tiva ▁can ▁be ▁found ▁here ▁ .
▁a ▁minor ▁infection ▁such ▁as ▁a ▁cold ▁should ▁not ▁be ▁a ▁problem ▁ , ▁but ▁your ▁doctor ▁will ▁advise ▁whether ▁you ▁could ▁still ▁be ▁vaccin ated ▁with ▁puma rix ▁ .
▁if ▁you ▁forget ▁to ▁take ▁traje nta
▁the ▁ pharma c ological ▁properties ▁of ▁the ▁synth e tic ▁and ▁reco mbin ant ▁pe pti des ▁have ▁been ▁demonstrat ed ▁to ▁be ▁qualitativ ely ▁and ▁quantitat ive ly ▁equivalent ▁ .
▁the ▁200 ▁mg ▁tablets ▁also ▁contain ▁ir on ▁oxid e ▁red ▁( ▁e 172 ▁) ▁ .
▁in ▁volunteer s ▁with ▁normal ▁ki dne y ▁function ▁ , ▁total ▁clear ance ▁( ▁cl tot ▁) ▁amount s ▁to
▁in ▁a ▁phase ▁2 ▁clinic al ▁trial ▁( ▁study ▁v 87 p 3 ▁) ▁adult ▁subject s ▁a ged ▁18- 65 ▁years ▁prime d ▁6-8 ▁years ▁previously ▁with ▁2 ▁dos es ▁of ▁m f 59 - ad ju vante d ▁h 5 n 3 ▁vaccin e ▁/ ▁a ▁/ ▁du ck ▁/ ▁sing a pore ▁/ ▁97 ▁were ▁ad minister ed ▁2 ▁boost er ▁dos es ▁of ▁a flu nov ▁ .
▁content s ▁: ▁1 ▁vi al ▁with ▁3000 ▁iu ▁octo co g ▁alfa ▁ , ▁1 ▁vi al ▁with ▁5 ▁ml ▁ster ilised ▁water ▁for ▁inject ions ▁ , ▁1 ▁bax ject ▁i i ▁device ▁ .
▁for ▁the ▁l yo phil isa te ▁and ▁the ▁solve nt ▁: ▁3- ml ▁vi als ▁of ▁glass ▁type ▁i ▁closed ▁with ▁a ▁ha logen o but yl ▁rub ber ▁stopper ▁and ▁seal ed ▁with ▁a ▁code d ▁aluminium ▁cap ▁ .
▁for ▁patients ▁with ▁renal ▁ang i om yo lipo ma ▁and ▁severe ▁im pair ment ▁of ▁ liver ▁function ▁vot ubi a ▁is ▁only ▁recommended ▁if ▁the ▁desire d ▁benefit ▁out we igh s ▁the ▁risk ▁ .
▁as ▁this ▁medicinal ▁product ▁contain s ▁an hydro us ▁la ctos e ▁as ▁an ▁ex cip ient ▁ , ▁patients ▁with ▁rare ▁heredita ry ▁problems ▁of ▁gala ctos e ▁in tolerance ▁ , ▁the ▁la pp ▁lac tase ▁de fici en cy ▁or ▁gluco se - gala ctos e ▁mala b sor p tion ▁should ▁not ▁take ▁this ▁medicine ▁ .
▁if ▁you ▁have ▁any ▁further ▁questions ▁ , ▁please ▁ask ▁your ▁doctor ▁ , ▁nurse ▁or ▁ pharma ci st ▁ .
▁impuls e ▁control ▁disorder s ▁: ▁path ological ▁gambling ▁ , ▁increased ▁libido ▁ , ▁hyper sexual ity ▁ , ▁comp ul sive ▁spending ▁or ▁buying ▁ , ▁bin ge ▁eating ▁and ▁comp ul sive ▁eating ▁can ▁occur ▁in ▁patients ▁treated ▁with ▁dop amine ▁ago nist s ▁and ▁/ ▁or ▁other ▁dop amine rg ic ▁treatment s ▁such ▁as ▁com tes s ▁in ▁association ▁with ▁levo do pa ▁( ▁see ▁section ▁4.4 ▁) ▁ .
▁further ▁increase s ▁of ▁25 ▁% ▁of ▁the ▁previous ▁dose ▁may ▁be ▁made ▁at ▁monthly ▁interval s ▁until ▁the ▁individual ▁target ▁ha emo glob in ▁level ▁is ▁obtain ed ▁ .
▁ons ets ▁of ▁immun ity ▁have ▁been ▁demonstrat ed ▁1 ▁week ▁after ▁primary ▁vaccin ation ▁course ▁for ▁r hin otra che itis ▁ , ▁ca lici virus ▁and ▁pan le uc op enia ▁component s ▁ , ▁and ▁2 ▁weeks ▁after ▁primary ▁vaccin ation ▁course ▁for ▁fel ine ▁leuk a emia ▁component ▁ .
▁date ▁of ▁first ▁author isation ▁: ▁13 ▁ju ne ▁2013
▁in ▁women ▁receiving ▁dar una vir ▁/ ▁rito na vir ▁600 ▁/ ▁100 ▁mg ▁twice ▁daily ▁during ▁the ▁second ▁tri mester ▁of ▁pre gna ncy ▁ , ▁mean ▁intra - individu al ▁values ▁for ▁total ▁dar una vir ▁c max ▁ , ▁au c 12 h ▁and ▁cm in ▁were ▁28 ▁% ▁ , ▁24 ▁% ▁and ▁17 ▁% ▁lower ▁ , ▁respective ly ▁ , ▁as ▁compared ▁with ▁post part um ▁; ▁during ▁the ▁third ▁tri mester ▁of ▁pre gna ncy ▁ , ▁total ▁dar una vir ▁c max ▁ , ▁au c 12 h ▁and ▁cm in ▁values ▁were ▁19 ▁% ▁ , ▁17 ▁% ▁lower ▁and ▁2 ▁% ▁higher ▁ , ▁respective ly ▁ , ▁as ▁compared ▁with ▁post part um ▁ .
▁rub bing ▁will ▁not ▁remove ▁ adh ering ▁und is solve d ▁es char ▁in ▁areas ▁where ▁the ▁es char ▁still ▁remain s ▁ .
▁un com mon ▁dry ▁mouth ▁ , ▁vom i ting ▁ , ▁abdominal ▁pain ▁ , ▁gloss ody nia ▁ , ▁mouth ▁ha e mor r hage ▁ , ▁abdominal ▁tender ness ▁ , ▁fa e ces ▁disco lou red ▁ , ▁flat ul ence ▁ , ▁food ▁pois o ning ▁ , ▁frequent ▁bo wel ▁movement s ▁ , ▁ha e mate mesi s ▁ , ▁oral ▁disco m fort
▁pre pande mic ▁influenza ▁vaccin e ▁( ▁h 5 n 1 ▁) ▁( ▁split ▁vir ion ▁ , ▁in activa red ▁ , ▁ad ju vante d ▁)
▁she lf ▁life ▁after ▁first ▁opening ▁the ▁container ▁: ▁6 ▁months ▁ .
▁if ▁you ▁have ▁had ▁external ▁be am ▁radi ation ▁( ▁a ▁type ▁of ▁radio therapy ▁) ▁to ▁more ▁than ▁a ▁quarter ▁of ▁your ▁bone ▁mar row ▁ .
▁some ▁patients ▁have ▁experienced ▁con s tip ation ▁at ▁a ▁fre que ncy ▁not ▁known ▁( ▁cannot ▁be ▁determine d ▁from ▁the ▁available ▁data ▁) ▁when ▁sax ag lip tin ▁was ▁used ▁alone ▁or ▁in ▁combination ▁ .
▁the ▁full ▁e par ▁for ▁my cla us en ▁can ▁be ▁found ▁on ▁the ▁agency ▁' s ▁website ▁: ▁ema . europa . eu ▁/ ▁find ▁medicine ▁/ ▁human ▁medicine s ▁/ ▁european ▁public ▁assessment ▁reports ▁ .
▁keep ▁taking ▁je nta du eto ▁until ▁your ▁doctor ▁tell s ▁you ▁to ▁stop ▁ .
▁fer ta vid ▁50 ▁iu ▁/ ▁0.5 ▁ml ▁solution ▁for ▁inject ion ▁: ▁each ▁vi al ▁contain s ▁the ▁active ▁substance ▁fol li trop in ▁beta ▁ , ▁a ▁hormone ▁known ▁as ▁fol lic le - stimul ating ▁hormone ▁( ▁f sh ▁) ▁ , ▁in ▁a ▁strength ▁of ▁50 ▁iu ▁in ▁0.5 ▁ml ▁a que ous ▁solution ▁per ▁vi al ▁ .
▁the ▁stea dy ▁state ▁12- ho ur ▁area ▁under ▁the ▁plasma ▁concentration ▁versus ▁time ▁cur ve ▁was ▁9 2.5 ▁ng . hr ▁/ ▁ml ▁ .
▁end ogen ous ▁red ▁cell ▁reserve ▁= ▁blood ▁volume ▁[ ▁ml ▁] ▁x ▁( ▁pc v ▁- ▁33 ▁) ▁ ÷ ▁100 ▁women ▁: ▁blood ▁volume ▁[ ▁ml ▁] ▁= ▁41 ▁[ ▁ml ▁/ ▁kg ▁] ▁x ▁body ▁weight ▁[ ▁kg ▁] ▁+ ▁1200 ▁[ ▁ml ▁] ▁men ▁: ▁blood ▁volume ▁[ ▁ml ▁] ▁= ▁44 ▁[ ▁ml ▁/ ▁kg ▁] ▁x ▁body ▁weight ▁[ ▁kg ▁] ▁+ ▁1600 ▁[ ▁ml ▁] ▁( ▁body ▁weight ▁45 ▁kg ▁)
▁what ▁you ▁need ▁to ▁know ▁before ▁you ▁take ▁in vega
▁more ▁patients ▁on ▁or lista t ▁or ▁place bo ▁lost ▁base line ▁body ▁weight ▁of ▁at ▁least ▁5 ▁% ▁at ▁12 ▁weeks ▁or ▁10 ▁% ▁at ▁one ▁year ▁in ▁the ▁xen dos ▁study ▁than ▁in ▁the ▁five ▁2- year ▁studies ▁ .
▁what ▁to via z ▁is ▁and ▁what ▁it ▁is ▁used ▁for
▁comparison ▁of ▁the ▁images ▁obtain ed ▁with ▁rapi s can ▁to ▁those ▁obtain ed ▁with ▁ad enos ine ▁was ▁perform ed ▁as ▁follow s ▁ .
▁treatment ▁of ▁symptom a tic ▁ana emia ▁associated ▁with ▁chronic ▁ki dne y ▁disease ▁( ▁ ck d ▁) ▁in ▁adult ▁patients ▁( ▁see ▁section ▁5.1 ▁) ▁ .
▁so dium ▁hydro xi de ▁( ▁for ▁ph ▁adjust ment ▁) ▁hydro chol ric ▁acid ▁( ▁for ▁ph ▁adjust ment ▁)
▁if ▁this ▁happens ▁to ▁you ▁ , ▁do ▁not ▁drive ▁or ▁use ▁any ▁tools ▁or ▁machines ▁ .
▁do ▁not ▁mix ▁zo le dro nic ▁acid ▁my lan ▁concentrat e ▁with ▁calci um - conta ining ▁or ▁other ▁di valent ▁ cation - conta ining ▁solutions ▁such ▁as ▁la cta ted ▁ ringer ▁' s ▁solution ▁ .
▁please ▁consult ▁your ▁child ▁' s ▁doctor ▁in ▁the ▁event ▁of ▁any ▁side ▁effects ▁as ▁the ▁doctor ▁may ▁have ▁to ▁adjust ▁the ▁dose ▁of ▁this ▁medicine ▁and ▁the ▁other ▁anti ep ile ptic ▁medicine ▁( ▁s ▁) ▁ .
▁pure va x ▁r cp ▁contain s ▁small ▁amount s ▁of ▁we ak en ed ▁or ▁killed ▁virus es ▁that ▁cause ▁the ▁disease s ▁listed ▁above ▁ .
▁the ▁bottle ▁is ▁a ▁high - dens ity ▁poly e thy lene ▁( ▁hd pe ▁) ▁plastic ▁bottle ▁contain ing ▁120 ▁tablets ▁and ▁3 ▁de sic cant ▁pou ches ▁ , ▁fitte d ▁with ▁a ▁poly propyl ene ▁( ▁pp ▁) ▁child ▁resist ant ▁ closure ▁ .
▁package ▁le a flet ▁: ▁information ▁for ▁the ▁user
▁also ▁contain s ▁la ctos e ▁mono hydrat e ▁ .
▁5 ▁how ▁to ▁store ▁rap tiva
▁interaction s ▁between ▁prezi sta ▁/ ▁rito na vir ▁and ▁anti ret rovi ral ▁and ▁non - anti ret rovi ral ▁medicinal ▁products ▁are ▁listed ▁in ▁the ▁table ▁below ▁( ▁not ▁determine d ▁as ▁" ▁ nd ▁" ▁) ▁ .
▁star lix ▁120 ▁mg ▁film - co ated ▁tablets ▁na te gli ni de
▁the ▁ch mp ▁decided ▁that ▁gli vec ▁' s ▁benefits ▁are ▁greater ▁than ▁its ▁risk s ▁and ▁recommended ▁that ▁it ▁be ▁given ▁marketing ▁author isation ▁ .
▁what ▁is ▁the ▁risk ▁associated ▁with ▁prote los ▁?
▁re - evalua tion ▁by ▁the ▁veterinar ian ▁should ▁take ▁place ▁5 ▁months ▁after ▁treatment ▁or ▁earlier ▁if ▁clinic al ▁sign s ▁recu r ▁ .
▁the ▁european ▁commission ▁gran ted ▁a ▁marketing ▁author isation ▁valid ▁throughout ▁the ▁european ▁union ▁for ▁ada su ve ▁on ▁20 ▁februar y ▁2013 ▁ .
▁in ▁pregnant ▁gauche r ▁patients ▁and ▁those ▁inte nding ▁to ▁become ▁pregnant ▁ , ▁a ▁risk - bene fit ▁treatment ▁assessment ▁is ▁required ▁for ▁each ▁pre gna ncy ▁ .
▁the ▁mean ▁pe ak ▁( ▁c max ▁) ▁and ▁total ▁( ▁au c ▁) ▁exposure s ▁were ▁approximately ▁114 ▁ng ▁/ ▁ml ▁and ▁1 4,000 ▁ng h ▁/ ▁ml ▁ , ▁respective ly ▁ , ▁after ▁multiple ▁sub cuta ne ous ▁1.5 ▁mg ▁dos es ▁of ▁du la glut ide ▁in ▁patients ▁with ▁type ▁2 ▁diabetes ▁ .
▁breast - feed ing ▁should ▁be ▁dis continu ed ▁during ▁treatment ▁with ▁z y delig ▁ .
▁major ▁cy to gene tic ▁response ▁ , ▁ha e mat ological ▁response ▁ , ▁molecular ▁response ▁( ▁evaluation ▁of ▁minimal ▁residu al ▁disease ▁) ▁ , ▁time ▁to ▁accelerat ed ▁phase ▁or ▁blas t ▁crisis ▁and ▁survival ▁are ▁main ▁seconda ry ▁end point s ▁ .
▁each ▁pre - fill ed ▁sy ringe ▁contain s ▁500 ▁micro gram s ▁of ▁darbe po etin ▁alfa ▁in ▁1 ▁ml ▁( ▁500 ▁μ g ▁/ ▁ml ▁) ▁ .
▁na tali zum ab ▁is ▁a ▁reco mbin ant ▁human ised ▁anti - α 4- integr in ▁anti body ▁produced ▁in ▁a ▁mur ine ▁cell ▁line ▁by ▁reco mbin ant ▁d na ▁technology ▁ .
▁an ▁increase ▁in ▁weight ▁and ▁in ▁levels ▁of ▁blood ▁lipid s ▁and ▁gluco se ▁may ▁occur ▁during ▁anti ret rovi ral ▁ therapy ▁ .
▁incide nce ▁rate ▁of ▁zo ster ▁per ▁1,000 ▁person ▁years
▁novo rap id ▁pump car t ▁should ▁be ▁kept ▁out ▁of ▁reach ▁of ▁others ▁ , ▁especially ▁children ▁ .
▁on ▁the ▁basis ▁of ▁limited ▁experience ▁with ▁sil tu xim ab ▁the ▁present ▁data ▁do ▁not ▁suggest ▁any ▁increased ▁risk ▁of ▁malign an cy ▁ .
▁disc ard ▁any ▁un used ▁medicinal ▁product ▁after ▁opening ▁ .
▁total ▁parti al ▁se iz ure ▁fre que ncy ▁( ▁media n ▁) ▁% ▁change
▁following ▁the ▁second ▁initiat ion ▁dose ▁ , ▁monthly ▁maintenance ▁dos es ▁can ▁be ▁ad minister ed ▁in ▁either ▁the ▁del to id ▁or ▁glu te al ▁muscle ▁ .
▁that ▁use ▁of ▁a trip la ▁should ▁be ▁avoid ed ▁with ▁con com i tant ▁or ▁recent ▁use ▁of ▁nep hro toxic ▁medicinal ▁products ▁ .
▁how ▁to ▁store ▁leg anto
▁if ▁the ▁number ▁of ▁white ▁cell s ▁in ▁your ▁blood ▁has ▁decrease d ▁ .
▁no ▁dos age ▁adjust ment ▁is ▁necessary ▁based ▁on ▁renal ▁im pair ment ▁( ▁see ▁section ▁5.2 ▁) ▁ .
▁10 ▁dos es ▁: ▁powder ▁( ▁10 ▁bottle s ▁) ▁+ ▁solve nt ▁( ▁10 ▁bottle s ▁) ▁50 ▁dos es ▁: ▁powder ▁( ▁50 ▁bottle s ▁) ▁+ ▁solve nt ▁( ▁50 ▁bottle s ▁)
▁severe ▁renal ▁im pair ment ▁with ▁creati nine ▁clear ance ▁< ▁35 ▁ml ▁/ ▁min ▁( ▁see ▁section ▁4.4 ▁) ▁ .
▁similar ▁results ▁were ▁seen ▁in ▁the ▁second ▁study ▁after ▁24 ▁weeks ▁ , ▁but ▁tra cle er ▁did ▁not ▁have ▁any ▁effect ▁on ▁digital ▁ul cer ▁hea ling ▁ .
▁common ▁side ▁effects ▁( ▁may ▁affect ▁up ▁to ▁1 ▁in ▁10 ▁people ▁) ▁factor ▁vii i ▁inhibi tors ▁ , ▁head ache ▁and ▁fe ver ▁ .
▁brin a ves s ▁is ▁dos ed ▁by ▁patient ▁body ▁weight ▁ , ▁with ▁a ▁maximum ▁calcula ted ▁dose ▁based ▁upon ▁113 ▁kg ▁ .
▁proven ge ▁should ▁be ▁used ▁with ▁cau tion ▁in ▁immun o com pro mised ▁patients ▁in ▁general ▁including ▁patients ▁taking ▁system ic ▁immun os up press ive ▁ therapy ▁ , ▁after ▁care ful ▁consideration ▁of ▁the ▁potential ▁risk - bene fit ▁on ▁an ▁individ i ual ▁basis ▁ .
▁the ▁decision ▁to ▁ad minister ▁reco mbin ant ▁er y thro po iet ins ▁should ▁be ▁based ▁on ▁a ▁benefit - risk ▁assessment ▁with ▁the ▁participation ▁of ▁the ▁individual ▁patient ▁ , ▁which ▁should ▁take ▁into ▁account ▁the ▁specific ▁clinic al ▁context ▁ .
▁in dina vir ▁plasma ▁concentration s ▁may ▁be ▁expected ▁( ▁cy p 3 a ▁in duction ▁) ▁ .
▁the ▁available ▁literature ▁indicate s ▁that ▁the ▁ pharma cok ine tics ▁of ▁som a trop in ▁are ▁similar ▁in ▁men ▁and ▁women ▁ .
▁treatment ▁should ▁only ▁be ▁given ▁to ▁patients ▁with ▁moderat e ▁ana emia ▁( ▁ hb ▁10 ▁- ▁13 ▁g ▁/ ▁dl ▁[ ▁6. 21 ▁- ▁8. 07 ▁mm ol ▁/ ▁l ▁] ▁ , ▁no ▁ir on ▁de fici en cy ▁) ▁if ▁blood ▁con serv ing ▁procedure s ▁are ▁not ▁available ▁or ▁in sufficient ▁when ▁the ▁schedule d ▁major ▁el ective ▁surgery ▁requires ▁a ▁large ▁volume ▁of ▁blood ▁( ▁4 ▁or ▁more ▁unit s ▁of ▁blood ▁for ▁female s ▁or ▁5 ▁or ▁more ▁unit s ▁for ▁male s ▁) ▁ .
▁additional ▁ser o type s ▁in ▁ preven ar ▁13
▁contact ▁with ▁soft ▁contact ▁l enses ▁is ▁to ▁be ▁avoid ed ▁ .
▁vel cade ▁1 ▁mg ▁powder ▁for ▁solution ▁for ▁inject ion ▁is ▁for ▁intra ven ous ▁use ▁only ▁ .
▁3 ▁ , ▁5 ▁or ▁7 ▁cm ▁ball oon ▁( ▁130 ▁j ▁/ ▁cm ▁)
▁women ▁of ▁child be aring ▁age ▁should ▁use ▁effective ▁contra ception ▁during ▁and ▁up ▁to ▁1 ▁month ▁after ▁receiving ▁treatment ▁with ▁a bra xan e ▁ .
▁the ▁vaccin e ▁can ▁be ▁used ▁during ▁pre gna ncy ▁and ▁lac tation ▁ .
▁in ▁a ▁study ▁of ▁64 ▁patients ▁with ▁rhe um ato id ▁ar thri tis ▁that ▁were ▁treated ▁with ▁hum ira ▁ , ▁there ▁was ▁no ▁evidence ▁of ▁depression ▁of ▁de lay ed - type ▁hyper sensitiv ity ▁ , ▁depression ▁of ▁immun o glob ulin ▁levels ▁ , ▁or ▁change ▁in ▁enumera tion ▁of ▁effect or ▁t - ▁ , ▁b ▁ , ▁- ▁nk - cell s ▁ , ▁mono cy te ▁/ ▁macro pha ges ▁ , ▁and ▁neutro phil s ▁ .
▁fam pyr a ▁was ▁effective ▁in ▁improving ▁walking ▁speed s ▁ .
▁however ▁ , ▁there ▁was ▁no ▁difference ▁between ▁the ▁two ▁medicine s ▁in ▁how ▁long ▁the ▁patients ▁lived ▁without ▁their ▁nerv e ▁disease ▁getting ▁worse ▁ .
▁a ▁single ▁hum ira ▁pen ▁may ▁be ▁store d ▁at ▁temperature s ▁up ▁to ▁a ▁maximum ▁of ▁25 ▁° ▁c ▁for ▁a ▁period ▁of ▁up ▁to ▁14 ▁days ▁ .
▁patients ▁infect ed ▁with ▁human ▁immun o de fici en cy ▁virus ▁( ▁hi v ▁)
▁description ▁on ▁how ▁to ▁prepare ▁and ▁ad minister ▁the ▁in fusion ▁including ▁safety ▁information ▁;
▁kar vez ide ▁is ▁for ▁oral ▁use ▁ .
▁the ▁european ▁commission ▁gran ted ▁a ▁marketing ▁author isation ▁valid ▁throughout ▁the ▁european ▁union ▁for ▁abil ify ▁main tena ▁on ▁15 ▁november ▁2013 ▁ .
▁it ▁is ▁very ▁important ▁that ▁you ▁take ▁all ▁the ▁medicine s ▁pre scribe d ▁by ▁your ▁surge on ▁ , ▁otherwise ▁holo c lar ▁may ▁not ▁work ▁ .
▁the ▁european ▁commission ▁gran ted ▁a ▁marketing ▁author isation ▁valid ▁throughout ▁the ▁european ▁union ▁for ▁hum ira ▁on ▁8 ▁september ▁2003 ▁ .
▁le flu nom ide ▁win thro p ▁100 ▁mg ▁film - co ated ▁tablets ▁are ▁white ▁to ▁almost ▁white ▁and ▁round ▁ .
▁temo zo lom ide ▁he xal ▁5 ▁mg ▁hard ▁capsule s
▁the ▁amount ▁of ▁ jal ra ▁people ▁have ▁to ▁take ▁varie s ▁de pending ▁on ▁their ▁condition ▁ .
▁three ▁of ▁the ▁parti al ▁responder s ▁were ▁subsequent ly ▁rendere d ▁disease ▁free ▁by ▁surgery ▁ .
▁suicida l ▁idea tion ▁ , ▁psycho sis ▁ , ▁aggressiv e ▁behaviour ▁ , ▁confusion ▁ , ▁agita tion ▁ , ▁ang er ▁ , ▁mood ▁alter ed ▁ , ▁ab normal ▁behaviour ▁ner vous ness ▁ , ▁sleep ▁disorder ▁ , ▁decrease d ▁libido ▁ , ▁a pathy ▁ , ▁ab normal ▁dream s ▁ , ▁cry ing ▁ ,
▁con s tella ▁produce s ▁more ▁frequent ▁bo wel ▁movement s ▁and ▁di ar r ho e a ▁( ▁loo ser ▁sto ol s ▁) ▁when ▁it ▁is ▁taken ▁with ▁food ▁than ▁when ▁it ▁is ▁taken ▁on ▁an ▁empty ▁stomach ▁( ▁see ▁section ▁3 ▁) ▁ .
▁each ▁prolong ed - release ▁tablet ▁contain s ▁2. 25 ▁mg ▁pra mi pe xo le ▁di hydro ch lor ide ▁mono hydrat e ▁equivalent ▁to ▁1. 57 ▁mg ▁pra mi pe xo le ▁ .
▁zo le dro nic ▁acid ▁act avis ▁should ▁not ▁be ▁used ▁during ▁pre gna ncy ▁ .
▁using ▁these ▁medicine s ▁to ▁sup press ▁the ▁immun e ▁system ▁may ▁further ▁increase ▁this ▁risk ▁ .
▁reduce d ▁oss ification ▁was ▁observe d ▁at ▁1.0 ▁mg ▁/ ▁kg ▁/ ▁day ▁ .
▁fre que ncies ▁are ▁define d ▁as ▁: ▁very ▁common ▁( ▁1 ▁/ ▁10 ▁) ▁ , ▁common ▁( ▁1 ▁/ ▁100 ▁to ▁< ▁1 ▁/ ▁10 ▁) ▁ , ▁un com mon ▁( ▁1 ▁/ ▁1,000 ▁to ▁< ▁1 ▁/ ▁100 ▁) ▁ , ▁rare ▁( ▁1 ▁/ ▁10,000 ▁to ▁< ▁1 ▁/ ▁1,000 ▁) ▁ , ▁very ▁rare ▁( ▁< ▁1 ▁/ ▁10,000 ▁) ▁and ▁not ▁known ▁( ▁cannot ▁be ▁estima ted ▁from ▁the ▁available ▁data ▁) ▁ .
▁irregular ▁heart ▁beat ▁ liver ▁disorder
▁the lin ▁was ▁more ▁effective ▁than ▁place bo ▁at ▁improving ▁exercise ▁capacity ▁ .
▁take ▁bara clu de ▁as ▁long ▁as ▁your ▁doctor ▁has ▁told ▁you ▁ .
▁in ▁the ▁studies ▁compar ing ▁te sa vel ▁with ▁other ▁medicine s ▁ , ▁the ▁effective ness ▁of ▁adding ▁te sa vel ▁to ▁met form in ▁was ▁similar ▁to ▁that ▁of ▁adding ▁gli pi zi de ▁ .
▁what ▁is ▁revi nty ▁el lip ta ▁and ▁what ▁is ▁it ▁used ▁for ▁?
▁the ▁possibility ▁to ▁include ▁patients ▁in ▁the ▁registr y ▁study ▁to ▁facilita te ▁the ▁collection ▁of ▁long ▁term ▁ef fica cy ▁and ▁safety ▁data ▁;
▁store ▁the ▁vi als ▁in ▁the ▁original ▁package ▁in ▁order ▁to ▁protect ▁from ▁light ▁ .
▁although ▁the ▁clinic al ▁significa nce ▁of ▁the ▁in duction ▁of ▁anti bo dies ▁has ▁not ▁been ▁fully ▁elu cida ted ▁ , ▁the ▁development ▁of ▁neutral ising ▁anti bo dies ▁is ▁associated ▁with ▁reduce d ▁ef fica cy ▁on ▁clinic al ▁and ▁m ri ▁variable s ▁ .
▁do ▁not ▁use ▁in ▁animals ▁with ▁severe ▁system ic ▁disease ▁or ▁in ▁animals ▁that ▁are ▁mori bund ▁ .
▁the ▁committee ▁recommended ▁that ▁re pag lini de ▁kr ka ▁be ▁given ▁marketing ▁author isation ▁ .
▁with ▁a ▁history ▁suggest ive ▁of ▁ tors ades ▁de ▁point es ▁vent ri cular ▁ta chy car dia ▁( ▁ab normal ▁heart ▁ rhythm s ▁) ▁;
▁the ▁non - in feri or ity ▁of ▁neuro blo c ▁compared ▁to ▁bo tul inum ▁toxin ▁type ▁a ▁was ▁further ▁support ed ▁by ▁a ▁responder ▁analysis ▁where ▁similar ▁percentage s ▁of ▁subject s ▁showed ▁improvement ▁in ▁the ▁tw str s ▁score ▁at ▁week ▁4 ▁of ▁session ▁1 ▁( ▁86 ▁% ▁neuro blo c ▁and ▁85 ▁% ▁boto x ▁) ▁ , ▁and ▁a ▁similar ▁proportion ▁of ▁subject s ▁experienced ▁at ▁least ▁a ▁20 ▁% ▁decrease ▁from ▁base line ▁in ▁the ▁tw str s ▁score ▁at ▁week ▁4 ▁of ▁session ▁1 ▁( ▁51 ▁% ▁neuro blo c ▁ , ▁47 ▁% ▁boto x ▁) ▁ .
▁the ▁pe ak ▁anti body ▁response ▁was ▁seen ▁3 ▁months ▁following ▁treatment ▁ .
▁2 ▁fatal ities ▁due ▁to ▁se psis ▁have ▁been ▁reported ▁in ▁patients ▁treated ▁with ▁to pote can ▁( ▁see ▁section ▁4.4 ▁)
▁patients ▁random ized ▁to ▁to cili zum ab ▁had ▁few er ▁ac r 30 ▁fl ares ▁and ▁higher ▁overall ▁ac r ▁response s ▁than ▁patients ▁receiving ▁place bo ▁regardless ▁of ▁a ▁history ▁of ▁prior ▁biologi c ▁use ▁ .
▁after ▁stop ping ▁the ▁treatment ▁ , ▁few ▁anti body ▁positive ▁patients ▁were ▁followed - up ▁for ▁anti body ▁status ▁; ▁the ▁percentage ▁decrease d ▁to ▁approximately ▁90 ▁% ▁within ▁3 ▁months ▁and ▁30 ▁% ▁at ▁6 ▁months ▁or ▁beyond ▁ .
▁if ▁you ▁have ▁a ▁history ▁of ▁epi le ptic ▁se iz ures ▁if ▁you ▁have ▁recently ▁experienced ▁a ▁my o card ial ▁in far ction ▁( ▁heart ▁attack ▁) ▁ , ▁or ▁if ▁you ▁are ▁suffering ▁from ▁con ges tive ▁heart ▁failure ▁or ▁from ▁an ▁un control led ▁hyper tension ▁( ▁high ▁blood ▁pressure ▁) ▁ .
▁the ▁committee ▁recommended ▁that ▁at osi ban ▁sun ▁be ▁given ▁marketing ▁author isation ▁ .
▁switch ing ▁from ▁rey ata z ▁oral ▁powder ▁to ▁rey ata z ▁capsule s ▁is ▁encourage d ▁as ▁soon ▁as ▁patients ▁are ▁able ▁to ▁consistent ly ▁swa llow ▁capsule s ▁ .
▁also ▁ , ▁it ▁must ▁not ▁be ▁mix ed ▁with ▁animal ▁source ▁insulin s ▁or ▁insulin ▁analog ues ▁ .
▁there ▁are ▁no ▁data ▁on ▁the ▁effects ▁of ▁of atum um ab ▁on ▁human ▁fertil ity ▁ .
▁following ▁multiple ▁oral ▁administration s ▁ , ▁the ▁stea dy ▁state ▁is ▁reached ▁by ▁approximately ▁the ▁eight h ▁daily ▁dose ▁ .
▁posterior ▁rever sible ▁en cep halo pathy ▁syndrome ▁( ▁pres ▁)
▁one ▁vi al ▁of ▁ 8,000 ▁unit s ▁metal yse ▁powder ▁and ▁one ▁pre - fill ed ▁sy ringe ▁contain ing ▁8 ▁ml ▁water ▁for ▁inject ions
▁the ▁solution ▁is ▁contain ed ▁in ▁type ▁i ▁fli nt ▁glass ▁cart ridge s ▁ , ▁seal ed ▁with ▁but yl ▁or ▁hal o but yl ▁disc ▁seal s ▁and ▁plu nger ▁head s ▁and ▁are ▁secure d ▁with ▁aluminium ▁seal s ▁ .
▁following ▁intra ven ous ▁administration ▁ , ▁plasma ▁concentration s ▁of ▁ pix ant rone ▁reached ▁the ▁maximal ▁concentration ▁at ▁the ▁end ▁of ▁in fusion ▁and ▁then ▁decline d ▁poly - ex ponent i ally ▁ .
▁ hb va x pro ▁5 ▁micro gram s ▁ , ▁suspens ion ▁for ▁inject ion
▁you ▁should ▁not ▁breast - feed ▁during ▁treatment ▁with ▁exe lon ▁trans der mal ▁patch es ▁ .
▁tel ▁: ▁+ ▁36 ▁1 ▁299 ▁ 890
▁dose ▁increase s ▁in ▁patients ▁with ▁mild ▁and ▁moderat e ▁he pati c ▁im pair ment ▁should ▁be ▁based ▁on ▁clinic al ▁response ▁and ▁to ler ability ▁ .
▁the ▁applica nt ▁/ ▁mah ▁com mit s ▁to ▁provide ▁the ▁results ▁of ▁a ▁study ▁in ▁a ▁pre gna ncy ▁registr y ▁conduct ed ▁with ▁are pan rix ▁ .
▁content s ▁of ▁the ▁pack ▁and ▁other ▁information ▁what ▁az om yr ▁contain s
▁animal ▁studies ▁did ▁not ▁show ▁that ▁in hal ed ▁human ▁insulin ▁accumula tes ▁in ▁the ▁lung ▁ .
▁for ▁the ▁long ▁term ▁treatment ▁vim pat ▁tablets ▁and ▁sy rup ▁are ▁available ▁ .
▁posterior ▁rever sible ▁en cep halo pathy ▁/ ▁rever sible ▁posterior ▁leuk o ence pha lo pathy ▁syndrome ▁†
▁part ▁the ▁fur ▁on ▁the ▁cat ▁' s ▁ne ck ▁at ▁the ▁base ▁of ▁the ▁skull ▁until ▁the ▁skin ▁is ▁visible ▁ .
▁data ▁are ▁too ▁limited ▁to ▁support ▁the ▁safety ▁and ▁effective ness ▁of ▁e vice l ▁in ▁children ▁ .
▁using ▁beta fer on ▁with ▁other ▁medicine s ▁that ▁mod ify ▁the ▁immun e ▁system ▁response ▁is ▁not ▁recommended ▁ , ▁except ▁anti - in flam ma tory ▁medicine s ▁called ▁corti co steroid s ▁or ▁the ▁ad re no cor tico tropi c ▁hormone ▁( ▁ac th ▁) ▁ .
▁0 . 49 ▁% ▁[ ▁ rr ▁1. 43 ▁( ▁95 ▁% ▁confidence ▁interval ▁ 1.00 ▁- ▁2. 06 ▁) ▁] ▁; ▁the ▁incide nce ▁of ▁fatal ▁se psis ▁cases ▁was ▁increased ▁for ▁patients ▁taking ▁tel mis ar tan ▁( ▁0.3 3 ▁% ▁) ▁vs . ▁patients ▁taking ▁place bo ▁( ▁0.1 6 ▁% ▁) ▁[ ▁ rr ▁2. 07 ▁( ▁95 ▁% ▁confidence ▁interval ▁1. 14 ▁- ▁3. 76 ▁) ▁] ▁ .
▁approximately ▁79 ▁% ▁of ▁si tag lip tin ▁is ▁ex cre ted ▁un change d ▁in ▁the ▁urin e ▁ .
▁very ▁common ▁( ▁ ≥ ▁1 ▁/ ▁10 ▁) ▁; ▁common ▁( ▁ ≥ ▁1 ▁/ ▁100 ▁to ▁< ▁1 ▁/ ▁10 ▁) ▁; ▁un com mon ▁( ▁ ≥ ▁1 ▁/ ▁1,000 ▁to ▁< ▁1 ▁/ ▁100 ▁) ▁; ▁rare ▁( ▁ ≥ ▁1 ▁/ ▁10,000 ▁to ▁< ▁1 ▁/ ▁1,000 ▁) ▁; ▁very ▁rare ▁( ▁< ▁1 ▁/ ▁10,000 ▁) ▁and ▁not ▁known ▁( ▁cannot ▁be ▁estima ted ▁from ▁available ▁data ▁) ▁advers e ▁reaction s ▁are ▁presente d ▁according ▁to ▁system ▁organ ▁class ▁in ▁table ▁1 ▁ .
▁because ▁olan za pine ▁may ▁cause ▁som nol ence ▁and ▁di zzi ness ▁ , ▁patients ▁should ▁be ▁cau tion ed ▁about ▁operating ▁machine ry ▁ , ▁including ▁motor ▁vehicles ▁ .
▁when ▁looking ▁at ▁all ▁hay fe ver ▁symptoms ▁except ▁for ▁na sal ▁con gestion ▁ , ▁patients ▁taking ▁a er ina ze ▁reported ▁a ▁re duction ▁in ▁symptoms ▁of ▁46 . 0 ▁% ▁ , ▁compared ▁with ▁3 5.9 ▁% ▁in ▁those ▁taking ▁pseudo ep hed rine ▁alone ▁ .
▁other ▁un identifi ed ▁component s ▁account ed ▁only ▁for ▁ 0.6 ▁% ▁of ▁the ▁dose ▁ .
▁in ▁women ▁with ▁recent ▁or ▁ongoing ▁ thro mbo e mbol ic ▁disease ▁or ▁women ▁with ▁generally ▁recog ni sed ▁risk ▁factors ▁for ▁ thro mbo e mbol ic ▁events ▁ , ▁such ▁as ▁personal ▁or ▁family ▁history ▁ , ▁treatment ▁with ▁go nado trop ins ▁may ▁further ▁increase ▁the ▁risk ▁for ▁ag grav ation ▁or ▁occur r ence ▁of ▁such ▁events ▁ .
▁as ▁an ▁ad jun ct ▁to ▁die t ▁and ▁exercise ▁for ▁the ▁treatment ▁of ▁obes e ▁patients ▁( ▁b mi ▁30 ▁kg ▁/ ▁m 2 ▁) ▁ , ▁or ▁over weight ▁patients ▁( ▁b mi ▁> ▁27 ▁kg ▁/ ▁m 2 ▁) ▁with ▁associated ▁risk ▁factor ▁( ▁s ▁) ▁ , ▁such ▁as ▁type ▁2 ▁diabetes ▁or ▁dys li pida emia ▁( ▁see ▁section ▁5.1 ▁) ▁ .
▁each ▁film - co ated ▁tablet ▁contain s ▁el tro mbo pag ▁ola mine ▁equivalent ▁to ▁75 ▁mg ▁el tro mbo pag
▁it ▁is ▁part ▁of ▁a ▁treatment ▁ reducing ▁the ▁amount ▁of ▁virus ▁in ▁the ▁blood ▁ .
▁as ▁a ▁precau tion ary ▁measure ▁ , ▁it ▁is ▁prefer able ▁to ▁avoid ▁the ▁use ▁of ▁pic ato ▁during ▁pre gna ncy ▁ .
▁these ▁types ▁of ▁cancer ▁affect ▁the ▁cell s ▁of ▁the ▁li ning ▁of ▁the ▁mouth ▁or ▁the ▁ thro at ▁ , ▁or ▁of ▁organ s ▁such ▁as ▁the ▁la ryn x ▁( ▁voice ▁box ▁) ▁ .
▁for ▁children ▁hea vier ▁than ▁20 ▁kg ▁ , ▁som a trop in ▁bio partner s ▁20 ▁mg ▁powder ▁and ▁solve nt ▁for ▁prolong ed - release ▁suspens ion ▁for ▁inject ion ▁is ▁available ▁ .
▁cop alia ▁is ▁used ▁to ▁treat ▁high ▁blood ▁pressure ▁in ▁adults ▁whose ▁blood ▁pressure ▁is ▁not ▁control led ▁enough ▁with ▁either ▁am lo di pine ▁or ▁val sar tan ▁on ▁its ▁own ▁ .
▁however ▁ , ▁close ▁clinic al ▁monitoring ▁should ▁be ▁perform ed ▁during ▁the ▁combination ▁and ▁short ly ▁after ▁antibiotic ▁treatment ▁ .
▁a bla var ▁is ▁for ▁diagnostic ▁use ▁ .
▁the ▁au c ▁ , ▁cm in ▁ , ▁and ▁c max ▁of ▁amp rena vir ▁were ▁increased ▁by ▁29 ▁% ▁ , ▁27 ▁% ▁ , ▁and ▁47 ▁% ▁ , ▁respective ly ▁ .
▁children ▁with ▁poly arti cular ▁juvenil e ▁ idio pathi c ▁ar thri tis
▁table ▁1 ▁: ▁interaction s ▁between ▁i del alis ib ▁and ▁other ▁medicinal ▁products ▁that ▁are ▁cy p 3 a ▁substrat es
▁co - administration ▁of ▁ri lp ivi rine ▁with ▁medicinal ▁products ▁that ▁increase ▁gas tric ▁ph ▁may ▁result ▁in ▁decrease d ▁plasma ▁concentration s ▁of ▁ri lp ivi rine ▁which ▁could ▁potential ly ▁reduce ▁the ▁ therapeut ic ▁effect ▁of ▁edu rant ▁ .
▁abdominal ▁pain ▁was ▁common ly ▁reported ▁as ▁an ▁advers e ▁reaction ▁ .
▁pregnant ▁staff ▁should ▁not ▁handle ▁the ▁product ▁ .
▁clinic al ▁studies ▁have ▁evaluat ed ▁dos es ▁rang ing ▁from ▁15 ▁to ▁60 ▁unit s ▁/ ▁kg ▁every ▁other ▁week ▁ .
▁end ▁stage ▁renal ▁disease ▁( ▁es rd ▁)
▁feeling s ▁of ▁nu mb ness ▁or ▁ting ling
▁a ▁total ▁of ▁3 22 ▁( ▁3 8.1 ▁% ▁) ▁of ▁all ▁patients ▁were ▁not ▁ evalua ble ▁for ▁mm r ▁at ▁60 ▁months ▁( ▁99 ▁in ▁the ▁ni lo tin ib ▁300 ▁mg ▁twice ▁daily ▁group ▁ , ▁93 ▁in ▁the ▁ni lo tin ib ▁400 ▁mg ▁twice ▁daily ▁group ▁and ▁130 ▁in ▁the ▁imati ni b ▁group ▁) ▁due ▁to ▁missing ▁/ ▁un evalua ble ▁pc r ▁assessment s ▁( ▁n ▁= ▁9 ▁) ▁ , ▁a typ ical ▁tran script s ▁at ▁base line ▁( ▁n ▁= ▁8 ▁) ▁or ▁dis continu ation ▁prior ▁to ▁the ▁60- mont h ▁time ▁point ▁( ▁n ▁= ▁305 ▁) ▁ .
▁the ▁results ▁from ▁a ▁long ▁term ▁open ▁label ▁study ▁in ▁ 449 ▁patients ▁ , ▁with ▁continuo us ▁treatment ▁for ▁up ▁to ▁one ▁year ▁ , ▁confirm ed ▁that ▁chronic ▁use ▁of ▁mir vas o ▁is ▁safe ▁and ▁effective ▁ .
▁other ▁medicine s ▁and ▁kom bog ly ze
▁reco mbin ant ▁f sh ▁is ▁bio chem ically ▁very ▁similar ▁to ▁urin ary ▁human ▁f sh ▁and ▁is ▁distribu ted ▁ , ▁metabol ised ▁ , ▁and ▁ex cre ted ▁in ▁the ▁same ▁way ▁ .
▁car cino geni city ▁and ▁geno toxic ity ▁studies ▁have ▁not ▁been ▁conduct ed ▁with ▁nu trop in ▁aq ▁ .
▁in ▁this ▁follow - up ▁ , ▁vaccin e ▁ef fica cy ▁for ▁frequent ▁om ▁( ▁define d ▁as ▁at ▁least ▁3 ▁episode s ▁within ▁6 ▁months ▁) ▁was ▁18 ▁% ▁( ▁95 ▁% ▁ci ▁: ▁1 ▁ , ▁32 ▁) ▁ , ▁for ▁chronic ▁o titi s ▁media ▁with ▁ef fusion ▁ , ▁50 ▁% ▁( ▁95 ▁% ▁ci ▁: ▁15 ▁ , ▁71 ▁) ▁ , ▁and ▁for ▁tym pan osto my ▁tube ▁place ment ▁ , ▁39 ▁% ▁( ▁95 ▁% ▁ci ▁: ▁4 ▁ , ▁61 ▁) ▁ .
▁there ▁are ▁no ▁adequat e ▁human ▁data ▁to ▁determine ▁the ▁safety ▁of ▁pi og lita zone ▁during ▁pre gna ncy ▁ .
▁for ▁both ▁lung ▁cancer ▁and ▁pan creati c ▁cancer ▁ , ▁doctor s ▁should ▁take ▁the ▁patient ▁' s ▁chances ▁of ▁survival ▁into ▁account ▁when ▁pre scribi ng ▁tar ce va ▁ .
▁ry zo deg ▁can ▁be ▁used ▁in ▁adolescents ▁and ▁children ▁from ▁the ▁age ▁of ▁2 ▁years ▁with ▁diabetes ▁mell itus ▁ .
▁what ▁benefits ▁of ▁nu wi q ▁have ▁been ▁shown ▁in ▁studies ▁?
▁these ▁are ▁patients ▁in ▁whom ▁ , ▁following ▁the ▁initial ▁administration ▁of ▁simul ect ▁ , ▁the ▁con com i tant ▁immun os up pression ▁was ▁dis continu ed ▁prematur ely ▁due ▁ , ▁for ▁example ▁ , ▁to ▁abandon ed ▁transplant ation ▁or ▁early ▁loss ▁of ▁the ▁graf t ▁ .
▁the ▁inject ion ▁site ▁can ▁become ▁infect ed ▁( ▁un com mon ▁) ▁; ▁the ▁skin ▁may ▁become ▁swo llen ▁tender ▁and ▁hard ▁and ▁the ▁whole ▁area ▁could ▁be ▁very ▁pain ful ▁ .
▁iba ndro nic ▁acid ▁accord ▁3 ▁mg ▁solution ▁for ▁inject ion ▁in ▁pre - fill ed ▁sy ringe ▁must ▁not ▁be ▁mix ed ▁with ▁calci um - conta ining ▁solutions ▁( ▁such ▁as ▁ ringer - lac tate ▁solution ▁ , ▁calci um ▁hep arin ▁) ▁or ▁other ▁intra ven ously ▁ad minister ed ▁medicinal ▁products ▁ .
▁treatment ▁together ▁with ▁radio therapy ▁( ▁con com i tant ▁phase ▁) ▁first ▁followed ▁by ▁treatment ▁with ▁only ▁temo med ac ▁( ▁mono therapy ▁phase ▁) ▁ .
▁oral ▁contra cep tives ▁and ▁other ▁steroid al ▁agents ▁: ▁results ▁of ▁in ▁vi tro ▁studies ▁demonstrat e ▁that ▁du lo xe tine ▁does ▁not ▁induc e ▁the ▁cata ly tic ▁activity ▁of ▁cy p 3 a ▁ .
▁tha li domi de ▁cel gene ▁50 ▁mg ▁hard ▁capsule s
▁the ▁european ▁commission ▁gran ted ▁a ▁marketing ▁author isation ▁valid ▁throughout ▁the ▁eu ▁for ▁to pote can ▁ho spira ▁on ▁10 ▁ju ne ▁2010 ▁ .
▁ir besar tan ▁hydro ch lor o thi azi de ▁zen tiva ▁is ▁used ▁to ▁treat ▁high ▁blood ▁pressure ▁ , ▁when ▁treatment ▁with ▁ir besar tan ▁or ▁hydro ch lor o thi azi de ▁alone ▁did ▁not ▁provide ▁adequat e ▁control ▁of ▁your ▁blood ▁pressure ▁ .
▁5 ▁how ▁to ▁store ▁glu bra va
▁if ▁not ▁used ▁immediately ▁ , ▁in - use ▁storage ▁times ▁and ▁conditions ▁are ▁the ▁responsibility ▁of ▁the ▁user ▁ .
▁met form in ▁may ▁act ▁via ▁three ▁mechanism s ▁:
▁all ▁of ▁the ▁patients ▁received ▁or encia ▁for ▁four ▁months ▁ , ▁before ▁the ▁122 ▁who ▁responde d ▁were ▁then ▁either ▁switch ed ▁to ▁place bo ▁or ▁continued ▁receiving ▁or encia ▁ .
▁filter s ▁made ▁of ▁poly vin yli den e ▁fluor ide ▁( ▁p vd f ▁) ▁or ▁nylon ▁must ▁not ▁be ▁used ▁ .
▁brin telli x ▁5 ▁mg ▁film - co ated ▁tablets ▁brin telli x ▁10 ▁mg ▁film - co ated ▁tablets ▁brin telli x ▁15 ▁mg ▁film - co ated ▁tablets ▁brin telli x ▁20 ▁mg ▁film - co ated ▁tablets
▁imati ni b ▁act avis ▁contain s ▁le ci thin ▁( ▁so ya ▁)
▁use ▁in ▁the ▁pa e dia tric ▁patient ▁population ▁is ▁not ▁recommended ▁ .
▁nespo ▁is ▁a ▁clear ▁ , ▁colour less ▁or ▁slightly ▁pe ar ly ▁liquid ▁ .
▁the ▁main ▁study ▁was ▁carried ▁out ▁in ▁two ▁phase s ▁in ▁151 ▁dog s ▁with ▁mast ▁cell ▁tu mo urs ▁ .
▁by ▁increasing ▁levels ▁of ▁dop amine ▁in ▁the ▁parts ▁of ▁the ▁brain ▁that ▁control ▁movement ▁and ▁co - ordina tion ▁ , ▁az il ect ▁improve s ▁the ▁sign s ▁and ▁symptoms ▁of ▁par kin son ▁' s ▁disease ▁ , ▁such ▁as ▁sti ff ness ▁and ▁slow ness ▁of ▁movement ▁ .
▁av ag lim ▁tablets ▁contain ▁a ▁small ▁amount ▁of ▁la ctos e ▁ .
▁take ▁half ▁a ▁glass ▁of ▁still ▁( ▁non - car bona ted ▁) ▁water ▁ .
▁om e ▁types ▁of ▁cancer ▁like ▁cancer ▁of ▁the ▁o eso pha gus ▁and ▁bile ▁ duct ▁feeling ▁di zzy ▁ , ▁fa int ▁or ▁light ▁head ed ▁when ▁standing ▁up
▁powder ▁for ▁concentrat e ▁for ▁dispersi on ▁for ▁in fusion ▁4 ▁mg ▁mi fa mur ti de
▁for ▁patients ▁with ▁ros 1- posi tive ▁n sc lc ▁ , ▁for ▁whom ▁no ▁specific ▁treatment s ▁are ▁currently ▁available ▁ , ▁the ▁ch mp ▁not ed ▁the ▁evidence ▁of ▁a ▁high ▁response ▁rate ▁ , ▁in ▁particular ▁for ▁patients ▁who ▁had ▁previously ▁received ▁other ▁cancer ▁treatment s . ther e fore ▁the ▁ch mp ▁decided ▁that ▁xal kori ▁' s ▁benefits ▁are ▁greater ▁than ▁its ▁risk s ▁and ▁recommended ▁that ▁it ▁be ▁given ▁marketing ▁author isation ▁ .
▁make ▁sure ▁the ▁plu nger ▁is ▁push ed ▁all ▁the ▁way ▁into ▁the ▁sy ringe ▁ .
▁put ▁the ▁out er ▁need le ▁cover ▁on ▁ .
▁certi fec t ▁67 ▁mg ▁/ ▁60 . 3 ▁mg ▁/ ▁80 ▁mg ▁spot - on ▁solution ▁for ▁dog s ▁2 -10 ▁kg ▁certi fec t ▁134 ▁mg ▁/ ▁12 0.6 ▁mg ▁/ ▁160 ▁mg ▁spot - on ▁solution ▁for ▁dog s ▁10-20 ▁kg ▁certi fec t ▁26 8 ▁mg ▁/ ▁24 1.2 ▁mg ▁/ ▁320 ▁mg ▁spot - on ▁solution ▁for ▁dog s ▁20 -40 ▁kg ▁certi fec t ▁40 2 ▁mg ▁/ ▁36 1.8 ▁mg ▁/ ▁480 ▁mg ▁spot - on ▁solution ▁for ▁dog s ▁40 -60 ▁kg
▁red ness ▁ , ▁heat ▁ , ▁unusual ▁swe lling ▁of ▁skin ▁or ▁joint ▁abdominal ▁pain ▁/ ▁tender ness ▁and ▁/ ▁or ▁change ▁in ▁bo wel ▁function
▁t wyn sta ▁can ▁also ▁be ▁used ▁in ▁place ▁of ▁treatment ▁with ▁tel mis ar tan ▁and ▁am lo di pine ▁in ▁patients ▁who ▁are ▁taking ▁both ▁medicine s ▁as ▁separate ▁tablets ▁ .
▁allergi c ▁reaction s ▁: ▁allergi c - type ▁reaction s ▁ , ▁including ▁ana phy la xis ▁ , ▁skin ▁ rash ▁ , ▁ur tica ria ▁ , ▁ang io ede ma ▁ , ▁dys p no e a ▁and ▁hypo tension ▁ , ▁occur ring ▁on ▁initial ▁or ▁subsequent ▁treatment ▁ , ▁have ▁been ▁reported ▁in ▁patients ▁receiving ▁fil gra s tim ▁ .
▁what ▁you ▁need ▁to ▁know ▁before ▁you ▁take ▁v fen d ▁do ▁not ▁take ▁v fen d ▁:
▁in vira se ▁is ▁used ▁by ▁hi v -1 - infect ed ▁adults ▁ .
▁dog s ▁should ▁not ▁be ▁bat hed ▁or ▁shampoo ed ▁from ▁48 ▁hours ▁before ▁treatment ▁ .
▁con com i tant ▁use ▁of ▁ri oci gu at ▁with ▁p de 5 ▁inhibi tors ▁ , ▁including ▁ta dala fil ▁ , ▁is ▁contra indica ted ▁( ▁see ▁section ▁4.3 ▁) ▁ .
▁it ▁represent s ▁approximately ▁10 ▁% ▁of ▁the ▁concentration ▁of ▁valde co x ib ▁; ▁because ▁of ▁this ▁metabol ite ▁' s ▁low ▁concentration ▁ , ▁it ▁is ▁not ▁expected ▁to ▁contribute ▁a ▁significant ▁clinic al ▁effect ▁after ▁administration ▁of ▁ therapeut ic ▁dos es ▁of ▁pare co x ib ▁ .
▁patients ▁had ▁a ▁media n ▁plate let ▁count ▁of ▁19 ▁x ▁109 ▁/ ▁l ▁at ▁study ▁entry ▁ .
▁clo pido gre l ▁zen tiva ▁contain s ▁hydro gen ated ▁cas tor ▁oil
▁what ▁is ▁the ▁risk ▁associated ▁with ▁cho le sta gel ▁?
▁risk ▁of ▁symptom a tic ▁hypo tension
▁risk ▁of ▁loss ▁of ▁ therapeut ic ▁effect ▁and
▁un com mon ▁( ▁may ▁affect ▁up ▁to ▁1 ▁in ▁100 ▁people ▁) ▁:
▁refer ▁to ▁summary ▁of ▁product ▁character istic s ▁for ▁riba vir in ▁and ▁pe g inter fer on ▁alfa ▁for ▁additional ▁information ▁ .
▁tu mo urs ▁of ▁the ▁hypo thala mus ▁or ▁pit uit ary ▁g land ▁;
▁considering ▁their ▁mechanism ▁of ▁action ▁ , ▁the ▁con com i tant ▁use ▁of ▁these ▁medicinal ▁products ▁is ▁not ▁recommended ▁ .
▁the ▁words ▁" ▁keep ▁out ▁of ▁the ▁sight ▁and ▁reach ▁of ▁children ▁"
▁bu mp y ▁ rash ▁blood ▁infection ▁ .
▁with ▁care ful ▁rec hallen ge ▁fa bra zy me ▁has ▁been ▁re - ad minister ed ▁to ▁all ▁6 ▁patients ▁who ▁test ed ▁positive ▁for ▁ ige ▁anti bo dies ▁or ▁had ▁a ▁positive ▁skin ▁test ▁to ▁fa bra zy me ▁in ▁a ▁clinic al ▁trial ▁ .
▁each ▁tablet ▁contain s ▁ 285 . 80 ▁mg ▁la ctos e ▁mono hydrat e ▁ .
▁ tyl valo sin ▁( ▁as ▁ tyl valo sin ▁tart rate ▁) ▁4 2.5 ▁mg ▁/ ▁g
▁only ▁the ▁re fill ▁kit ▁( ▁sy ringe ▁and ▁stop cock ▁) ▁ , ▁re fill ▁need les ▁ , ▁port ▁loca ting ▁template ▁suppli ed ▁by ▁med tronic ▁minim ed ▁and ▁steril e ▁rin se ▁bu ffer ▁solution ▁manufacture d ▁by ▁sano fi - ave ntis ▁ deutschland ▁g m bh ▁should ▁be ▁used ▁with ▁insu man ▁implant able ▁to ▁flu sh ▁the ▁cat heter ▁ .
▁your ▁other ▁hand ▁will ▁be ▁free ▁to ▁move ▁the ▁plu nger ▁ .
▁if ▁not ▁used ▁immediately ▁ , ▁in - use ▁storage ▁times ▁and ▁conditions ▁prior ▁to ▁use ▁are ▁the ▁responsibility ▁of ▁the ▁user ▁and ▁would ▁normal ly ▁not ▁be ▁longer ▁than ▁24 ▁hours ▁at ▁2 ▁° ▁c ▁to ▁8 ▁° ▁c ▁ , ▁unless ▁dilu tion ▁has ▁taken ▁place ▁in ▁control led ▁and ▁valida ted ▁a se ptic ▁conditions ▁ .
▁therefore ▁ , ▁patients ▁should ▁be ▁advise d ▁not ▁to ▁wear ▁contact ▁l enses ▁during ▁treatment ▁with ▁y ello x ▁ .
▁vi cto za ▁is ▁used ▁in ▁adults ▁who ▁have ▁type ▁2 ▁diabetes ▁to ▁control ▁their ▁blood ▁gluco se ▁( ▁sugar ▁) ▁level ▁ .
▁further ▁in ▁this ▁le a flet ▁it ▁tell s ▁you ▁how ▁to ▁deal ▁with ▁mild ▁hypo gly ca emia ▁( ▁see ▁section ▁3 ▁: ▁if ▁you ▁take ▁more ▁ huma log ▁mix 50 ▁than ▁you ▁need ▁) ▁ . ▁if ▁you ▁are ▁allergi c ▁( ▁hyper sensitiv e ▁) ▁to ▁insulin ▁li s pro ▁or ▁any ▁of ▁the ▁other ▁ingredients ▁of ▁this ▁medicine ▁( ▁listed ▁in ▁section ▁6 ▁) ▁ .
▁after ▁24 ▁hours ▁ , ▁the ▁mean ▁cum ul ative ▁ab sor p tion ▁( ▁including ▁accumula tion ▁in ▁the ▁der mis ▁) ▁through ▁human ▁skin ▁was ▁0.2 ▁% ▁of ▁the ▁ad minister ed ▁dose ▁ .
▁no ▁dos age ▁adjust ment ▁is ▁necessary ▁in ▁female ▁patients ▁ .
▁tablet ▁core ▁: ▁la ctos e ▁mono hydrat e ▁ , ▁po vido ne ▁ , ▁cro spo vido ne ▁type ▁a ▁ , ▁pre gel atin ized ▁star ch ▁( ▁mai ze ▁) ▁ , ▁tal c ▁ , ▁an hydro us ▁collo i dal ▁si lica ▁ , ▁la ctos e ▁an hydro us ▁and ▁magnesium ▁stea rate ▁ .
▁zo meta ▁has ▁been ▁studie d ▁in ▁over ▁ 3,000 ▁adults ▁with ▁bone ▁metas tas es ▁in ▁three ▁main ▁studies ▁looking ▁at ▁its ▁ability ▁to ▁prevent ▁bone ▁damage ▁ .
▁sign s ▁of ▁osteo ne cro sis ▁include ▁:
▁hyper sensitiv ity ▁to ▁the ▁active ▁substance ▁or ▁to ▁any ▁of ▁the ▁ex cip ient s ▁listed ▁in ▁section ▁6.1 ▁..
▁ pharma co therapeut ic ▁group ▁: ▁op h thal m ological s ▁/ ▁anti ne ova s cular isation ▁agents ▁at c ▁code ▁: ▁s 01 la 05
▁pot ac ta sol ▁4 ▁mg ▁powder ▁for ▁concentrat e ▁for ▁solution ▁for ▁in fusion
▁and rogen ▁de privat ion ▁ therapy ▁may ▁prolong ▁the ▁q t ▁interval
▁when ▁rever sal ▁of ▁neutro p enia ▁has ▁been ▁achieve d ▁ , ▁the ▁minimal ▁effective ▁dose ▁to ▁maintain ▁a ▁normal ▁neutro phil ▁count ▁should ▁be ▁established ▁ .
▁redde ning ▁of ▁the ▁skin ▁with ▁bli sters ▁or ▁peeling ▁ .
▁you ▁should ▁throw ▁away ▁the ▁bottle ▁four ▁weeks ▁after ▁you ▁first ▁opened ▁it ▁to ▁prevent ▁infection s ▁ , ▁and ▁use ▁a ▁new ▁bottle ▁ .
▁this ▁presentation ▁is ▁intended ▁for ▁multiple ▁use ▁ .
▁data ▁cut off ▁: ▁07 ▁sep ▁2012
▁breast - feed ing ▁should ▁be ▁stopped ▁during ▁treatment ▁with ▁i clusi g ▁ .
▁children ▁were ▁followed ▁until ▁3.5 ▁years ▁of ▁age ▁ .
▁a ▁1 ▁ml ▁sy ringe ▁; ▁a ▁long ▁need le ▁( ▁for ▁example ▁ 0.8 ▁40 ▁mm ▁[ ▁21 ▁gau ge ▁1.5 ▁in ch ▁] ▁) ▁to ▁be ▁used ▁to ▁add ▁water ▁for ▁inject ions ▁to ▁the ▁vir af eron pe g ▁powder ▁vi al ▁;
▁if ▁you ▁have ▁any ▁further ▁questions ▁on ▁the ▁use ▁of ▁this ▁medicine ▁ , ▁ask ▁a ▁doctor ▁or ▁ pharma ci st ▁ .
▁dose ▁re duction ▁of ▁cep lene ▁is ▁normal ly ▁not ▁required ▁in ▁he pat ically ▁im pair ed ▁patients ▁ , ▁but ▁cau tion ▁should ▁be ▁used ▁in ▁these ▁patients ▁ .
▁a ▁risk ▁management ▁plan ▁has ▁been ▁developed ▁to ▁ensure ▁that ▁rasi lam lo ▁is ▁used ▁as ▁safe ly ▁as ▁possible ▁ .
▁improvement ▁in ▁exercise ▁capacity ▁was ▁ac com pani ed ▁by ▁improvement ▁in ▁multiple ▁clinic ally ▁relevant ▁seconda ry ▁end point s ▁ .
▁swo llen ▁g lands ▁( ▁lymph ▁no des ▁) ▁ , ▁agita tion ▁ , ▁tre mor ▁ , ▁ab normal ▁dream ▁ , ▁excessive ▁muscle ▁activity ▁ , ▁de personal isation ▁( ▁not ▁feeling ▁like ▁yourself ▁) ▁ , ▁medicine ▁ dependence ▁ , ▁am ne sia ▁( ▁memory ▁disturb ance ▁) ▁ , ▁loss ▁of ▁interest ▁ , ▁ex a gger ated ▁feeling ▁of ▁well ▁being ▁ , ▁convuls ion ▁( ▁fit s ▁) ▁ , ▁speech ▁disorder ▁ , ▁small ▁pupil ▁size ▁ , ▁difficult y ▁urin ating ▁ , ▁eye ▁ inflammation ▁or ▁infection ▁ , ▁rapid ▁or ▁slow ▁heart ▁beat ▁ , ▁low ▁blood ▁pressure ▁ , ▁palp it ations ▁ , ▁my o card ial ▁in far ction ▁( ▁heart ▁attack ▁) ▁ , ▁che st ▁tight ness ▁ , ▁short ness ▁of ▁breath ▁ , ▁as th ma ▁ , ▁ya w ning ▁ , ▁pain ▁and ▁so res ▁in ▁mouth ▁ , ▁ton gue ▁disco lou ration ▁ , ▁ac ne ▁ , ▁skin ▁no du le ▁ , ▁hair ▁loss ▁ , ▁dry ▁or ▁scal ing ▁skin ▁ , ▁ inflammation ▁of ▁joint s ▁ , ▁urin ary ▁tract ▁infection ▁ , ▁ab normal ▁blood ▁tests ▁ , ▁blood ▁in ▁urin e ▁ , ▁ab normal ▁e ja c ulation ▁ , ▁menstrua l ▁or ▁vaginal ▁problems ▁ , ▁ki dne y ▁ stone ▁ , ▁protein ▁in ▁your ▁urin e ▁ , ▁pain ful ▁or ▁difficult ▁urin ation ▁ , ▁ sensitiv ity ▁to ▁heat ▁or ▁cold ▁ , ▁heat ▁stroke ▁ , ▁loss ▁of ▁appetit e ▁ , ▁feeling s ▁of ▁hostil ity ▁ .
▁combination ▁anti ret rovi ral ▁ therapy ▁has ▁been ▁associated ▁with ▁metabol ic ▁ab normal ities ▁such ▁as b lood ▁tri gly ceri des ▁increased ▁ , ▁blood ▁cholesterol ▁increased ▁ , ▁insulin ▁resist ance ▁ , ▁hyper gly ca emia ▁and ▁hyper lac ta emia ▁ .
▁in ▁both ▁pro phy la xis ▁studies ▁ , ▁a sper gil los is ▁was ▁the ▁most ▁common ▁break through ▁infection ▁ .
▁blad der ▁cat heter isation ▁should ▁be ▁under tak en ▁in ▁patients ▁with ▁urin ary ▁ob struct ion ▁ .
▁pack ▁of ▁7 ▁only ▁for ▁first ▁week ▁of ▁dos ing ▁ , ▁28 ▁and ▁98
▁overall ▁response ▁rate ▁was ▁49 ▁% ▁in ▁the ▁xe li ri ▁and ▁48 ▁% ▁in ▁the ▁fol fir i ▁arm ▁( ▁p ▁= ▁0 . 76 ▁) ▁ .
▁if ▁you ▁take ▁more ▁clo pido gre l ▁he xal ▁than ▁you ▁should
▁in ▁pre clin ical ▁studies ▁knock out ▁mi ce ▁la cking ▁rank ▁or ▁rank l ▁had ▁an ▁ absence ▁of ▁lac tation ▁due ▁to ▁inhibi tion ▁of ▁mamma ry ▁g land ▁matur ation ▁( ▁lo bulo - al ve o lar ▁g land ▁development ▁during ▁pre gna ncy ▁) ▁and ▁exhibi ted ▁im pair ment ▁of ▁lymph ▁no de ▁formation ▁ .
▁approximately ▁62 ▁% ▁of ▁rano lazi ne ▁is ▁ bound ▁to ▁plasma ▁protein s ▁ , ▁and ▁therefore ▁ , ▁complete ▁clear ance ▁by ▁ha e modi al ysis ▁is ▁un like ly ▁ .
▁this ▁dose ▁is ▁adequat ely ▁deliver ed ▁by ▁one ▁pump ▁activa tion ▁ .
▁me at ▁and ▁of fal ▁: ▁pig s ▁: ▁13 ▁days ▁ .
▁le flu nom ide ▁med ac ▁15 ▁mg ▁film - co ated ▁tablets ▁are ▁white ▁to ▁almost ▁white ▁and ▁round ▁with ▁a ▁diameter ▁of ▁about ▁7 ▁mm ▁ .
▁accident al ▁one - time ▁exposure ▁to ▁free zing ▁temperature s ▁does ▁not ▁advers ely ▁affect ▁the ▁stabilit y ▁of ▁gra stof il ▁ .
▁no ▁car cino geni city ▁studies ▁have ▁been ▁conduct ed ▁with ▁te li thro my cin ▁ .
▁it ▁is ▁not ▁intended ▁to ▁provide ▁practical ▁advice ▁on ▁how ▁to ▁use ▁nu wi q ▁ .
▁feno fi bra te ▁is ▁a ▁fi bric ▁acid ▁deriva tive ▁whose ▁lipid ▁mod ifying ▁effects ▁reported ▁in ▁humans ▁are ▁media ted ▁via ▁activa tion ▁of ▁pero xi some ▁prolifera tor ▁activa ted ▁receptor ▁type ▁al pha ▁( ▁ ppar ▁) ▁ .
▁c ▁60 ▁mg ▁/ ▁m 2 ▁i . v . ▁ , ▁days ▁22 -25 ▁ , ▁29 -32
▁adults ▁not ▁previously ▁vaccin ated ▁with ▁23- valent ▁pneu moc oc cal ▁poly s ac char ide ▁vaccin e
▁in vo kana ▁has ▁been ▁evaluat ed ▁in ▁9 ▁main ▁studies ▁in vol ving ▁a ▁total ▁of ▁around ▁10,000 ▁patients ▁with ▁type ▁2 ▁diabetes ▁ .
▁ha emo glob in ▁decrease d ▁white ▁blood ▁cell ▁count ▁decrease d
▁hyper sensitiv ity ▁to ▁the ▁active ▁substance s ▁or ▁to ▁any ▁of ▁the ▁ex cip ient s ▁listed ▁in ▁section ▁6.1 ▁ , ▁or ▁to ▁other ▁sul fon ami de - der i ved ▁substance s ▁( ▁hydro ch lor o thi azi de ▁is ▁a ▁sul fon ami de - der i ved ▁substance ▁)
▁this ▁does ▁not ▁affect ▁normal ▁operation ▁of ▁the ▁sy ringe ▁and ▁the ▁sy ringe ▁can ▁be ▁rota ted ▁in ▁the ▁device ▁ .
▁ri lu zole ▁stop s ▁the ▁release ▁of ▁glu tama te ▁and ▁this ▁may ▁help ▁in ▁prevent ing ▁the ▁nerv e ▁cell s ▁being ▁damage d ▁ .
▁have ▁a ▁condition ▁called ▁' ▁auto im mu ne ▁hepatitis ▁' ▁are ▁taking ▁be pri dil ▁ , ▁pi moz ide ▁ , ▁oral ▁mida zola m ▁ , ▁oral ▁tri azo lam ▁ , ▁sim vasta tin ▁ , ▁lo vasta tin ▁ , ▁al fuz os in ▁ , ▁si lo dos in ▁ , ▁' ▁ergo t ▁' ▁type ▁medicine s ▁( ▁such ▁as ▁di hydro - er go tamine ▁ , ▁er gon ovine ▁ , ▁ergo tamine ▁or ▁met hy ler gon ovine ▁) ▁ , ▁lume fant rine ▁ , ▁hal o fant rine ▁ , ▁que tiap ine ▁ , ▁or ▁ty ros ine ▁kina se ▁inhibi tors ▁ .
▁met hyl thi oni nium ▁chlor ide ▁prove blue ▁is ▁a ▁' ▁hybrid ▁generic ▁medicine ▁' ▁ .
▁patients ▁with ▁al z heim er ▁' s ▁disease ▁may ▁los e ▁weight ▁ .
▁symptoms ▁of ▁diabetes ▁in si pid us ▁include ▁pas sing ▁a ▁lot ▁of ▁urin e ▁and ▁feeling ▁ thir sty ▁ .
▁inter stiti al ▁lung ▁disease ▁( ▁ inflammation ▁of ▁the ▁tissu e ▁around ▁the ▁air ▁sa cks ▁of ▁the ▁lung s ▁) ▁ .
▁nepa fen ac ▁under go es ▁relative ly ▁rapid ▁bio activa tion ▁to ▁am fen ac ▁via ▁intra o cular ▁hydro las es ▁ .
▁in cre lex ▁works ▁in ▁the ▁same ▁way ▁as ▁natural ▁ ig f -1 ▁ , ▁re plac ing ▁the ▁missing ▁hormone ▁and ▁helping ▁the ▁child ▁to ▁grow ▁taller ▁ .
▁label ▁amb er ▁glass ▁bottle ▁120 ▁and ▁210 ▁ml
▁in ▁clinic al ▁studies ▁with ▁cho ndro c elect ▁a ▁per ios te al ▁f lap ▁was ▁used ▁as ▁a ▁bi ological ▁membran e ▁ .
▁the ▁potential ▁risk ▁of ▁co ugh ▁related ▁se que la e ▁during ▁treatment
▁treatment ▁of ▁ana emia ▁associated ▁with ▁chronic ▁renal ▁failure ▁in ▁adult ▁and ▁pa e dia tric ▁patients ▁on ▁ha e modi al ysis ▁and ▁adult ▁patients ▁on ▁per ito ne al ▁di al ysis ▁( ▁see ▁section ▁4.4 ▁) ▁ .
▁children ▁( ▁non ▁approved ▁use ▁) ▁and ▁patients ▁with ▁under ly ing ▁neuro mus cular ▁disorder s ▁including ▁s w allowing ▁disorder s ▁are ▁at ▁increased ▁risk ▁of ▁these ▁advers e ▁reaction s ▁ .
▁the ▁powder ▁is ▁a ▁white ▁to ▁off - white ▁cake ▁and ▁the ▁solve nt ▁is ▁a ▁colour less ▁liquid ▁ .
▁how ▁is ▁on brez ▁bre ezh a ler ▁used ▁?
▁li pro log ▁mix 50 ▁100 ▁unit s ▁/ ▁ml ▁suspens ion ▁for ▁inject ion ▁in ▁cart ridge
▁the ▁marketing ▁author isation ▁is ▁valid ▁for ▁an ▁unlimited ▁period ▁ .
▁the ▁most ▁serious ▁side ▁effect ▁reported ▁with ▁ste lara ▁is ▁serious ▁hyper sensitiv ity ▁( ▁allergi c ▁reaction ▁) ▁ .
▁people ▁with ▁known ▁hyper sensitiv ity ▁to ▁non ▁ste rio dal ▁anti - in flam ma tory ▁drugs ▁( ▁ nsa ids ▁) ▁should ▁avoid ▁contact ▁with ▁the ▁veterinar y ▁medicinal ▁product ▁ .
▁the ▁ef fica cy ▁of ▁das atin ib ▁is ▁based ▁on ▁ha e mat ological ▁and ▁cy to gene tic ▁response ▁rates ▁ .
▁the ▁company ▁will ▁also ▁provide ▁an ▁educational ▁plan ▁for ▁doctor s ▁and ▁patients ▁ .
▁in ▁cases ▁of ▁severe ▁cardio pul mon ary ▁depression ▁ , ▁administration ▁of ▁se vo flu rane ▁should ▁be ▁dis continu ed ▁ , ▁the ▁ existence ▁of ▁a ▁patent ▁air way ▁ensure d ▁ , ▁and ▁assist ed ▁or ▁control led ▁ventilation ▁with ▁pure ▁oxygen ▁initiat ed ▁ .
▁the ▁full ▁e par ▁for ▁pla vi x ▁can ▁be ▁found ▁on ▁the ▁agency ▁' s ▁website ▁ema . europa . eu ▁/ ▁find ▁medicine ▁/ ▁human ▁medicine s ▁/ ▁european ▁public ▁assessment ▁reports ▁ .
▁this ▁medicine ▁works ▁by ▁inhibi ting ▁the ▁growth ▁of ▁ab normal ▁cell s ▁in ▁the ▁disease s ▁listed ▁below ▁ .
▁u ab ▁mer ck ▁sharp ▁& ▁do h me ▁ , ▁tel ▁ . ▁:
▁part ▁of ▁the ▁decrease ▁can ▁be ▁attribut ed ▁to ▁ex cre tion ▁of ▁64 cu ▁into ▁the ▁bile ▁ , ▁urin e ▁and ▁fa e ces ▁ .
▁the ▁need le ▁cap ▁of ▁the ▁sy ringe ▁may ▁contain ▁dry ▁rub ber ▁( ▁la tex ▁) ▁ .
▁intermedi ate ▁carton ▁of ▁the ▁multi pack s ▁of ▁360 ▁( ▁4 ▁pack s ▁of ▁90 ▁x ▁1 ▁tablets ▁) ▁- ▁without ▁blue ▁box ▁- ▁80 ▁mg ▁/ ▁5 ▁mg
▁if ▁you ▁experience ▁prolong ed ▁ble ed ing ▁when ▁taking ▁clo pido gre l ▁kr ka ▁d . d ▁ .
▁in ▁children ▁ , ▁som a trop in ▁bio partner s ▁should ▁be ▁ad minister ed ▁sub cuta ne ously ▁at ▁a ▁concentration ▁of ▁20 ▁mg ▁/ ▁ml ▁ .
▁rare ▁side ▁effects ▁( ▁may ▁affect ▁up ▁to ▁1 ▁in ▁1,000 ▁people ▁) ▁:
▁each ▁film - co ated ▁tablet ▁contain s ▁75 ▁mg ▁of ▁ir besar tan ▁ex cip ient ▁with ▁known ▁effect ▁:
▁ri lona cept ▁regener on ▁80 ▁mg ▁/ ▁ml ▁powder ▁and ▁solve nt ▁for ▁solution ▁for ▁inject ion ▁ri lona cept
▁the ▁maximum ▁recommended ▁dose ▁of ▁inom ax ▁is ▁20 ▁pp m ▁and ▁this ▁dose ▁should ▁not ▁be ▁exceed ed ▁ .
▁no ▁additional ▁advers e ▁reaction s ▁to ▁those ▁reported ▁for ▁normal ▁dos es ▁were ▁reported ▁ .
▁you ▁may ▁want ▁to ▁consider ▁asking ▁a ▁family ▁member ▁or ▁close ▁friend ▁to ▁help ▁you ▁stay ▁alert ▁to ▁sign s ▁of ▁depression ▁or ▁changes ▁in ▁your ▁behaviour ▁ .
▁the ▁active ▁substance ▁in ▁op ry mea ▁ , ▁pra mi pe xo le ▁ , ▁is ▁a ▁dop amine ▁ago nist ▁ , ▁which ▁imita tes ▁the ▁action ▁of ▁dop amine ▁ .
▁the ▁vaccin e ▁is ▁used ▁to ▁prevent ▁vir a emia ▁( ▁the ▁presence ▁of ▁the ▁virus ▁in ▁the ▁blood ▁) ▁in ▁ca ttle ▁from ▁three ▁months ▁of ▁age ▁ .
▁over ▁the ▁course ▁of ▁this ▁6- year ▁study ▁ , ▁42 ▁% ▁of ▁the ▁insulin ▁g lar gine ▁100 ▁unit s ▁/ ▁ml ▁group ▁did ▁not ▁experience ▁any ▁hypo gly ca emia ▁ .
▁push ▁the ▁plu nger ▁slowly ▁to ▁inject ▁the ▁solve nt ▁into ▁the ▁powder ▁vi al ▁ .
▁zal asta ▁2.5 ▁mg ▁tablets
▁the ▁exp i ry ▁date ▁refer s ▁to ▁the ▁last ▁day ▁of ▁the ▁month ▁ .
▁the ▁patient ▁or ▁their ▁partner ▁may ▁carry ▁out ▁the ▁inject ion ▁if ▁they ▁have ▁been ▁train ed ▁and ▁have ▁access ▁to ▁expert ▁advice ▁ .
▁in ▁a ▁poole d ▁analysis ▁of ▁two ▁five - year ▁open - label ▁extension ▁studies ▁( ▁ 586 ▁patients ▁total ▁) ▁the ▁combine d ▁graf t ▁and ▁patient ▁survival ▁rates ▁were ▁not ▁statistic ally ▁different ▁for ▁the ▁basi li xim ab ▁and ▁place bo ▁groups ▁ .
▁the ▁safety ▁and ▁ef fica cy ▁of ▁bio po in ▁in ▁children ▁and ▁adolescents ▁a ged ▁up ▁to ▁17 ▁years ▁have ▁not ▁yet ▁been ▁established ▁ .
▁it ▁is ▁given ▁as ▁an ▁in fusion ▁into ▁your ▁ve in
▁treatment - na ï ve ▁hi v -1 ▁infect ed ▁patients
▁use ▁during ▁pre gna ncy ▁ , ▁lac tation ▁or ▁la y
▁the ▁patient ▁may ▁carry ▁out ▁the ▁inject ion ▁herself ▁if ▁she ▁is ▁well - motiv ated ▁ , ▁has ▁been ▁adequat ely ▁train ed ▁and ▁has ▁access ▁to ▁expert ▁advice ▁ .
▁therefore ▁the ▁use ▁of ▁this ▁medicine ▁in ▁children ▁and ▁adolescents ▁is ▁not ▁recommended ▁ .
▁therefore ▁ , ▁this ▁medicinal ▁product ▁must ▁be ▁dis continu ed ▁prior ▁to ▁ , ▁or ▁at ▁the ▁time ▁of ▁the ▁test ▁and ▁not ▁re institut ed ▁until ▁48 ▁hours ▁after ward s ▁ , ▁and ▁only ▁after ▁renal ▁function ▁has ▁been ▁re - evalua ted ▁and ▁found ▁to ▁be ▁normal ▁( ▁see ▁section ▁4.4 ▁) ▁ .
▁animal ▁reproduc tion ▁studies ▁with ▁form ote rol ▁have ▁shown ▁a ▁somewhat ▁reduce d ▁fertil ity ▁in ▁male ▁rat s ▁at ▁high ▁system ic ▁exposure ▁and ▁implant ation ▁los ses ▁as ▁well ▁as ▁decrease d ▁early ▁post na tal ▁survival ▁and ▁birth ▁weight ▁at ▁considera bly ▁higher ▁system ic ▁exposure s ▁than ▁those ▁reached ▁during ▁clinic al ▁use ▁ .
▁usually ▁the ▁advers e ▁reaction s ▁caused ▁by ▁en ta ca pone ▁are ▁mild ▁to ▁moderat e ▁ .
▁the ▁physician ▁should ▁be ▁consulte d ▁when ▁using ▁other ▁medication s ▁in ▁addition ▁to ▁li pro log ▁kwi k pen ▁( ▁see ▁section ▁4.4 ▁) ▁ .
▁use ▁the ▁inject ion ▁method ▁as ▁instru cted ▁by ▁your ▁doctor ▁ , ▁ pharma ci st ▁or ▁nurse ▁ .
▁the ▁primary ▁end point ▁in ▁ra ▁study ▁v ▁was ▁the ▁percent ▁of ▁patients ▁who ▁achieve d ▁an ▁ac r ▁50 ▁response ▁at ▁week ▁52 ▁ .
▁common ▁: ▁mood ▁disorder s ▁ , ▁ depressiv e ▁disorder s ▁ner vous ▁system ▁disorder s
▁z y pre xa ▁5 ▁mg ▁co ated ▁tablets
▁in ▁that ▁case ▁ , ▁infants ▁received ▁a ▁second ▁load ing ▁dose ▁of ▁20 ▁mg ▁/ ▁kg ▁ca ffe ine ▁cit rate ▁after ▁treatment ▁day ▁1 ▁and ▁before ▁treatment ▁day ▁8 ▁ .
▁do ▁not ▁use ▁if ▁foi l ▁po uch ▁seal ▁is ▁damage d ▁ .
▁use ▁the ▁veni punct ure ▁kit ▁suppli ed ▁with ▁the ▁product ▁ , ▁insert ▁the ▁need le ▁into ▁a ▁ve in ▁ .
▁what ▁measure s ▁are ▁being ▁taken ▁to ▁ensure ▁the ▁safe ▁use ▁of ▁photo bar r ▁?
▁from ▁a ▁micro bi ological ▁point ▁of ▁view ▁ , ▁the ▁product ▁should ▁be ▁used ▁immediately ▁ .
▁each ▁tablet ▁contain s ▁100 ▁mg ▁rito na vir ▁ .
▁when ▁ad minister ing ▁dro tre co gin ▁alfa ▁( ▁activa ted ▁) ▁at ▁low ▁flow ▁rates ▁( ▁less ▁than ▁approximately ▁5 ▁ml ▁/ ▁hr ▁) ▁ , ▁the ▁in fusion ▁set ▁must ▁be ▁prime d ▁for ▁approximately ▁15 ▁minutes ▁at ▁a ▁flow ▁rate ▁of ▁approximately ▁5 ▁ml ▁/ ▁hr ▁ .
▁after ▁a ▁minimum ▁of ▁60 ▁months ▁follow - up ▁the ▁cum ul ative ▁rate ▁of ▁permanent ▁dis continu ation ▁due ▁to ▁grade ▁3 ▁or ▁4 ▁mye los up pression ▁was ▁2.3 ▁% ▁ .
▁after ▁receiving ▁adequat e ▁training ▁ , ▁you ▁ , ▁a ▁family ▁member ▁ , ▁friend ▁or ▁care r ▁can ▁use ▁re bi f ▁sy ring es ▁to ▁ad minister ▁the ▁medicine ▁at ▁home ▁ .
▁in ▁addition ▁ , ▁an ▁updated ▁r mp ▁should ▁be ▁submitted
▁sud den ▁w hee zing ▁ , ▁swe lling ▁of ▁your ▁lips ▁ , ▁ton gue ▁and ▁ thro at ▁ , ▁ rash ▁ , ▁fa in ting ▁or ▁difficult ies ▁in ▁s w allowing ▁( ▁severe ▁allergi c ▁reaction ▁ , ▁seen ▁rare ly ▁)
▁there ▁is ▁no ▁known ▁specific ▁anti do te ▁for ▁bort ez om ib ▁over dos e ▁ .
▁cho le sta gel ▁may ▁be ▁used ▁together ▁with ▁a ▁stati n ▁and ▁the ▁die t ▁low ▁in ▁fat ▁and ▁cholesterol ▁when ▁patients ▁are ▁not ▁appropriate ly ▁control led ▁by ▁the ▁stati n ▁on ▁its ▁own ▁ .
▁in ▁patients ▁with ▁a ▁history ▁of ▁mild ▁ liver ▁disease ▁or ▁ab normal ▁alan ine ▁amino transfer ase ▁( ▁alt ▁) ▁ , ▁as parta te ▁amino transfer ase ▁( ▁a st ▁) ▁and ▁/ ▁or ▁bilir u bin ▁at ▁base line ▁ , ▁bi mato prost ▁had ▁no ▁advers e ▁reaction s ▁on ▁ liver ▁function ▁over ▁24 ▁months ▁ .
▁how ▁to ▁store ▁lymph ose ek
▁when ▁possible ▁ , ▁di pyr ida mo le ▁should ▁be ▁with held ▁for ▁at ▁least ▁two ▁days ▁prior ▁to ▁rapi s can ▁administration ▁( ▁see ▁section ▁4.5 ▁) ▁ .
▁nu ede xta ▁should ▁be ▁dis continu ed ▁immediately ▁if ▁ thro mbo cy top enia ▁occur s ▁ , ▁unless ▁the ▁ thro mbo cy top enia ▁is ▁clearly ▁not ▁drug - related ▁ .
▁stop ▁taking ▁viva nza ▁and ▁contact ▁your ▁doctor ▁immediately ▁ .
▁do ▁not ▁use ▁a ▁pre - fill ed ▁pen ▁that ▁is ▁f rozen ▁or ▁if ▁it ▁has ▁been ▁left ▁in ▁direct ▁sun light ▁ .
▁co - administration ▁of ▁sa quina vir ▁and ▁rito na vir ▁has ▁led ▁to ▁severe ▁advers e ▁reaction s ▁ , ▁main ly ▁diabet ic ▁keto a cidos is ▁and ▁ liver ▁disorder s ▁ , ▁especially ▁in ▁patients ▁with ▁pre - exist ing ▁ liver ▁disease ▁ .
▁ab se a med ▁has ▁no ▁or ▁negli gi ble ▁influence ▁on ▁the ▁ability ▁to ▁drive ▁and ▁use ▁machines ▁ .
▁in ▁cases ▁of ▁severe ▁ha e mat ological ▁reaction s ▁ , ▁including ▁pa ncy top enia ▁ , ▁au bagi o ▁and ▁any ▁con com i tant ▁mye los up press ive ▁treatment ▁must ▁be ▁dis continu ed ▁and ▁a ▁teri flu nom ide ▁accelerat ed ▁elimina tion ▁procedure ▁should ▁be ▁considered ▁ .
▁increased ▁protein ▁levels ▁in ▁urin e
▁treatment ▁with ▁the ▁highest ▁strength ▁of ▁imp rida ▁h ct ▁was ▁more ▁effective ▁at ▁treat ing ▁hyper tension ▁than ▁dual ▁combination s ▁contain ing ▁any ▁of ▁the ▁two ▁active ▁substance s ▁ .
▁a baca vir ▁has ▁a ▁we ak ▁potential ▁to ▁cause ▁chr om oso mal ▁damage ▁both ▁in ▁vi tro ▁and ▁in ▁vivo ▁at ▁high ▁test ed ▁concentration s ▁ .
▁170 ▁09 ▁sol na ▁swe den
▁in vega ▁6 ▁mg ▁prolong ed - release ▁tablets ▁pali peri done
▁dra xx in ▁is ▁effective ▁against ▁the ▁bacteria ▁that ▁most ▁common ly ▁cause ▁br d ▁ , ▁s rd ▁ , ▁ ib k ▁and ▁foot ▁rot ▁ .
▁no ▁dose ▁adjust ment ▁is ▁necessary ▁for ▁patients ▁with ▁pre - exist ing ▁mild ▁he pati c ▁im pair ment ▁ , ▁child - p ugh ▁class ▁a ▁ .
▁no ▁serious ▁vaccin e - related ▁advers e ▁experiences ▁were ▁reported ▁ .
▁also ▁in ▁conditions ▁such ▁as ▁ul cer ative ▁col itis ▁ , ▁and ▁intestinal ▁at ony ▁ .
▁studies ▁in ▁animals ▁have ▁shown ▁reproduc tive ▁ toxic ity ▁( ▁see ▁section ▁5.3 ▁) ▁ .
▁applicable ▁to ▁dar una vir ▁boost ed ▁with ▁co bici stat ▁ , ▁not ▁when ▁boost ed ▁with ▁rito na vir ▁:
▁treatment ▁with ▁z y delig ▁must ▁be ▁with held ▁in ▁the ▁event ▁of ▁a ▁grade ▁3 ▁or ▁4 ▁amino transfer ase ▁eleva tion ▁( ▁alan ine ▁amino transfer ase ▁[ ▁alt ▁] ▁/ ▁as parta te ▁amino transfer ase ▁[ ▁a st ▁] ▁> ▁5 ▁x ▁upp er ▁limit ▁of ▁normal ▁[ ▁ul n ▁] ▁) ▁ .
▁no ▁clinic ally ▁relevant ▁interrupt ion ▁of ▁p 2 y 12 ▁inhibi tion ▁was ▁observe d ▁in ▁phase ▁i ii ▁studies ▁when ▁600 ▁mg ▁clo pido gre l ▁was ▁ad minister ed ▁immediately ▁after ▁dis continu ation ▁of ▁the ▁can gre lor ▁in fusion ▁ .
▁the ▁total ▁dose ▁is ▁6 ▁tablets ▁per ▁day ▁ ,
▁gastro inte stin al ▁symptoms ▁could ▁occur ▁ .
▁see ▁also ▁section ▁" ▁doce ta xel ▁accord ▁contain s ▁et han ol ▁( ▁alcohol ▁) ▁" ▁below ▁ .
▁a ▁target ▁ap tt ▁of ▁50 -70 ▁seconds ▁was ▁recommended ▁ .
▁ vic tre lis ▁was ▁also ▁shown ▁to ▁be ▁effective ▁in ▁some ▁patients ▁whose ▁treatment ▁was ▁short en ed ▁following ▁blood ▁tests ▁in ▁which ▁the ▁virus ▁could ▁no ▁longer ▁be ▁detect ed ▁in ▁their ▁blood ▁ .
▁si f rol ▁0 . 18 ▁mg ▁tablets ▁pra mi pe xo le
▁tell ▁your ▁doctor ▁immediately ▁if ▁you ▁or ▁your ▁family ▁notice ▁any ▁symptoms ▁listed ▁below ▁:
▁number ▁of ▁subject s ▁with ▁influenza
▁at ▁the ▁beginning ▁of ▁the ▁preventiv e ▁ therapy ▁with ▁kin zal mono ▁80 ▁mg ▁ , ▁blood ▁pressure ▁should ▁be ▁frequently ▁monitor ed ▁ .
▁talk ▁to ▁your ▁baby ▁' s ▁doctor ▁before ▁your ▁new born ▁is ▁given ▁pey ona ▁ .
▁the ▁card ▁remind s ▁patients ▁about ▁key ▁symptoms ▁that ▁need ▁to ▁be ▁reported ▁immediately ▁to ▁the ▁physician ▁/ ▁nurse ▁ .
▁there ▁were ▁more ▁cardiac ▁events ▁in ▁vil dag lip tin ▁treated ▁patients ▁with ▁ny ha ▁class ▁i ii ▁heart ▁failure ▁compared ▁to ▁place bo ▁ .
▁follow ▁the ▁instructions ▁and ▁recommendations ▁from ▁your ▁doctor ▁regarding ▁the ▁use ▁of ▁novo rap id ▁in ▁a ▁pump ▁ .
▁if ▁large ▁bu bble s ▁can ▁be ▁seen ▁ , ▁slowly ▁push ▁the ▁plu nger ▁back ▁into ▁the ▁sy ringe ▁ .
▁however ▁ , ▁the ▁ch mp ▁considered ▁that ▁its ▁effects ▁on ▁ reducing ▁the ▁rate ▁of ▁ex ace rb ations ▁were ▁too ▁small ▁to ▁recommend ▁the ▁use ▁for ▁ reducing ▁ex ace rb ations ▁ .
▁white ▁ob long ▁tablets ▁of ▁ 3.8 ▁mm ▁en grave d ▁with ▁the ▁code ▁number ▁' ▁51 h ▁' ▁on ▁one ▁side ▁ .
▁the ▁other ▁study ▁( ▁ 456 ▁patients ▁) ▁compared ▁byd ure on ▁with ▁insulin ▁g lar gine ▁as ▁add - on ▁treatment ▁to ▁met form in ▁with ▁or ▁without ▁a ▁sul phon y lu rea ▁ .
▁people ▁with ▁known ▁hyper sensitiv ity ▁( ▁allergi c ▁) ▁to ▁melo xi cam ▁should ▁avoid ▁contact ▁with ▁the ▁product ▁ .
▁one ▁dose ▁( ▁1 ▁ml ▁) ▁contain s ▁: ▁por cine ▁circo virus ▁type ▁2 ▁or f 2 ▁protein ▁carb om er
▁hyper sensitiv ity ▁to ▁the ▁active ▁substance ▁or ▁to ▁any ▁of ▁the ▁ex cip ient s ▁listed ▁in ▁section ▁6.1 ▁ , ▁or ▁di ph ther ia ▁to xo id ▁( ▁cr m 19 7 ▁) ▁ , ▁or ▁a ▁life - th rea te ning ▁reaction ▁after ▁previous ▁administration ▁of ▁a ▁vaccin e ▁contain ing ▁similar ▁component s ▁( ▁see ▁section ▁4.4 ▁) ▁ .
▁the ▁european ▁commission ▁gran ted ▁a ▁marketing ▁author isation ▁valid ▁throughout ▁the ▁european ▁union ▁for ▁signifo r ▁on ▁24 ▁april ▁2012 ▁ .
▁4 ▁years ▁for ▁bli sters ▁ .
▁what ▁you ▁need ▁to ▁know ▁before ▁xo fi go ▁is ▁used
▁do ▁not ▁use ▁this ▁veterinar y ▁medicinal ▁product ▁after ▁the ▁exp i ry ▁date ▁which ▁is ▁state d ▁on ▁the ▁label ▁and ▁carton ▁after ▁exp ▁ .
▁riba vir in ▁concentration ▁in ▁semi nal ▁fluid ▁is ▁approximately ▁two - fold ▁higher ▁compared ▁to ▁se rum ▁ .
▁in ▁the ▁post - marketing ▁setting ▁ , ▁isola ted ▁cases ▁of ▁sick le ▁cell ▁crise s ▁have ▁been ▁reported ▁in ▁patients ▁with ▁sick le ▁cell ▁trait ▁or ▁sick le ▁cell ▁disease ▁( ▁see ▁section ▁4.4 ▁) ▁ .
▁epi vir ▁is ▁un like ly ▁to ▁affect ▁your ▁ability ▁to ▁drive ▁or ▁use ▁machines ▁ .
▁u ab ▁alvo gen ▁bal tics ▁tel ▁: ▁+ ▁370 ▁5 ▁215 30 88 ▁cz ▁/ ▁si ▁/ ▁sk ▁/ ▁uk
▁the ▁active ▁substance ▁in ▁clo pido gre l ▁b ms ▁ , ▁clo pido gre l ▁ , ▁is ▁an ▁inhibi tor ▁of ▁plate let ▁ aggregat ion ▁ .
▁the ▁mutation s ▁detect ed ▁among ▁the ▁das atin ib - tre ated ▁patients ▁were ▁t 3 15 i ▁ , ▁f 3 17 i ▁/ ▁l ▁and ▁v 2 99 l ▁ .
▁ros u vasta tin ▁10 ▁mg ▁q d
▁what ▁measure s ▁are ▁being ▁taken ▁to ▁ensure ▁the ▁safe ▁and ▁effective ▁use ▁of ▁de fit elio ▁?
▁a my vid ▁800 ▁mb q ▁/ ▁ml ▁: ▁one ▁multi dos e ▁vi al ▁of ▁10 ▁ml ▁capacity ▁contain ing ▁1 ▁to ▁10 ▁ml ▁of ▁solution ▁ , ▁correspond ing ▁to ▁800 ▁to ▁8000 ▁mb q ▁at ▁date ▁and ▁time ▁of ▁ca lib ration ▁ .
▁the ▁majority ▁of ▁these ▁may ▁be ▁due ▁to ▁cy tok ine ▁release ▁during ▁in fusion ▁ .
▁the ▁animals ▁received ▁either ▁cer enia ▁tablets ▁at ▁a ▁dose ▁of ▁8 ▁mg ▁/ ▁kg ▁body weight ▁or ▁a ▁place bo ▁for ▁up ▁to ▁two ▁consecutiv e ▁days ▁ .
▁consequent ly ▁ , ▁ren vela ▁should ▁not ▁be ▁taken ▁simultan e ously ▁with ▁ci pro flo xa cin ▁ .
▁blood ▁clo tting ▁can ▁be ▁a ▁problem ▁when ▁blood ▁flow ▁is ▁disturb ed ▁in ▁any ▁way ▁ .
▁pra da xa ▁is ▁contra indica ted ▁in ▁patients ▁with ▁severe ▁renal ▁im pair ment
▁do ▁not ▁use ▁solutions ▁that ▁are ▁cloud y ▁or ▁have ▁parti cles ▁ .
▁in ▁157 ▁imi qui mod - tre ated ▁male ▁patients ▁ , ▁the ▁combine d ▁total ▁clear ance ▁rate ▁was ▁23 ▁% ▁as ▁compared ▁to ▁5 ▁% ▁in ▁161 ▁vehicle - tre ated ▁patients ▁( ▁95 ▁% ▁ci ▁for ▁rate ▁difference ▁: ▁3 ▁% ▁to ▁36 ▁% ▁ , ▁p ▁< ▁0.0 01 ▁) ▁ .
▁it ▁is ▁not ▁known ▁whether ▁sa prop ter in ▁or ▁its ▁metabol ites ▁are ▁ex cre ted ▁in ▁human ▁breast ▁milk ▁ .
▁looking ▁at ▁the ▁results ▁of ▁the ▁two ▁studies ▁taken ▁together ▁ , ▁viral ▁load s ▁had ▁fallen ▁by ▁an ▁average ▁of ▁99 ▁% ▁after ▁24 ▁weeks ▁in ▁the ▁patients ▁adding ▁cel sen tri ▁to ▁optim ised ▁background ▁ therapy ▁ , ▁compared ▁with ▁90 ▁% ▁in ▁those ▁adding ▁place bo ▁ .
▁by ▁block ing ▁these ▁enzym es ▁ , ▁ri va stig mine ▁act avis ▁allows ▁levels ▁of ▁a ce tyl cho line ▁to ▁be ▁increased ▁in ▁the ▁brain ▁ , ▁helping ▁to ▁reduce ▁the ▁symptoms ▁of ▁al z heim er ▁' s ▁disease ▁and ▁dem entia ▁associated ▁with ▁par kin son ▁' s ▁disease ▁ .
▁it ▁is ▁available ▁as ▁tablets ▁( ▁50 ▁mg ▁) ▁ .
▁the ▁linear ▁clear ance ▁was ▁estima ted ▁as ▁a ▁parameter ▁in ▁the ▁population ▁ pharma cok ine tic ▁analysis ▁and ▁was ▁ 9.5 ▁ml ▁/ ▁h ▁ .
▁iba fli n ▁3 ▁% ▁oral ▁gel
▁there ▁is ▁no ▁information ▁on ▁the ▁effect ▁of ▁ava stin ▁in ▁patients ▁with ▁un control led ▁hyper tension ▁at ▁the ▁time ▁of ▁initiat ing ▁ therapy ▁ .
▁con com i tant ▁use ▁of ▁rif ampi cin ▁or ▁other ▁strong ▁cy p 3 a 4 ▁induc ers ▁and ▁imati ni b ▁should ▁be ▁avoid ed ▁ .
▁he pati c ▁and ▁renal ▁im pair ment ▁use
▁there ▁are ▁no ▁adequat e ▁data ▁from ▁the ▁use ▁of ▁the ▁bi mato prost ▁/ ▁ timo lol ▁fixed ▁combination ▁in ▁pregnant ▁women ▁ .
▁bela ta cept ▁bind s ▁to ▁cd 80 ▁and ▁cd 86 ▁on ▁anti gen ▁present ing ▁cell s ▁ .
▁to ▁encourage ▁patients ▁to ▁contact ▁their ▁ms ▁physician ▁and ▁/ ▁or ▁general ▁prac ti tioner ▁if ▁they ▁experience ▁any ▁of ▁the ▁sign s ▁and ▁symptoms ▁discuss ed ▁in ▁the ▁patient ▁education ▁card ▁;
▁this ▁means ▁the ▁medicine ▁gets ▁into ▁your ▁system ▁quickly ▁to ▁reli eve ▁your ▁break through ▁pain ▁ .
▁treatment ▁of ▁foot ▁rot ▁should ▁therefore ▁be ▁under tak en ▁along ▁with ▁other ▁f lock ▁management ▁tools ▁ , ▁for ▁example ▁providing ▁dry ▁environment ▁ .
▁any ▁shak ing ▁ , ▁invert ing ▁or ▁other ▁mechanic al ▁stress ▁of ▁the ▁holo c lar ▁container ▁should ▁be ▁avoid ed ▁ .
▁six ty - fi ve ▁percent ▁of ▁the ▁patients ▁studie d ▁in ▁the ▁sc n ▁trial ▁program ▁were ▁under ▁18 ▁years ▁of ▁age ▁ .
▁however ▁ , ▁your ▁doctor ▁will ▁assess ▁whether ▁the ▁possible ▁benefit ▁in ▁terms ▁of ▁prevent ing ▁small po x ▁would ▁out we igh ▁the ▁potential ▁risk s ▁of ▁giving ▁you ▁this ▁vaccin e ▁ .
▁sub mission ▁of ▁final ▁study ▁report
▁how ▁to ▁store ▁cop alia ▁h ct
▁if ▁you ▁use ▁more ▁ lon que x ▁than ▁you ▁should ▁ , ▁talk ▁to ▁your ▁doctor ▁ .
▁1 ▁advers e ▁reaction s ▁observe d ▁for ▁az ar ga
▁if ▁you ▁take ▁more ▁li pro log ▁bas al ▁than ▁you ▁need ▁ , ▁a ▁low ▁blood ▁sugar ▁may ▁occur ▁ .
▁name ▁and ▁address ▁of ▁the ▁manufacture r ▁of ▁the ▁bi ological ▁active ▁substance s
▁taking ▁or ▁using ▁other ▁medicine s ▁and ▁cosmetic s
▁store ▁flat ▁in ▁the ▁original ▁sa chet ▁and ▁carton ▁ .
▁card board ▁box ▁with ▁1 ▁colour less ▁glass ▁vi al ▁contain ing ▁20 ▁ml ▁ , ▁50 ▁ml ▁ , ▁100 ▁ml ▁or ▁250 ▁ml ▁ .
▁eleva ted ▁trans ami nas es ▁and ▁hyper bili ru bina emia ▁( ▁grade ▁3-4 ▁) ▁were ▁reported ▁primari ly ▁in ▁patients ▁with ▁ab normal ▁values ▁at ▁base line ▁ .
▁patients ▁in ▁steroid - free ▁re mission ▁for ▁> ▁= ▁90 ▁days a
▁due ▁to ▁limited ▁ab sor p tion ▁a ▁ce iling ▁effect ▁with ▁no ▁further ▁increase ▁in ▁average ▁plasma ▁exposure ▁is ▁expected ▁at ▁supra therapeut ic ▁dos es ▁of ▁50 ▁mg ▁ri varo xa ban ▁or ▁above ▁ .
▁do ▁not ▁attempt ▁to ▁inject ▁yourself ▁until ▁you ▁are ▁sure ▁that ▁you ▁understand ▁how ▁to ▁prepare ▁the ▁inject ion ▁solution ▁and ▁give ▁the ▁inject ion ▁to ▁yourself ▁ .
▁the ▁company ▁will ▁ensure ▁that ▁all ▁health care ▁professionals ▁who ▁are ▁expected ▁to ▁use ▁the ▁medicine ▁are ▁provided ▁with ▁information ▁on ▁how ▁to ▁enter ▁their ▁patients ▁in ▁the ▁registr y ▁ .
▁take ▁special ▁care ▁with ▁tri tan rix ▁hep b ▁:
▁no ▁effects ▁on ▁fo e tal ▁development ▁have ▁been ▁observe d ▁in ▁rat s ▁and ▁rabbi ts ▁at ▁the ▁highest ▁dos es ▁test ed ▁ .
▁what ▁measure s ▁are ▁being ▁taken ▁to ▁ensure ▁the ▁safe ▁and ▁effective ▁use ▁of ▁edu rant ▁?
▁sil den a fil ▁teva ▁25 ▁mg ▁film - co ated ▁tablets ▁sil den a fil
▁effect ▁of ▁i vac af tor ▁on ▁other ▁ef fica cy ▁end point s ▁in ▁studies ▁1 ▁and ▁2
▁stop ▁taking ▁vot rien t ▁and ▁se ek ▁medical ▁advice ▁immediately ▁if ▁you ▁get ▁any ▁of ▁these ▁symptoms ▁ , ▁or ▁if ▁you ▁get ▁head ache ▁ac com pani ed ▁with ▁any ▁of ▁these ▁symptoms ▁ .
▁after ▁stop ping ▁insulin ▁in fusion ▁or ▁remo val ▁or ▁re position ing ▁of ▁the ▁per ito ne al ▁cat heter ▁ , ▁focal ▁he pati c ▁stea tos is ▁seems ▁to ▁be ▁rever sible ▁and ▁without ▁clinic al ▁consequ ence ▁( ▁see ▁section ▁4. 8 ▁) ▁ .
▁therefore ▁ , ▁patients ▁should ▁be ▁advise d ▁not ▁to ▁drive ▁or ▁operate ▁machines ▁until ▁their ▁individual ▁sus cept i bility ▁to ▁in vega ▁is ▁known ▁ .
▁leve ti race tam ▁has ▁shown ▁un wan ted ▁reproduc tive ▁effects ▁in ▁animal ▁studies ▁at ▁dose ▁levels ▁higher ▁than ▁you ▁would ▁need ▁to ▁control ▁your ▁se iz ures ▁ .
▁cialis ▁10 ▁mg ▁tablets ▁ta dala fil
▁un com mon ▁: ▁di ar r ho e a ▁ , ▁gloss itis ▁ , ▁na use a ▁ , ▁stomach ▁disco m fort ▁ , ▁vom i ting
▁the ▁op a ▁geometri c ▁mean ▁titre s ▁for ▁ser o type s ▁1 ▁ , ▁3 ▁and ▁5 ▁were ▁lower ▁than ▁the ▁titre s ▁for ▁each ▁of ▁the ▁other ▁additional ▁ser o type s ▁; ▁the ▁clinic al ▁relevan ce ▁of ▁this ▁observation ▁is ▁un know n ▁ .
▁§ ▁§ ▁a cute ▁= ▁0 ▁to ▁24 ▁hours ▁post - ini ti ation ▁of ▁che mo therapy ▁ .
▁based ▁on ▁a ▁ pharma cok ine tic ▁study ▁with ▁12 ▁subject s ▁ ≥ ▁12 ▁years ▁with ▁v wd ▁ , ▁the ▁following ▁ pharma cok ine tic ▁character istic s ▁for ▁v w f ▁: ▁r co ▁ , ▁v w f ▁: ▁ag ▁ , ▁v w f ▁: ▁c b ▁and ▁f vii i ▁: ▁c ▁were ▁observe d ▁:
▁ra vs ▁were ▁detect ed ▁in ▁8 ▁% ▁of ▁patients ▁at ▁base line ▁by ▁population ▁se que ncing ▁ .
▁syn flor ix ▁should ▁under ▁no ▁circumstances ▁be ▁ad minister ed ▁intra vas cular ly ▁or ▁intra der m ally ▁ .
▁frequent ▁blad der ▁empty ing ▁should ▁be ▁encourage d ▁after ▁dos ing ▁to ▁minimi se ▁radi ation ▁exposure ▁ .
▁30 ▁film - co ated ▁tablets ▁: ▁eu ▁/ ▁1 ▁/ ▁09 ▁/ ▁ 558 ▁/ ▁ 011 ▁500 ▁film - co ated ▁tablets ▁: ▁eu ▁/ ▁1 ▁/ ▁09 ▁/ ▁ 558 ▁/ ▁01 2
▁light ▁mineral ▁oil ▁0.3 1 ▁ml
▁the ▁media n ▁ed s s ▁score ▁at ▁base line ▁was ▁2. 50 ▁; ▁ 298 ▁patients ▁( ▁25. 5 ▁% ▁) ▁had ▁an ▁ed s s ▁score ▁› ▁3.5 ▁at ▁base line ▁ .
▁no ▁riba vir in ▁effects ▁were ▁observe d ▁regarding ▁neuro be havi o ural ▁or ▁reproduc tive ▁development ▁ .
▁melo xi cam ▁is ▁metabol ised ▁to ▁an ▁alcohol ▁ , ▁an ▁acid ▁deriva tive ▁and ▁to ▁several ▁po lar ▁metabol ites ▁ .
▁stoc rin ▁has ▁not ▁been ▁adequat ely ▁studie d ▁in ▁patients ▁with ▁advanced ▁hi v ▁disease ▁ , ▁na mely ▁in ▁patients ▁with ▁cd 4 ▁count s ▁< ▁50 ▁cell s ▁/ ▁mm 3 ▁ , ▁or ▁after ▁failure ▁of ▁prote ase ▁inhibi tor ▁( ▁pi ▁) ▁contain ing ▁regime ns ▁ .
▁the ▁ab sor p tion ▁of ▁hydro ch lor o thi azi de ▁ , ▁after ▁an ▁oral ▁dose ▁ , ▁is ▁rapid ▁( ▁t max ▁about ▁2 ▁hours ▁) ▁ .
▁total ▁volume ▁of ▁recon stitu ted ▁suspens ion ▁required
▁only ▁use ▁the ▁on brez ▁bre ezh a ler ▁in hal er ▁contain ed ▁in ▁this ▁pack ▁ .
▁the ▁inject ion ▁site ▁disco m fort ▁was ▁generally ▁mild ▁and ▁trans ient ▁in ▁nature ▁and ▁occur red ▁predomina nt ly ▁after ▁the ▁first ▁inject ion ▁ .
▁if ▁you ▁stop ▁taking ▁dal ires p
▁a cute ▁in fusion ▁reaction s ▁such ▁as ▁chill s ▁ , ▁fatigue ▁ , ▁fe ver ▁ , ▁na use a ▁ , ▁and ▁joint ▁a che ▁were ▁frequently ▁observe d ▁in ▁clinic al ▁studies ▁ .
▁these ▁include ▁po tas s ium - ▁spar ing ▁di ure tics ▁ , ▁po tas s ium ▁supplement s ▁ .
▁push ▁the ▁plu nger ▁until ▁the ▁air ▁bu bble s ▁are ▁gone ▁ .
▁if ▁you ▁take ▁comp et act ▁with ▁other ▁medicine s ▁for ▁diabetes ▁ , ▁it ▁is ▁more ▁likely ▁that ▁your ▁blood ▁sugar ▁could ▁fall ▁below ▁the ▁normal ▁level ▁( ▁hypo gly ca emia ▁) ▁ .
▁treatment ▁against ▁is os pora ▁should ▁a im ▁to ▁min imize ▁the ▁she dding ▁of ▁oo cy st s ▁into ▁the ▁environment ▁ , ▁there by ▁ reducing ▁the ▁risk ▁for ▁re infect ion ▁in ▁groups ▁/ ▁kenne ls ▁with ▁known ▁and ▁re curr ing ▁is os pora ▁infection s ▁ .
▁particular s ▁to ▁appear ▁on ▁the ▁out er ▁packaging ▁pack ▁of ▁25 ▁vi als ▁of ▁em ul sion
▁special ▁precau tions ▁for ▁disposa l ▁and ▁other ▁handling
▁do ▁not ▁allow ▁other ▁animals ▁contact ▁with ▁the ▁application ▁site ▁for ▁at ▁least ▁72 ▁hours ▁after ▁application ▁ .
▁ ator vasta tin ▁( ▁40 ▁mg ▁once ▁daily ▁) ▁/ ▁ri lp ivi rine 1
▁patients ▁should ▁not ify ▁their ▁physician ▁if ▁they ▁become ▁pregnant ▁during ▁treatment ▁with ▁a comp lia ▁ .
▁the ▁active ▁substance ▁in ▁me man tine ▁accord ▁ , ▁me man tine ▁ , ▁is ▁an ▁anti dem entia ▁medicine ▁ .
▁spri me o ▁h ct ▁150 ▁mg ▁/ ▁25 ▁mg ▁film - co ated ▁tablets
▁pro quad ▁- ▁powder ▁in ▁vi al ▁and ▁solve nt ▁in ▁pre - fill ed ▁sy ringe ▁with ▁1 ▁un attache d ▁need le ▁- ▁pack ▁of ▁1 ▁ , ▁10 ▁ , ▁20
▁detailed ▁information ▁on ▁this ▁medicinal ▁product ▁is ▁available ▁on ▁the ▁website ▁of ▁the ▁european ▁medicine s ▁agency ▁http ▁: ▁/ ▁/ ▁www . ema . europa . eu ▁ .
▁no ▁formal ▁conclusion ▁can ▁be ▁draw n ▁regarding ▁the ▁effects ▁of ▁bo sent an ▁on ▁anti ret rovi ral ▁drug ▁ef fica cy ▁( ▁see ▁also ▁section ▁4.4 ▁) ▁ .
▁increase ▁in ▁blood ▁cholesterol ▁levels
▁based ▁on ▁this ▁and ▁all ▁other ▁available ▁data ▁ , ▁the ▁committee ▁decided ▁that ▁metal yse ▁' s ▁benefits ▁are ▁greater ▁than ▁its ▁risk s ▁and ▁recommended ▁that ▁it ▁be ▁given ▁marketing ▁author isation ▁ .
▁if ▁your ▁solo star ▁is ▁in ▁cool ▁storage ▁ , ▁take ▁it ▁out ▁1 ▁to ▁2 ▁hours ▁before ▁you ▁inject ▁to ▁allow ▁it ▁to ▁warm ▁up ▁ .
▁this ▁medicine ▁may ▁be ▁used ▁while ▁your ▁partner ▁is ▁breast - feed ing ▁ .
▁there ▁are ▁no ▁adequat e ▁data ▁from ▁the ▁use ▁of ▁iba ndro nic ▁acid ▁in ▁pregnant ▁women ▁ .
▁1,4 07 ▁patients ▁under go ing ▁abdominal ▁surgery ▁treated ▁up ▁to ▁9 ▁days
▁patients ▁should ▁be ▁monitor ed ▁close ly ▁to ▁ensure ▁that ▁the ▁lo west ▁approved ▁dose ▁of ▁dy ne po ▁is ▁used ▁to ▁provide ▁adequat e ▁control ▁of ▁the ▁symptoms ▁of ▁ana emia ▁ .
▁always ▁take ▁this ▁medicine ▁exactly ▁as ▁your ▁doctor ▁has ▁told ▁you ▁to ▁ .
▁what ▁you ▁need ▁to ▁know ▁before ▁you ▁use ▁lu veri s ▁do ▁not ▁use ▁lu veri s ▁:
▁the ▁marketing ▁author isation ▁holder ▁shall ▁complete ▁the ▁following ▁programme ▁of ▁studies ▁within ▁the ▁specifi ed ▁time ▁frame ▁ , ▁the ▁results ▁of ▁which ▁shall ▁form ▁the ▁basis ▁of ▁the ▁annual ▁rea sses s ment ▁of ▁the ▁benefit ▁/ ▁risk ▁profile ▁ .
▁the ▁vi al ▁is ▁to ▁be ▁used ▁in ▁con jun ction ▁with ▁an ▁appropriate ▁sy ringe ▁( ▁100 ▁unit ▁mark ings ▁) ▁ .
▁vitamin ▁d 3 ▁is ▁a ▁nutri ent ▁that ▁is ▁found ▁in ▁some ▁food s ▁ , ▁but ▁is ▁also ▁made ▁in ▁the ▁skin ▁through ▁exposure ▁to ▁natural ▁sun light ▁ .
▁each ▁vi al ▁contain s ▁100 ▁mg ▁be va ci zum ab ▁ .
▁the ▁total ▁usual ▁dose ▁should ▁not ▁exceed ▁1. 95 ▁g ▁/ ▁m 2 ▁/ ▁day ▁ .
▁leg anto ▁contain s ▁the ▁active ▁substance ▁roti go tine ▁ .
▁before ▁you ▁take ▁ex a lief ▁do ▁not ▁take ▁ex a lief ▁if ▁:
▁the ▁ pharma cok ine tics ▁of ▁vir am une ▁prolong ed - release ▁has ▁also ▁been ▁studie d ▁in ▁a ▁multiple ▁dose ▁ pharma cok ine tics ▁study ▁( ▁study ▁110 0.1 489 ▁) ▁in ▁24 ▁hi v -1 ▁infect ed ▁patients ▁who ▁switch ed ▁from ▁chronic ▁vir am une ▁immediate - release ▁ therapy ▁to ▁vir am une ▁prolong ed - release ▁ .
▁mida zola m ▁may ▁accumula te ▁in ▁patients ▁with ▁chronic ▁renal ▁failure ▁or ▁im pair ed ▁he pati c ▁function ▁whilst ▁in ▁patients ▁with ▁im pair ed ▁cardiac ▁function ▁it ▁may ▁cause ▁decrease d ▁clear ance ▁of ▁mida zola m ▁ .
▁dys p no e a ▁ , ▁co ugh ▁ , ▁sore ▁ thro at ▁ , ▁adult ▁respirator y ▁di stress ▁syndrome ▁ , ▁respirator y ▁failure
▁intro na ▁may ▁be ▁ad minister ed ▁using ▁either ▁glass ▁or ▁plastic ▁disposa ble ▁inject ion ▁sy ring es ▁ .
▁pure gon ▁150 ▁iu ▁/ ▁0.5 ▁ml ▁solution ▁for ▁inject ion ▁eu ▁/ ▁1 ▁/ ▁96 ▁/ ▁ 008 ▁/ ▁0 26
▁however ▁ , ▁if ▁you ▁prefer ▁ , ▁you ▁may ▁pin ch ▁the ▁skin ▁to ▁create ▁a ▁firm er ▁surface ▁for ▁your ▁inject ion ▁( ▁figure ▁5 b ▁) ▁ .
▁however ▁ , ▁if ▁inter cours e ▁has ▁already ▁occur red ▁ , ▁pre gna ncy ▁should ▁be ▁exclu ded ▁before ▁the ▁actual ▁start ▁of ▁e vra ▁or ▁the ▁woman ▁has ▁to ▁wait ▁for ▁her ▁first ▁menstrua l ▁period ▁ .
▁to ▁reduce ▁the ▁like li hood ▁of ▁go ut ▁fl ares ▁after ▁initiat ion ▁of ▁kry ste xx a ▁pro phy la xis ▁with ▁col chi cine ▁or ▁a ▁non - steroid al ▁anti - in flam ma tory ▁drug ▁( ▁n said ▁) ▁is ▁recommended ▁ .
▁choose ▁the ▁level ▁that ▁most ▁close ly ▁fit s ▁your ▁daily ▁routine ▁ .
▁63 ▁% ▁of ▁patients ▁on ▁pra mi pe xo le ▁and ▁52 ▁% ▁of ▁patients ▁on ▁place bo ▁reported ▁at ▁least ▁one ▁advers e ▁drug ▁reaction ▁ .
▁before ▁use ▁ , ▁the ▁powder ▁must ▁be ▁mix ed ▁with ▁the ▁gel ▁produc ing ▁a ▁uniform ▁gel ▁ .
▁the ▁safety ▁of ▁vera flo x ▁has ▁not ▁been ▁established ▁during ▁pre gna ncy ▁and ▁lac tation ▁in ▁cat s ▁and ▁dog s ▁ .
▁single ▁plasma ▁sample s ▁were ▁obtain ed ▁approximately ▁4 -8 ▁hours ▁after ▁the ▁first ▁application ▁on ▁days ▁3 ▁or ▁4 ▁from ▁patients ▁a ged ▁from ▁2 ▁months ▁to ▁2 ▁years ▁with ▁impet igo ▁or ▁with ▁seconda ri ly ▁infect ed ▁traumat ic ▁les ions ▁or ▁der mato ses ▁( ▁note ▁that ▁reta pam ulin ▁is ▁not ▁indicate d ▁for ▁use ▁in ▁seconda ri ly ▁infect ed ▁der mato ses ▁) ▁ .
▁possible ▁sign s ▁of ▁la ctic ▁acid osis ▁are ▁:
▁following ▁administration ▁of ▁tel zir ▁ , ▁the ▁half - life ▁of ▁amp rena vir ▁is ▁ 7.7 ▁hours ▁ .
▁therefore ▁ , ▁cyst e amine ▁bit art rate ▁should ▁not ▁be ▁used ▁during ▁pre gna ncy ▁ , ▁particularly ▁during ▁the ▁first ▁tri mester ▁ , ▁unless ▁clearly ▁necessary ▁( ▁see ▁section ▁4.4 ▁) ▁ .
▁in ▁the ▁case ▁of ▁late ▁clinic al ▁deteriora tion ▁de spite ▁treatment ▁with ▁tra cle er ▁( ▁i . e . ▁ , ▁after ▁several ▁months ▁of ▁treatment ▁) ▁ , ▁the ▁treatment ▁should ▁be ▁re - asse s sed ▁ .
▁as ▁in ▁plato ▁ , ▁most ▁reported ▁dys p no e a ▁was ▁mild ▁to ▁moderat e ▁in ▁intens ity ▁( ▁see ▁section ▁4.4 ▁) ▁ .
▁each ▁vi al ▁contain s ▁130 ▁mg ▁of ▁uste kin um ab ▁in ▁26 ▁ml ▁ .
▁the ▁tablets ▁should ▁be ▁taken ▁at ▁least ▁two ▁hours ▁before ▁or ▁four ▁hours ▁after ▁any ▁products ▁such ▁as ▁anta cid s ▁ , ▁dair y ▁products ▁( ▁or ▁other ▁calci um ▁contain ing ▁food ▁products ▁) ▁ , ▁or ▁mineral ▁supplement s ▁contain ing ▁poly valent ▁ca tions ▁( ▁e . g . ▁ir on ▁ , ▁calci um ▁ , ▁magnesium ▁ , ▁aluminium ▁ , ▁sele nium ▁and ▁z inc ▁) ▁( ▁see ▁section s ▁4.5 ▁and ▁5.2 ▁) ▁ .
▁interaction ▁with ▁in vira se ▁/ ▁rito na vir ▁not ▁studie d . -
▁because ▁my fen ax ▁is ▁a ▁generic ▁medicine ▁and ▁is ▁bio e qui valent ▁to ▁the ▁reference ▁medicine ▁ , ▁its ▁benefits ▁and ▁risk s ▁are ▁taken ▁as ▁being ▁the ▁same ▁as ▁the ▁reference ▁medicine ▁' s ▁ .
▁other ▁information ▁about ▁in fan rix ▁he xa ▁:
▁therefore ▁ , ▁the ▁committee ▁decided ▁that ▁ri va stig mine ▁1 ▁a ▁ pharma ▁' s ▁benefits ▁are ▁greater ▁than ▁its ▁risk s ▁and ▁recommended ▁that ▁it ▁be ▁given ▁marketing ▁author isation ▁ .
▁bottle ▁of ▁10 ▁and ▁50 ▁ml
▁close ▁monitoring ▁of ▁blood ▁gluco se ▁concentration s ▁and ▁dose ▁tit ration ▁as ▁appropriate ▁are ▁recommended ▁when ▁in hal ed ▁human ▁insulin ▁is ▁used ▁in ▁these ▁patients ▁ .
▁tabula ted ▁list ▁of ▁advers e ▁reaction s
▁before ▁use ▁: ▁store ▁in ▁a ▁refrigera tor ▁( ▁2 ▁° ▁c ▁- ▁8 ▁° ▁c ▁) ▁ .
▁this ▁is ▁a ▁special ▁type ▁of ▁vaccin e ▁that ▁is ▁designed ▁to ▁help ▁with ▁the ▁management ▁of ▁a ▁future ▁pande mic ▁ .
▁for ▁patients ▁who ▁are ▁dos ed ▁initial ly ▁at ▁doce ta xel ▁75 ▁mg ▁/ ▁m 2 ▁in ▁combination ▁with ▁ci s plat in ▁and ▁whose ▁na dir ▁of ▁plate let ▁count ▁during ▁the ▁previous ▁course ▁of ▁ therapy ▁is ▁< ▁2 5,000 ▁cell s ▁/ ▁mm 3 ▁ , ▁or ▁in ▁patients ▁who ▁experience ▁febr ile ▁neutro p enia ▁ , ▁or ▁in ▁patients ▁with ▁serious ▁non - ha e mat ologic ▁ toxic ities ▁ , ▁the ▁doce ta xel ▁dose ▁in ▁subsequent ▁cycle s ▁should ▁be ▁reduce d ▁to ▁65 ▁mg ▁/ ▁m 2 ▁ .
▁press ing ▁the ▁pen ▁down ▁will ▁insert ▁the ▁need le ▁and ▁automatically ▁start ▁the ▁inject ion ▁ .
▁such ▁conditions ▁should ▁be ▁correct ed ▁before ▁the ▁administration ▁of ▁i firma sta ▁ .
▁statement ▁of ▁active ▁and ▁other ▁substance s
▁insu man ▁rapid ▁is ▁a ▁clear ▁ , ▁colour less ▁solution ▁for ▁inject ion ▁ , ▁with ▁no ▁solid ▁parti cles ▁visible ▁ , ▁and ▁of ▁a ▁water - like ▁consiste ncy ▁ .
▁read ▁all ▁of ▁this ▁le a flet ▁carefully ▁before ▁you ▁start ▁using ▁this ▁medicine ▁because ▁it ▁contain s ▁important ▁information ▁for ▁you
▁this ▁also ▁app lies ▁to ▁un know n ▁or ▁emer ging ▁virus es ▁and ▁other ▁path ogen s ▁ .
▁each ▁single ▁in hal ation ▁provides ▁a ▁deliver ed ▁dose ▁( ▁the ▁dose ▁leaving ▁the ▁mouth piece ▁) ▁of ▁184 ▁micro gram s ▁of ▁flu ticas one ▁fur o ate ▁and ▁22 ▁micro gram s ▁of ▁vil ante rol ▁( ▁as ▁tri fen ata te ▁) ▁ .
▁further more ▁ , ▁iba ndro nic ▁acid ▁150 ▁mg ▁once ▁monthly ▁was ▁proven ▁superior ▁to ▁iba ndro nic ▁acid ▁2.5 ▁mg ▁daily ▁for ▁increase s ▁in ▁lum bar ▁spin e ▁b md ▁in ▁a ▁prospect ive ly ▁planned ▁analysis ▁at ▁one ▁year ▁ , ▁p ▁= ▁0.0 02 ▁ , ▁and ▁at ▁two ▁years ▁ , ▁p ▁< ▁0.0 01 ▁ .
▁progression ▁free ▁survival ▁assess ed ▁by ▁independent ▁review ▁was ▁similar ▁between ▁e ribu lin ▁and ▁cap e cita bine ▁with ▁media ns ▁of ▁4.1 ▁months ▁vs ▁4.2 ▁months ▁( ▁hr ▁1. 08 ▁; ▁[ ▁95 ▁% ▁ci ▁: ▁ 0.9 32 ▁ , ▁1. 250 ▁] ▁) ▁respective ly ▁ .
▁it ▁has ▁an ▁anti micro bi al ▁activity ▁similar ▁to ▁that ▁of ▁ce fti o fur ▁against ▁the ▁target ▁path ogen s ▁ .
▁how ▁is ▁circa din ▁used ▁?
▁chicken s ▁from ▁5 ▁weeks ▁of ▁age
▁the ▁ ecto para si tic ▁activity ▁of ▁fi pron il ▁and ▁( ▁s ▁) ▁- met hop rene ▁is ▁media ted ▁by ▁direct ▁contact ▁with ▁the ▁ ecto para sites ▁rather ▁than ▁by ▁system ic ▁exposure ▁ .
▁leve ti race tam ▁has ▁been ▁given ▁to ▁you ▁by ▁your ▁doctor ▁to ▁reduce ▁the ▁number ▁of ▁fit s ▁ .
▁take ▁the ▁10 ▁ml ▁sy ringe ▁out ▁of ▁the ▁package ▁ .
▁brown ish - orang e ▁ , ▁ oval ▁ , ▁bi con ve x ▁film - co ated ▁tablet ▁with ▁" ▁com t ▁" ▁en grave d ▁on ▁one ▁side ▁ .
▁with ▁multiple ▁mye loma ▁( ▁another ▁cancer ▁of ▁a ▁type ▁of ▁white ▁blood ▁cell ▁) ▁and ▁frequent ▁bacteria l ▁infection s ▁and ▁in ▁whom ▁vaccin ation ▁against ▁' ▁pneu moc oc cal ▁' ▁bacteria ▁has ▁failed ▁; ▁who ▁have ▁had ▁ha e mato po ie tic ▁( ▁blood ▁) ▁stem ▁cell ▁transplant ation ▁( ▁when ▁the ▁patient ▁receive s ▁stem ▁cell s ▁from ▁a ▁match ed ▁donor ▁to ▁help ▁resto re ▁the ▁bone ▁mar row ▁) ▁ .
▁after ▁con com i tant ▁administration ▁of ▁li xis en ati de ▁20 ▁m c g ▁and ▁rami pri l ▁5 ▁mg ▁during ▁6 ▁days ▁ , ▁the ▁au c ▁of ▁rami pri l ▁was ▁increased ▁by ▁21 ▁% ▁while ▁the ▁c max ▁was ▁decrease d ▁by ▁63 ▁% ▁ .
▁alcohol ▁in tolerance ▁( ▁facial ▁flu shing ▁or ▁skin ▁irrita tion ▁after ▁consum p tion ▁of ▁an ▁alcohol ic ▁be ver age ▁)
▁its ▁effect ▁may ▁improve ▁further ▁for ▁up ▁to ▁six ▁months ▁ .
▁xe lo da ▁500 ▁mg ▁film - co ated t ▁tablets
▁the ▁main ▁measure ▁of ▁effective ness ▁was ▁the ▁increase ▁in ▁height ▁of ▁patients ▁after ▁one ▁year ▁of ▁treatment ▁ .
▁if ▁you ▁have ▁blood ▁in ▁your ▁urin e ▁that ▁your ▁doctor ▁has ▁not ▁check ed ▁ .
▁the ▁br ▁consiste d ▁of ▁2 ▁investiga tor - sele cted ▁n ▁( ▁t ▁) ▁r tis ▁: ▁zid ovu dine ▁plus ▁la mi vu dine ▁or ▁te no fo vir ▁di so prox il ▁fumar ate ▁plus ▁em trici ta bine ▁ .
▁efa vir enz ▁is ▁a ▁non - com peti tive ▁inhibi tor ▁of ▁hi v -1 ▁rever se ▁tran script ase ▁( ▁ rt ▁) ▁and ▁does ▁not ▁significantly ▁inhibi t ▁hi v -2 ▁ rt ▁or ▁cel lular ▁d na ▁poly mera ses ▁( ▁ , ▁ , ▁or ▁) ▁ .
▁muscular ▁we ak ness ▁( ▁my as th enia ▁gravi s ▁) ▁tell ▁your ▁doctor ▁before ▁you ▁have ▁an ▁operation ▁that ▁you ▁are ▁using ▁az ar ga ▁as ▁ timo lol ▁may ▁change ▁effects ▁of ▁some ▁medicine s ▁used ▁during ▁ana es the sia . ▁if ▁you ▁have ▁a ▁history ▁of ▁ato py ▁( ▁a ▁tende ncy ▁to ▁develop ▁an ▁allergi c ▁reaction ▁) ▁and ▁severe ▁allergi c ▁reaction s ▁you ▁may ▁be ▁more ▁sensitive ▁to ▁developing ▁an ▁allergi c ▁reaction ▁whilst ▁using ▁az ar ga ▁and ▁adrenalin e ▁may ▁not ▁be ▁as ▁effective ▁to ▁treat ▁an ▁allergi c ▁reaction ▁ .
▁cu tane ous ▁lup us ▁( ▁character ized ▁by ▁ rash ▁/ ▁er y thema ▁on ▁skin ▁areas ▁that ▁are ▁expose d ▁to ▁light ▁)
▁dos age ▁adjust ment ▁of ▁the ▁con com i tant ▁medicinal ▁product ▁may ▁be ▁necessary ▁ .
▁close ▁medical ▁super vision ▁and ▁monitoring ▁should ▁continue ▁until ▁the ▁patient ▁recover s ▁ .
▁it ▁is ▁important ▁to ▁use ▁a ▁separate ▁steril e ▁sy ringe ▁and ▁need le ▁for ▁each ▁patient ▁to ▁prevent ▁transmission ▁of ▁infect i ous ▁agents ▁from ▁one ▁individual ▁to ▁another ▁ .
▁common ▁( ▁may ▁affect ▁up ▁to ▁1 ▁in ▁10 ▁people ▁) ▁: ▁feeling ▁sick ▁ , ▁heart burn ▁and ▁disco m fort ▁in ▁s w allowing ▁( ▁ inflammation ▁of ▁your ▁gull et ▁/ ▁food ▁pipe ▁)
▁doce ta xel ▁be long s ▁to ▁the ▁group ▁of ▁anti - cancer ▁medicine s ▁called ▁tax oid s ▁ .
▁the ▁european ▁commission ▁gran ted ▁a ▁marketing ▁author isation ▁valid ▁throughout ▁the ▁european ▁union ▁for ▁temo zo lom ide ▁he xal ▁on ▁15 ▁march ▁2010 ▁ .
▁activ yl ▁ti ck ▁plus ▁spot - ▁on ▁solution ▁for ▁large ▁dog s
▁the ▁study ▁will ▁evaluat e ▁over ▁a ▁minimum ▁of ▁1 ▁year ▁the ▁incide nce ▁of ▁all - ca use ▁mortal ity ▁and ▁advers e ▁events ▁of ▁special ▁interest ▁in ▁patients ▁with ▁system ic ▁lup us ▁er y thema tos us ▁ .
▁cha nelle ▁ pharma ce u tical s ▁manufacturing ▁l t d ▁ . ▁ , ▁l ough rea ▁ , ▁co . ▁gal way ▁ ,
▁age ▁of ▁6 ▁) ▁until ▁threat ▁is ▁resolve d ▁ .
▁based ▁on ▁this ▁plan ▁ , ▁safety ▁information ▁has ▁been ▁included ▁in ▁the ▁summary ▁of ▁product ▁character istic s ▁and ▁the ▁package ▁le a flet ▁for ▁sir tur o ▁ , ▁including ▁the ▁appropriate ▁precau tions ▁to ▁be ▁followed ▁by ▁health care ▁professionals ▁and ▁patients ▁ .
▁ha emo phil iac ▁patients ▁should ▁ , ▁therefore ▁ , ▁be ▁made ▁aware ▁of ▁the ▁possibility ▁of ▁increased ▁ble ed ing ▁ .
▁what ▁is ▁the ▁risk ▁associated ▁with ▁vi cto za ▁?
▁children ▁above ▁20 ▁kg ▁body ▁weight
▁fos amp rena vir ▁/ ▁rito na vir ▁/ ▁efa vir enz ▁( ▁700 ▁mg ▁twice ▁daily ▁/ ▁100 ▁mg ▁twice ▁daily ▁/ ▁600 ▁mg ▁once ▁daily ▁)
▁for ▁practical ▁information ▁about ▁using ▁come t riq ▁ , ▁patients ▁should ▁read ▁the ▁package ▁le a flet ▁or ▁contact ▁their ▁doctor ▁or ▁ pharma ci st ▁ .
▁content s ▁of ▁the ▁pack ▁and ▁other ▁information ▁what ▁cer vari x ▁contain s
▁these ▁effects ▁were ▁not ▁seen ▁at ▁dos es ▁ ≤ ▁30 ▁mg ▁/ ▁kg ▁ .
▁a ▁second ▁dose ▁of ▁the ▁vaccin e ▁should ▁be ▁given ▁after ▁an ▁interval ▁of ▁at ▁least ▁three ▁weeks ▁ .
▁clinic al ▁data ▁described ▁below ▁suggest ▁that ▁the ▁risk ▁for ▁clinic ally ▁meaning ful ▁interaction s ▁with ▁co - ad minister ed ▁medicinal ▁products ▁is ▁low ▁ .
▁clinic al ▁trial s ▁indicate ▁that ▁gender ▁does ▁not ▁have ▁a ▁clinic ally ▁significant ▁influence ▁on ▁the ▁plasma ▁concentration s ▁of ▁la cos ami de ▁ .
▁psychiatr ic ▁disorder s ▁: ▁un com mon ▁: ▁depression ▁ , ▁dis orientation ▁ , ▁anxiety ▁ , ▁ insomni a ▁ , ▁sleep ▁disorder ▁ , ▁ab normal ▁dream
▁insulin ▁human ▁win thro p ▁com b ▁25 ▁must ▁never ▁be ▁inject ed ▁intra ven ously ▁ .
▁in ▁a ▁fertil ity ▁and ▁early ▁em bry o nic ▁development ▁study ▁in ▁rat s ▁ , ▁ata zana vir ▁alter ed ▁o est rus ▁ cycling ▁with ▁no ▁effects ▁on ▁ma ting ▁or ▁fertil ity ▁ .
▁table ▁3 ▁dose ▁adjust ment ▁and ▁interrupt ion ▁of ▁treatment ▁for ▁renal ▁monitoring
▁pull ▁the ▁plu nger ▁until ▁the ▁top ▁of ▁the ▁barre l ▁meet s ▁the ▁line ▁that ▁match es ▁the ▁dose ▁pre scribe d ▁by ▁your ▁health ▁care ▁provider ▁ .
▁sign s ▁and ▁symptoms ▁of ▁de hydrat ion ▁include ▁increased ▁thi rst ▁ , ▁dry ▁mouth ▁ , ▁decrease d ▁urin e ▁fre que ncy ▁or ▁volume ▁ , ▁and ▁dark ▁colour ed ▁urin e ▁ .
▁clinic ally ▁significant ▁weight ▁gain ▁( ▁ ≥ ▁7 ▁% ▁) ▁appears ▁to ▁occur ▁more ▁frequently ▁in ▁the ▁ adolescent ▁population ▁compared ▁to ▁adults ▁with ▁comparable ▁exposure s ▁ .
▁this ▁helps ▁you ▁get ▁the ▁correct ▁dose ▁of ▁medicine ▁ .
▁per ▁1 ▁ml ▁dose ▁of ▁the ▁recon stitu ted ▁product ▁:
▁the ▁following ▁side ▁effects ▁are ▁very ▁common ▁( ▁these ▁can ▁affect ▁at ▁least ▁10 ▁in ▁every ▁100 ▁patients ▁) ▁:
▁store ▁in ▁accordance ▁with ▁local ▁regulations ▁for ▁radio active ▁substance s ▁ .
▁the ▁requirements ▁for ▁sub mission ▁of ▁periodic ▁safety ▁update ▁reports ▁for ▁this ▁medicinal ▁product ▁are ▁set ▁out ▁in ▁the ▁list ▁of ▁union ▁reference ▁dates ▁( ▁eur d ▁list ▁) ▁provided ▁for ▁under ▁article ▁107 c ▁( ▁7 ▁) ▁of ▁direct ive ▁2001 ▁/ ▁83 ▁/ ▁ec ▁and ▁any ▁subsequent ▁updates ▁published ▁on ▁the ▁european ▁medicine s ▁web - portal ▁ .
▁if ▁se rum ▁ phos pha te ▁is ▁< ▁0 . 48 ▁mm ol ▁/ ▁l ▁( ▁1.5 ▁mg ▁/ ▁dl ▁) ▁or ▁creati nine ▁clear ance ▁is ▁decrease d ▁to ▁< ▁70 ▁ml ▁/ ▁min ▁ , ▁renal ▁function ▁should ▁be ▁re - evalua ted ▁within ▁one ▁week ▁ , ▁including ▁measure ments ▁of ▁blood ▁gluco se ▁ , ▁blood ▁po tas s ium ▁and ▁urin e ▁gluco se ▁concentration s ▁( ▁see ▁section ▁4. 8 ▁) ▁ .
▁the ▁safety ▁and ▁ef fica cy ▁of ▁can a gli flo zin ▁in ▁patients ▁with ▁type ▁1 ▁diabetes ▁have ▁not ▁been ▁established ▁and ▁can a gli flo zin ▁should ▁not ▁be ▁used ▁for ▁treatment ▁of ▁patients ▁with ▁type ▁1 ▁diabetes ▁ .
▁tac rol imus ▁is ▁also ▁considera bly ▁metabol ised ▁in ▁the ▁intestinal ▁wall ▁ .
▁special ▁war nings ▁and ▁precau tions ▁for ▁use ▁specific ▁to ▁a cute ▁tibi a ▁fra c tures
▁urin ary ▁recovery ▁was ▁less ▁than ▁ 0.6 ▁% ▁of ▁the ▁applied ▁dose ▁at ▁week ▁16 ▁in ▁these ▁patients ▁ .
▁for ▁small ▁dog s ▁> ▁4.5 ▁- ▁10 ▁kg
▁in ▁this ▁study ▁in ▁patients ▁receiving ▁pi og lita zone ▁and ▁insulin ▁ , ▁a ▁higher ▁percentage ▁of ▁patients ▁with ▁heart ▁failure ▁was ▁observe d ▁in ▁patients ▁a ged ▁> ▁65 ▁years ▁compared ▁with ▁those ▁less ▁than ▁65 ▁years ▁( ▁ 9.7 ▁% ▁compared ▁to ▁4.0 ▁% ▁) ▁ .
▁interaction ▁studies ▁have ▁only ▁been ▁perform ed ▁in ▁adults ▁ .
▁to ▁prevent ▁the ▁development ▁of ▁tissu e ▁a dhe sions ▁at ▁und esi red ▁sites ▁ , ▁ensure ▁tissu e ▁areas ▁outside ▁the ▁desire d ▁application ▁area ▁are ▁adequat ely ▁clean sed ▁before ▁administration ▁of ▁ta chos il ▁( ▁see ▁section ▁ 6.6 ▁) ▁ .
▁always ▁use ▁a ▁new ▁pen ▁if ▁you ▁notice ▁that ▁your ▁blood ▁sugar ▁control ▁is ▁unexpected ly ▁getting ▁worse ▁ .
▁nespo ▁should ▁not ▁be ▁used ▁in ▁people ▁who ▁may ▁be ▁hyper sensitiv e ▁( ▁allergi c ▁) ▁to ▁darbe po etin ▁alfa ▁or ▁any ▁of ▁the ▁other ▁ingredients ▁ , ▁or ▁in ▁patients ▁who ▁have ▁poor ly ▁control led ▁high ▁blood ▁pressure ▁ .
▁sil den a fil ▁is ▁a ▁we ak ▁inhibi tor ▁of ▁the ▁cy to ch rom e ▁p 450 ▁iso form s ▁1 a 2 ▁ , ▁2 c 9 ▁ , ▁2 c 19 ▁ , ▁2 d 6 ▁ , ▁2 e 1 ▁and ▁3 a 4 ▁( ▁ ic 50 ▁> ▁150 ▁m ▁) ▁ .
▁te sa vel ▁is ▁also ▁indicate d ▁as ▁add - on ▁to ▁insulin ▁( ▁with ▁or ▁without ▁met form in ▁) ▁when ▁die t ▁and ▁exercise ▁plus ▁stable ▁dose ▁of ▁insulin ▁do ▁not ▁provide ▁adequat e ▁gly ca e mic ▁control ▁ .
▁what ▁information ▁is ▁still ▁a wa i ted ▁for ▁na gla zy me ▁?
▁documentation ▁of ▁child be aring ▁potential ▁status
▁the ▁recommended ▁dose ▁for ▁pre vention ▁of ▁skelet al ▁events ▁in ▁patients ▁with ▁breast ▁cancer ▁and ▁bone ▁metas tas es ▁is ▁6 ▁mg ▁intra ven ously ▁given ▁every ▁3-4 ▁weeks ▁ .
▁rota te q ▁can ▁be ▁given ▁at ▁the ▁same ▁time ▁as ▁other ▁vaccin ations ▁( ▁except ▁the ▁oral ▁poli o ▁vaccin e ▁ , ▁when ▁a ▁two - week ▁interval ▁is ▁needed ▁between ▁the ▁two ▁vaccin es ▁) ▁ .
▁the ▁ diagnos is ▁of ▁pw s ▁should ▁be ▁confirm ed ▁by ▁appropriate ▁genetic ▁testing ▁ .
▁for ▁the ▁full ▁list ▁of ▁all ▁side ▁effects ▁reported ▁with ▁sci nti mun ▁ , ▁see ▁the ▁package ▁le a flet ▁ .
▁# ▁dar una vir ▁au c ▁ ↓ ▁13 ▁%
▁if ▁a ▁patient ▁wish es ▁to ▁become ▁pregnant ▁ , ▁treatment ▁with ▁glu bra va ▁should ▁be ▁dis continu ed ▁ .
▁not ▁all ▁pack s ▁may ▁be ▁market ed ▁in ▁your ▁country ▁ .
▁to ▁stimula te ▁active ▁immun ity ▁against ▁bordet ella ▁bron chi se ptica ▁ .
▁patients ▁with ▁all ▁who ▁have ▁not ▁responde d ▁to ▁or ▁who ▁have ▁re lapse d ▁after ▁receiving ▁at ▁least ▁two ▁treatment s ▁have ▁a ▁very ▁poor ▁chance ▁of ▁survival ▁ .
▁rever sal ▁of ▁the ▁effects ▁of ▁ tma ▁has ▁been ▁observe d ▁after ▁treatment ▁dis continu ation ▁( ▁see ▁section ▁4. 8 ▁) ▁ .
▁te ar ▁off ▁the ▁foi l ▁wrap per ▁and ▁take ▁out ▁the ▁strip ▁of ▁5 ▁container s ▁ .
▁tap ▁the ▁top ▁of ▁the ▁pen ▁a ▁few ▁times ▁to ▁let ▁any ▁air ▁bu bble s ▁ rise ▁to ▁the ▁top ▁ .
▁each ▁1 ▁mg ▁film - co ated ▁tablet ▁contain s ▁1 ▁mg ▁of ▁varen ic line ▁( ▁as ▁tart rate ▁) ▁ .
▁after ▁one ▁or ▁two ▁weeks ▁ , ▁the ▁daily ▁dose ▁may ▁be ▁increased ▁in ▁steps ▁of ▁1 ▁mg ▁per ▁kg ▁every ▁one ▁or ▁two ▁weeks ▁until ▁an ▁appropriate ▁dose ▁is ▁reached ▁ .
▁61 118 ▁bad ▁vil bel ▁german y
▁what ▁is ▁la mi vu dine ▁/ ▁zid ovu dine ▁teva ▁?
▁each ▁tablet ▁contain s ▁36. 866 ▁mg ▁of ▁la ctos e ▁mono hydrat e ▁( ▁see ▁section ▁4.4 ▁) ▁ .
▁because ▁of ▁the ▁potential ▁for ▁serious ▁advers e ▁reaction s ▁in ▁nur sing ▁infants ▁ , ▁a ▁decision ▁should ▁be ▁made ▁either ▁to ▁dis continu e ▁breast - feed ing ▁or ▁av on ex ▁ therapy ▁ .
▁for ▁the ▁full ▁list ▁of ▁all ▁side ▁effects ▁reported ▁with ▁os lif ▁bre ezh a ler ▁ , ▁see ▁the ▁package ▁le a flet ▁ .
▁cap e cita bine ▁can ▁induc e ▁severe ▁skin ▁reaction s ▁such ▁as ▁ste ven s - joh n son ▁syndrome ▁and ▁ toxic ▁epi der mal ▁nec rol ysis ▁ .
▁how ▁has ▁to uje o ▁been ▁studie d ▁?
▁some ▁patients ▁with ▁long - standing ▁type ▁2 ▁diabetes ▁mell itus ▁and ▁heart ▁disease ▁or ▁previous ▁stroke ▁who ▁were ▁treated ▁with ▁pi og lita zone ▁accord ▁and ▁insulin ▁experienced ▁the ▁development ▁of ▁heart ▁failure ▁ .
▁the ▁committee ▁recommended ▁that ▁zar zio ▁be ▁given ▁marketing ▁author isation ▁ .
▁if ▁you ▁are ▁planning ▁to ▁have ▁a ▁baby ▁ , ▁your ▁doctor ▁may ▁decide ▁to ▁stop ▁your ▁treatment ▁with ▁e per zan ▁at ▁least ▁one ▁month ▁before ▁you ▁try ▁to ▁get ▁pregnant ▁ .
▁the ▁vaccin e ▁is ▁given ▁as ▁a ▁single ▁inject ion ▁into ▁a ▁muscle ▁ , ▁prefer ably ▁the ▁ne ck ▁muscle ▁behind ▁the ▁ear ▁ .
▁the ▁physician ▁pre - pre scription ▁check list ▁will ▁highlight ▁the ▁contra indica tions ▁to ▁the ▁use ▁of ▁amb ris en tan ▁and ▁important ▁pre - pre scription ▁assessment s ▁including ▁:
▁novo thir teen ▁is ▁used ▁to ▁prevent ▁ble ed ing ▁in ▁patients ▁who ▁do ▁not ▁have ▁enough ▁factor ▁xi ii ▁ .
▁the ▁effective ness ▁of ▁targ ret in ▁has ▁been ▁examine d ▁in ▁two ▁studies ▁in vol ving ▁a ▁total ▁of ▁193 ▁patients ▁with ▁ct cl ▁who ▁had ▁failed ▁on ▁at ▁least ▁two ▁previous ▁treatment s ▁ .
▁avoid ▁use ▁in ▁any ▁de hydrat ed ▁ , ▁hypo vola e mic ▁or ▁hypo tensi ve ▁animal ▁ , ▁as ▁there ▁is ▁a ▁potential ▁risk ▁of ▁increased ▁renal ▁ toxic ity ▁ .
▁read ▁all ▁of ▁this ▁le a flet ▁carefully ▁before ▁you ▁start ▁using ▁kent era
▁le nali domi de ▁works ▁in ▁a ▁number ▁of ▁different ▁ways ▁: ▁it ▁block s ▁the ▁development ▁of ▁ab normal ▁cell s ▁ , ▁prevent s ▁the ▁growth ▁of ▁blood ▁ves sels ▁within ▁tu mo urs ▁and ▁also ▁stimula tes ▁some ▁of ▁the ▁speciali sed ▁cell s ▁of ▁the ▁immun e ▁system ▁to ▁attack ▁the ▁ab normal ▁cell s ▁ .
▁similar ▁effects ▁were ▁seen ▁in ▁the ▁rabbi t ▁at ▁sub - therapeut ic ▁exposure ▁ .
▁in ▁the ▁20- week ▁study ▁( ▁n ▁= ▁225 ▁) ▁ , ▁no ▁significant ▁difference ▁was ▁observe d ▁in ▁the ▁primary ▁ef fica cy ▁end point ▁ , ▁i . e . ▁the ▁proportion ▁of ▁patients ▁who ▁required ▁a ▁r bc ▁trans fusion ▁after ▁day ▁28 ▁( ▁62 ▁% ▁of ▁e po etin ▁alfa ▁patients ▁versus ▁69 ▁% ▁of ▁standard ▁ therapy ▁patients ▁) ▁ .
▁two ▁10 ▁mg ▁tablets
▁→ ▁tell ▁your ▁ana est het ist ▁if ▁you ▁are ▁taking ▁ , ▁have ▁recently ▁taken ▁or ▁might ▁take ▁any ▁other ▁medicine s ▁ .
▁particular s ▁to ▁appear ▁on ▁the ▁out er ▁packaging ▁carton ▁for ▁bli ster ▁pack
▁auto im mu ne ▁disorder s ▁( ▁such ▁as ▁graves ▁' ▁disease ▁) ▁have ▁also ▁been ▁reported ▁to ▁occur ▁in ▁the ▁setting ▁of ▁immun e ▁re activa tion ▁; ▁however ▁ , ▁the ▁reported ▁time ▁to ▁ons et ▁is ▁more ▁variable ▁and ▁these ▁events ▁can ▁occur ▁many ▁months ▁after ▁initiat ion ▁of ▁treatment ▁ .
▁patients ▁on ▁urat e ▁lower ing ▁ therapy ▁( ▁ ult ▁)
▁the ▁stea dy - state ▁ pharma cok ine tics ▁of ▁an ▁et hin yl ▁est radio l ▁/ ▁le von org est rel ▁combination ▁oral ▁contra cep tive ▁were ▁not ▁significantly ▁alter ed ▁by ▁con com i tant ▁administration ▁of ▁rim ona bant ▁ .
▁men ▁who ▁are ▁at ▁an ▁increased ▁risk ▁of ▁fra c tures ▁; ▁men ▁and ▁women ▁who ▁are ▁at ▁an ▁increased ▁risk ▁of ▁fra c tures ▁due ▁to ▁long - term ▁treatment ▁with ▁gluco cor tico ids ▁( ▁a ▁type ▁of ▁steroid ▁) ▁ .
▁most ▁of ▁these ▁reaction s ▁were ▁not ed ▁during ▁the ▁2 ▁days ▁following ▁the ▁vaccin e ▁inject ion ▁ .
▁when ▁pup pies ▁are ▁known ▁to ▁have ▁high ▁levels ▁of ▁matern ally ▁deri ved ▁anti bo dies ▁( ▁special ▁type ▁of ▁protein s ▁ , ▁received ▁from ▁the ▁mother ▁in ▁the ▁milk ▁ , ▁that ▁help ▁the ▁body ▁to ▁fight ▁infection ▁) ▁ , ▁it ▁is ▁recommended ▁that ▁the ▁first ▁vaccin ation ▁is ▁given ▁at
▁in ▁an ▁oral ▁multiple - dos e ▁study ▁ , ▁au c τ ▁was ▁similar ▁in ▁subject s ▁with ▁moderat e ▁he pati c ▁cir r ho sis ▁( ▁child - p ugh ▁b ▁) ▁given ▁a ▁maintenance ▁dose ▁of ▁100 ▁mg ▁twice ▁daily ▁and ▁subject s ▁with ▁normal ▁he pati c ▁function ▁given ▁200 ▁mg ▁twice ▁daily ▁ .
▁clinic al ▁experience ▁of ▁mab ther a ▁sub cuta ne ous ▁formula tion ▁in ▁non - hod g kin ▁' s ▁lymph oma
▁omni trop e ▁15 ▁mg ▁/ ▁1.5 ▁ml ▁inject ion ▁som a trop in
▁if ▁not ▁used ▁immediately ▁ , ▁the ▁solution ▁can ▁be ▁store d ▁up ▁to ▁24 ▁hours ▁refrigera ted ▁2 ▁° ▁c -8 ▁° ▁c . ▁this ▁medicinal ▁product ▁is ▁for ▁single ▁use ▁only ▁ .
▁the ▁risk ▁of ▁arterial ▁ thro mbo e mbol ic ▁complica tions ▁or ▁of ▁a ▁cerebro vas cular ▁accident ▁in ▁ch c ▁users ▁increase s ▁in ▁women ▁with ▁risk ▁factors ▁( ▁see ▁table ▁) ▁ .
▁notes ▁: ▁the ▁analysis ▁is ▁based ▁on ▁all ▁available ▁data ▁ .
▁de x mede tomi dine ▁375 ▁micro gram s ▁/ ▁m 2 ▁( ▁m c g ▁/ ▁kg ▁) ▁( ▁ml ▁)
▁in ▁a ▁population ▁ pharma cok ine tic ▁analysis ▁ , ▁age ▁and ▁renal ▁im pair ment ▁were ▁not ▁shown ▁to ▁affect ▁tras tuz um ab ▁disposition ▁ .
▁rif ampi cin ▁reduce s ▁the ▁tela pre vir ▁plasma ▁au c ▁by ▁approximately ▁92 ▁% ▁ .
▁treatment ▁with ▁rey ata z ▁should ▁be ▁started ▁by ▁a ▁doctor ▁who ▁has ▁experience ▁in ▁the ▁treatment ▁of ▁hi v ▁infection ▁ .
▁these ▁side ▁effects ▁may ▁occur ▁with ▁certain ▁fre que ncies ▁ , ▁which ▁are ▁define d ▁as ▁follow s ▁:
▁how ▁does ▁sa vene ▁work ▁?
▁how ▁has ▁vec tra ▁3 d ▁been ▁studie d ▁?
▁response ▁rate ▁in ▁patients ▁with ▁prior ▁ ritu xim ab ▁ therapy
▁war nings ▁and ▁pre ▁cau tions
▁cau tion ▁is ▁advise d ▁when ▁treat ing ▁patients ▁ ≥ ▁65 ▁years ▁of ▁age ▁with ▁dos es ▁higher ▁than ▁10 ▁mg ▁vor tio xe tine ▁once ▁daily ▁for ▁which ▁data ▁are ▁limited ▁( ▁see ▁section ▁4.4 ▁) ▁ .
▁after ▁recon stitu tion ▁ , ▁store ▁below ▁25 ▁° ▁c ▁for ▁10 ▁days ▁or ▁in ▁a ▁refrigera tor ▁( ▁2 ▁° ▁c ▁- ▁8 ▁° ▁c ▁) ▁for ▁17 ▁days ▁ .
▁do ▁not ▁use ▁this ▁medicine ▁after ▁the ▁exp i ry ▁date ▁which ▁is ▁state d ▁on ▁the ▁bottle ▁label ▁and ▁carton ▁after ▁exp ▁ .
▁in ▁this ▁study ▁( ▁n ▁= ▁28 1 ▁) ▁ , ▁patients ▁with ▁multiple ▁mye loma ▁received ▁condition ing ▁with ▁mel phal an ▁( ▁200 ▁mg ▁/ ▁m 2 ▁) ▁prior ▁to ▁auto logo us ▁ha e mato po ie tic ▁stem ▁cell ▁transplant ation ▁ .
▁each ▁pack ▁also ▁contain s ▁a ▁poly propyl ene ▁me as uring ▁cup ▁( ▁graduate d ▁to ▁indicate ▁30 ▁ml ▁) ▁ , ▁poly propyl ene ▁oral ▁dos ing ▁sy ringe ▁( ▁3 ▁ml ▁) ▁with ▁hd pe ▁plu nger ▁and ▁a ▁l d pe ▁press - in ▁bottle ▁adapt or ▁ .
▁ pharma cok ine tics ▁of ▁az ils ar tan ▁do ▁not ▁differ ▁significantly ▁between ▁black ▁and ▁white ▁population s ▁ .
▁do ▁not ▁use ▁this ▁medicine ▁if ▁any ▁of ▁the ▁above ▁app lies ▁to ▁you ▁ .
▁re duction ▁in ▁the ▁number ▁of ▁red ▁blood ▁cell s ▁( ▁ana emia ▁) ▁ .
▁the ▁committee ▁recommended ▁that ▁vor ico na zole ▁accord ▁be ▁approved ▁for ▁use ▁in ▁the ▁eu ▁ .
▁results ▁of ▁animal ▁fertil ity ▁studies ▁have ▁shown ▁no ▁effect ▁on ▁male ▁and ▁female ▁fertil ity ▁ , ▁but ▁advers e ▁effects ▁on ▁male ▁reproduc tive ▁organ s ▁were ▁observe d ▁in ▁repeat ed ▁dose ▁ toxic ity ▁studies ▁( ▁see ▁section ▁5.3 ▁) ▁ .
▁this ▁should ▁be ▁taken ▁into ▁account ▁in ▁patients ▁with ▁diabetes ▁mell itus ▁ .
▁tell ▁your ▁doctor ▁immediately ▁and ▁stop ▁taking ▁le flu nom ide ▁teva ▁:
▁the ▁no a el ▁was ▁ ≥ ▁1800 ▁mg ▁/ ▁kg ▁/ ▁day ▁for ▁the ▁f 0 ▁female s ▁ , ▁and ▁for ▁the ▁survival ▁ , ▁growth ▁and ▁development ▁of ▁the ▁f 1 ▁off spring ▁up ▁to ▁we a ning ▁( ▁x ▁6 ▁the ▁mr hd ▁on ▁a ▁mg ▁/ ▁m 2 ▁basis ▁) ▁ .
▁em bry o fo e tal ▁ toxic ity ▁was ▁observe d ▁in ▁rabbi ts ▁in ▁the ▁ absence ▁of ▁matern al ▁ toxic ity ▁at ▁ ≥ ▁6.5 ▁times ▁the ▁mr hd ▁ .
▁there ▁is ▁no ▁experience ▁of ▁using ▁col obre a the ▁concurrent ly ▁with ▁other ▁in hal ed ▁anti bac teria l ▁agents ▁ .
▁ni vesti m ▁is ▁one ▁of ▁a ▁group ▁of ▁products ▁that ▁stimula te ▁the ▁production ▁of ▁white ▁blood ▁cell s ▁ .
▁you ▁should ▁be ▁aware ▁of ▁how ▁you ▁react ▁to ▁the ▁medicine ▁before ▁you ▁drive ▁or ▁use ▁machines ▁ .
▁cases ▁of ▁ha em ol ysis ▁have ▁been ▁reported ▁in ▁the ▁setting ▁of ▁missed ▁or ▁de lay ed ▁soli ris ▁dose ▁in ▁p nh ▁clinic al ▁trial s ▁( ▁see ▁also ▁section ▁4.4 ▁) ▁ .
▁exposure ▁of ▁5- fu ▁was ▁not ▁statistic ally ▁significantly ▁different ▁between ▁the ▁two ▁groups ▁ .
▁poly sor bate ▁80 ▁1. 175 ▁milli gram s ▁per ▁0.5 ▁ml ▁sor bit an ▁trio le ate ▁1. 175 ▁milli gram s ▁per ▁0.5 ▁ml
▁mira pe xin ▁1. 05 ▁mg ▁ , ▁1. 57 ▁mg ▁ , ▁2.1 ▁mg ▁ , ▁2. 62 ▁mg ▁and ▁3. 15 ▁mg ▁prolong ed - release ▁tablets ▁are ▁white ▁to ▁off - white ▁and ▁of ▁ oval ▁shape ▁ .
▁what ▁rap am une ▁looks ▁like ▁and ▁content s ▁of ▁the ▁pack
▁what ▁benefit ▁has ▁revi ta cam ▁shown ▁during ▁the ▁studies ▁?
▁ra ne xa ▁is ▁contra indica ted ▁in ▁patients ▁with ▁moderat e ▁or ▁severe ▁he pati c ▁im pair ment ▁( ▁see ▁section s ▁4.3 ▁and ▁5.2 ▁) ▁ .
▁aluminium ▁bli ster ▁contain ing ▁one ▁125 ▁mg ▁capsule ▁and ▁two ▁80 ▁mg ▁capsule s ▁ .
▁decrease d ▁appetit e ▁ , ▁hyper gly ca emia ▁ , ▁electro ly te ▁im balance
▁cau tion ▁should ▁be ▁exercise d ▁with ▁escala tion ▁of ▁mir cera ▁dos es ▁in ▁patients ▁with ▁chronic ▁renal ▁failure ▁ .
▁nespo ▁25 ▁micro gram s ▁solution ▁for ▁inject ion ▁in ▁a ▁vi al ▁ .
▁recommendations ▁on ▁how ▁to ▁mit iga te ▁these ▁risk s ▁through ▁appropriate ▁monitoring ▁and ▁management ▁to ▁be ▁provided ▁ .
▁very ▁common ▁: ▁na use a ▁ , ▁vom i ting ▁and ▁di ar r ho e a ▁( ▁all ▁of ▁which ▁may ▁be ▁severe ▁) ▁ , ▁con s tip ation ▁ , ▁abdominal ▁pain 1 ▁mu cos itis ▁ .
▁these ▁studies ▁are ▁still ▁ongoing ▁ .
▁dark ▁yellow ▁and ▁white ▁ , ▁print ed ▁with ▁" ▁sus tiva ▁" ▁on ▁the ▁dark ▁yellow ▁cap ▁and ▁" ▁50 ▁mg ▁" ▁on ▁the ▁white ▁body ▁ .
▁based ▁on ▁laborator y ▁animal ▁data ▁ , ▁gamit hro my cin ▁has ▁not ▁produced ▁any ▁evidence ▁of ▁select ive ▁development al ▁or ▁reproduc tive ▁effects ▁ .
▁educa te ▁patients ▁about ▁chronic ▁ liver ▁disease ▁and ▁the ▁risk ▁of ▁ thro mbo e mbol ic ▁events ▁ .
▁taking ▁a genera se ▁with ▁rito na vir ▁should ▁be ▁avoid ed ▁in ▁children ▁ .
▁any ▁person ▁inte nding ▁to ▁manufacture ▁ , ▁import ▁ , ▁possess ▁ , ▁sell ▁ , ▁supply ▁and ▁/ ▁or ▁use ▁in gel vac ▁circo flex ▁must ▁consult ▁the ▁relevant ▁member ▁state ▁' s ▁ competent ▁authority ▁on ▁the ▁current ▁vaccin ation ▁policies ▁prior ▁to ▁the ▁manufacture ▁ , ▁import ▁ , ▁possess ▁ , ▁sale ▁ , ▁supply ▁and ▁/ ▁or ▁use ▁ .
▁however ▁ , ▁in ▁a ▁9 ▁month ▁study ▁in ▁dog s ▁ , ▁no ▁organ ▁weight ▁changes ▁nor ▁gross ▁or ▁his to morph ologic ▁finding s ▁were ▁present ▁in ▁male ▁reproduc tive ▁organ s ▁at ▁system ic ▁exposure s ▁35 - fold ▁above ▁the ▁ therapeut ic ▁exposure ▁in ▁humans ▁at ▁40 ▁mg ▁ .
▁non - steroid al ▁anti - in flam ma tory ▁drugs ▁: ▁when ▁ang io ten sin ▁i i ▁anta gon ists ▁are ▁ad minister ed ▁simultan e ously ▁with ▁non - steroid al ▁anti - in flam ma tory ▁drugs ▁( ▁i . e . ▁select ive ▁co x -2 ▁inhibi tors ▁ , ▁a ce tyl sali cy lic ▁acid ▁( ▁> ▁3 ▁g ▁/ ▁day ▁) ▁and ▁non - sel ective ▁ nsa ids ▁) ▁ , ▁att en u ation ▁of ▁the ▁anti hy per tensi ve ▁effect ▁may ▁occur ▁ .
▁ser ologic ▁response s ▁obtain ed ▁with ▁the ▁sr h ▁as say ▁showed ▁that ▁100 ▁% ▁of ▁subject s ▁achieve d ▁ser o protec tion ▁and ▁100 ▁% ▁ser o con ver ted ▁after ▁two ▁7.5 ▁g ▁inject ions ▁ .
▁a plast ic ▁ana emia ▁ , ▁pure ▁red ▁cell ▁a plas ia ▁( ▁a ▁condition ▁where ▁the ▁body ▁stopped ▁or ▁reduce d ▁the
▁the ▁european ▁commission ▁gran ted ▁a ▁marketing ▁author isation ▁valid ▁throughout ▁the ▁eu ▁for ▁in fan rix ▁pent a ▁to ▁gla xo smith k line ▁bi ological s ▁s . a . ▁on ▁23 ▁octo ber ▁2000 ▁ .
▁due ▁to ▁the ▁high ▁proportion ▁of ▁prematur e ▁dis continu ation ▁( ▁42 ▁% ▁of ▁patients ▁dis continu ed ▁random ised ▁treatment ▁by ▁week ▁48 ▁) ▁ , ▁no ▁definitiv e ▁conclusion ▁can ▁be ▁draw n ▁regarding ▁the ▁equivale nce ▁between ▁the ▁treatment ▁regime ns ▁at ▁week ▁48 ▁ .
▁in ▁cyn om ol gus ▁mon key s ▁sax ag lip tin ▁produced ▁rever sible ▁skin ▁les ions ▁( ▁sc ab s ▁ , ▁ul cer ations ▁and ▁nec rosi s ▁) ▁in ▁extrem ities ▁( ▁ tail ▁ , ▁digit s ▁ , ▁s cro tum ▁and ▁/ ▁or ▁nos e ▁) ▁at ▁dos es ▁ ≥ ▁3 ▁mg ▁/ ▁kg ▁/ ▁day ▁ .
▁ha e mor r hage s ▁occur red ▁on ▁the ▁surface ▁of ▁the ▁retin a ▁( ▁pre reti nal ▁) ▁ , ▁under ▁the ▁retin a ▁( ▁sub reti nal ▁) ▁ , ▁or ▁within ▁the ▁retin al ▁tissu e ▁ .
▁no ▁dose ▁adjust ment ▁is ▁necessary ▁for ▁adult ▁or ▁pa e dia tric ▁patients ▁with ▁mild ▁renal ▁im pair ment ▁ .
▁patients ▁with ▁renal ▁im pair ment ▁( ▁see ▁section ▁4.2 ▁ , ▁4.4 ▁ , ▁and ▁5.2 ▁)
▁very ▁common ▁: ▁diabetes ▁mell itus ▁ , ▁hyper gly ca e mic ▁conditions ▁ , ▁hyper kala emia
▁ef fica cy ▁results ▁are ▁summa ris ed ▁in ▁table s ▁5 ▁and ▁6 ▁ .
▁ni men rix ▁should ▁under ▁no ▁circumstances ▁be ▁ad minister ed ▁intra vas cular ly ▁ , ▁intra der m ally ▁or ▁sub cuta ne ously ▁ .
▁kin zal kom b ▁80 ▁mg ▁/ ▁25 ▁mg ▁may ▁be ▁ad minister ed ▁once ▁daily ▁in ▁patients ▁whose ▁blood ▁pressure ▁is ▁not ▁adequat ely ▁control led ▁by ▁kin zal kom b ▁80 ▁mg ▁/ ▁12. 5 ▁mg ▁or ▁in ▁patients ▁who ▁have ▁been ▁previously ▁stabili sed ▁on ▁tel mis ar tan ▁and ▁hydro ch lor o thi azi de ▁given ▁separate ly ▁ .
▁my o card ial ▁in far ction ▁rates ▁were ▁slightly ▁increased ▁with ▁da biga tran ▁et ex ila te ▁110 ▁mg ▁twice ▁daily ▁and ▁150 ▁mg ▁twice ▁daily ▁compared ▁to ▁war far in ▁( ▁hazard ▁ratio ▁1. 29 ▁; ▁p ▁= ▁0.0 9 29 ▁and ▁hazard ▁ratio ▁1. 27 ▁; ▁p ▁= ▁0.1 240 ▁ , ▁respective ly ▁) ▁ .
▁the ▁other ▁ingredients ▁are ▁l - h isti dine ▁ , ▁l - h isti dine ▁mono hydro ch lor ide ▁mono hydrat e ▁ , ▁poly sor bate ▁80 ▁ , ▁suc rose ▁and ▁water ▁for ▁inject ions ▁ .
▁following ▁established ▁che mo therapy ▁for ▁solid ▁tu mo urs ▁ , ▁lymph om as ▁ , ▁and ▁lymph oid ▁leuk a emia ▁ , ▁it ▁is ▁expected ▁that ▁the ▁du ration ▁of ▁treatment ▁required ▁to ▁ful fil ▁these ▁criteri a ▁will ▁be ▁up ▁to ▁14 ▁days ▁ .
▁regular ▁ute rine ▁contract ions ▁of ▁at ▁least ▁30 ▁seconds ▁du ration ▁at ▁a ▁rate ▁of ▁4 ▁per ▁30 ▁minutes
▁hypo tension ▁reported ▁as ▁a ▁serious ▁advers e ▁experience ▁or ▁leading ▁to ▁medicine ▁dis continu ation ▁occur red ▁in ▁ch f ▁patients ▁following ▁exposure ▁to ▁brin a ves s ▁in ▁2. 9 ▁% ▁of ▁these ▁patients ▁compared ▁to ▁0 ▁% ▁in ▁place bo ▁ .
▁rare ▁cases ▁of ▁radi ation ▁pneu moni tis ▁have ▁been ▁reported ▁in ▁patients ▁receiving ▁con com i tant ▁radio therapy ▁ .
▁the ▁veterinar y ▁medicinal ▁product ▁is ▁presente d ▁in ▁10 ▁ml ▁ , ▁32 ▁ml ▁ , ▁100 ▁ml ▁ , ▁2 ▁x ▁100 ▁ml ▁and ▁200 ▁ml ▁poly e thy lene ▁tere ph thala te ▁screw ▁bottle s ▁with ▁hd pe ▁/ ▁l d pe ▁child ▁resist ant ▁cap s ▁ .
▁do ▁not ▁use ▁your ▁pen ▁or ▁need le ▁if ▁any ▁parts ▁are ▁broken ▁or ▁missing ▁ .
▁continue ▁treatment ▁for ▁four ▁weeks ▁ .
▁through ▁week ▁48 ▁ , ▁eos ino phil ia ▁[ ▁greater ▁than ▁the ▁upp er ▁limit ▁of ▁normal ▁of ▁> ▁ 0.7 ▁x ▁109 ▁/ ▁l ▁] ▁occur red ▁at ▁a ▁higher ▁rate ▁among st ▁patients ▁in ▁the ▁fu ze on ▁contain ing ▁group ▁( ▁12. 4 ▁patients ▁with ▁event ▁per ▁100 ▁patient - year s ▁) ▁compared ▁with ▁ob ▁alone ▁regime n ▁( ▁ 5.6 ▁patients ▁with ▁event ▁per ▁100 ▁patient - year s ▁) ▁ .
▁cere zy me ▁has ▁no ▁or ▁negli gi ble ▁influence ▁on ▁the ▁ability ▁to ▁drive ▁and ▁use ▁machines ▁ .
▁ask ▁your ▁doctor ▁or ▁ pharma ci st ▁to ▁write ▁down ▁the ▁number ▁of ▁each ▁strength ▁( ▁including ▁colour ▁) ▁that ▁you ▁need ▁to ▁take ▁each ▁dos ing ▁day ▁ .
▁in ▁che mo therapy ▁na ï ve ▁patients ▁treated ▁for ▁non - s mall ▁cell ▁lung ▁cancer ▁ , ▁the ▁recommended ▁dose ▁regime n ▁is ▁doce ta xel ▁75 ▁mg ▁/ ▁m 2 ▁immediately ▁followed ▁by ▁ci s plat in ▁75 ▁mg ▁/ ▁m 2 ▁over ▁30 -60 ▁minutes ▁ .
▁renal ▁and ▁urin ary ▁disorder s ▁:
▁death ▁and ▁permanent ▁dis ability ▁are ▁reported ▁in ▁patients ▁who ▁have ▁experienced ▁stroke ▁( ▁including ▁in trac rani al ▁ble ed ing ▁) ▁and ▁other ▁serious ▁ble ed ing ▁episode s ▁ .
▁take ▁the ▁solution ▁immediately ▁after ▁mix ing ▁ .
▁one ▁gram ▁of ▁proto py ▁0.1 ▁% ▁o int ment ▁contain s ▁1.0 ▁mg ▁tac rol imus ▁( ▁as ▁tac rol imus ▁mono hydrat e ▁) ▁ .
▁a erius ▁is ▁suppli ed ▁in ▁bli sters ▁compris ed ▁of ▁laminat e ▁bli ster ▁film ▁with ▁foi l ▁li dding ▁ .
▁intra ven ously ▁ad minister ed ▁zo le dro nic ▁acid ▁is ▁elimina ted ▁by ▁a ▁trip ha sic ▁process ▁: ▁rapid ▁bi pha sic ▁disappear ance ▁from ▁the ▁system ic ▁circulation ▁ , ▁with ▁half - live s ▁of ▁t ▁1⁄2 ▁α ▁0.2 4 ▁and ▁t ▁1⁄2 ▁β ▁1. 87 ▁hours ▁ , ▁followed ▁by ▁a ▁long ▁elimina tion ▁phase ▁with ▁a ▁terminal ▁elimina tion ▁half - life ▁of ▁t ▁1⁄2 ▁γ ▁146 ▁hours ▁ .
▁these ▁side ▁effects ▁resolve ▁once ▁treatment ▁has ▁stopped ▁ .
▁sanc uso ▁3.1 ▁mg ▁/ ▁24 ▁hours ▁trans der mal ▁patch ▁gran iset ron
▁however ▁ , ▁if ▁you ▁are ▁concerned ▁by ▁your ▁ble ed ing ▁ , ▁you ▁should ▁contact ▁your ▁doctor ▁straight away ▁( ▁see ▁section ▁2 ▁' ▁war nings ▁and ▁precau tions ▁' ▁) ▁ .
▁administration ▁of ▁activa ted ▁char co al ▁may ▁also ▁be ▁used ▁to ▁aid ▁in ▁the ▁remo val ▁of ▁una b sor bed ▁active ▁substance ▁ .
▁56 ▁capsule s ▁+ ▁1 ▁in hal er
▁this ▁medicine ▁may ▁also ▁stop ▁some ▁other ▁medicine s ▁from ▁working ▁as ▁well ▁ , ▁e . g . ▁levo do pa ▁( ▁used ▁to ▁treat ▁par kin son ▁' s ▁disease ▁) ▁ .
▁male ▁patients ▁or ▁their ▁female ▁partners ▁should ▁also ▁use ▁effective ▁contra ception ▁ .
▁it ▁is ▁not ▁intended ▁to ▁provide ▁practical ▁advice ▁on ▁how ▁to ▁use ▁garda sil ▁9 ▁ .
▁in ▁decidi ng ▁to ▁initiat e ▁treatment ▁with ▁a pti vus ▁ , ▁co - ad minister ed ▁with ▁low ▁dose ▁rito na vir ▁ , ▁care ful ▁consideration ▁should ▁be ▁given ▁to ▁the ▁treatment ▁history ▁of ▁the ▁individual ▁patient ▁and ▁the ▁pattern s ▁of ▁mutation s ▁associated ▁with ▁different ▁agents ▁ .
▁e po etin ▁alfa ▁he xal ▁is ▁given ▁by ▁inject ion ▁under ▁the ▁skin ▁ .
▁hold ▁the ▁bir d ▁with ▁its ▁head ▁til ted ▁to ▁one ▁side ▁ .
▁syn flor ix ▁was ▁also ▁shown ▁to ▁reduce ▁the ▁occur r ence ▁of ▁pneu monia ▁ .
▁er y thema ▁multi forme ▁( ▁infla mma tory ▁skin ▁ rash ▁) ▁lup us - like ▁syndrome
▁patients ▁ , ▁especially ▁el der ly ▁patients ▁and ▁those ▁receiving ▁di ure tic ▁ therapy ▁ , ▁should ▁be ▁appropriate ly ▁hydrat ed ▁prior ▁to ▁administration ▁of ▁zo le dro nic ▁acid ▁ .
▁pain ful ▁ inflammation ▁of ▁the ▁joint s ▁most ▁common ly ▁in ▁the ▁foot ▁( ▁go ut ▁) ▁;
▁patients ▁were ▁random ised ▁to ▁clo pido gre l ▁( ▁300 ▁mg ▁load ing ▁dose ▁followed ▁by ▁75 ▁mg ▁/ ▁day ▁ , ▁n ▁= ▁6 , 25 9 ▁) ▁or ▁place bo ▁( ▁n ▁= ▁6 , 30 3 ▁) ▁ , ▁both ▁given ▁in ▁combination ▁with ▁asa ▁( ▁75 -3 25 ▁mg ▁once ▁daily ▁) ▁and ▁other ▁standard ▁ therapie s ▁ .
▁two ▁random ised ▁ , ▁double - blind ▁ , ▁multi - centre ▁ , ▁place bo ▁control led ▁ , ▁phase ▁3 ▁pivo tal ▁studies ▁were ▁conduct ed ▁( ▁a ries -1 ▁and ▁2 ▁) ▁ .
▁the ▁starting ▁dose ▁is ▁1.5 ▁mg ▁twice ▁a ▁day ▁ .
▁1 ▁single ▁dose ▁1 ▁ml ▁pre - fill ed ▁sy ringe ▁with ▁2 ▁separate ▁need les
▁the ▁dose ▁may ▁later ▁be ▁increased ▁to ▁300 ▁mg ▁once ▁daily ▁de pending ▁on ▁blood ▁pressure ▁response ▁ .
▁on ▁the ▁day ▁of ▁ , ▁or ▁the ▁day ▁following ▁administration ▁of ▁spin os ad ▁at ▁a ▁dose ▁of ▁50- 75 ▁mg ▁/ ▁kg ▁body weight ▁ , ▁the ▁observe d ▁incide nce ▁of ▁vom i ting ▁in ▁the ▁global ▁field ▁trial ▁was ▁between ▁6 ▁% ▁and ▁11 ▁% ▁in ▁the ▁first ▁three ▁months ▁of ▁treatment ▁ .
▁there ▁is ▁an ▁apparent ▁trend ▁to ▁a ▁dose ▁relationship ▁to ▁a ▁time ▁to ▁recovery ▁of ▁base line ▁sy sto lic ▁blood ▁pressure ▁( ▁s b p ▁) ▁ .
▁the ▁symptoms ▁of ▁pm l ▁may ▁be ▁similar ▁to ▁an ▁ms ▁re lapse ▁ .
▁while ▁on ▁treatment ▁ , ▁invasi ve ▁dental ▁procedure s ▁should ▁be ▁perform ed ▁only ▁after ▁care ful ▁consideration ▁and ▁be ▁avoid ed ▁in ▁close ▁proximi ty ▁to ▁iba ndro nic ▁acid ▁administration ▁ .
▁minimum ▁particular s ▁to ▁appear ▁on ▁white ▁bli sters ▁or ▁strip s
▁hyper sensitiv ity ▁reaction s ▁may ▁have ▁symptoms ▁similar ▁to ▁ang io ede ma ▁attack s ▁ .
▁this ▁is ▁a ▁summary ▁of ▁the ▁european ▁public ▁assessment ▁report ▁( ▁e par ▁) ▁for ▁pi og lita zone ▁accord ▁ .
▁greater ▁than ▁70 ▁% ▁of ▁patients ▁en roll ed ▁exhibi ted ▁3 ▁+ ▁over expression ▁ .
▁these ▁are ▁considered ▁to ▁be ▁related ▁to ▁art ▁or ▁subsequent ▁pre gna ncy ▁ .
▁failure ▁to ▁do ▁so ▁may ▁result ▁in ▁pump ▁pocket ▁infection ▁and ▁subsequent ▁pump ▁ex plant ation ▁( ▁see ▁section ▁4.4 ▁) ▁ .
▁patients ▁had ▁to ▁agree ▁to ▁active ly ▁participat e ▁in ▁a ▁strict ▁rehabilita tion ▁protocol ▁and ▁follow - up ▁program ▁ .
▁random ization ▁was ▁strat ified ▁by ▁race ▁( ▁ea stern ▁asian ▁vs ▁non ▁ea stern ▁asian ▁) ▁ .
▁head ache ▁ , ▁stomach ▁pain ▁ , ▁feeling ▁tired ▁ , ▁feeling ▁blo ated ▁ , ▁flat ul ence
▁what ▁pag lita z ▁looks ▁like ▁and ▁content s ▁of ▁the ▁pack
▁what ▁at osi ban ▁sun ▁looks ▁like ▁and ▁content s ▁of ▁the ▁pack
▁the ▁recommended ▁dose ▁is ▁1 ▁mg ▁varen ic line ▁twice ▁daily ▁following ▁a ▁1- week ▁tit ration ▁as ▁follow s ▁:
▁these ▁vas cular ▁effects ▁may ▁be ▁complement ed ▁by ▁inhibi tion ▁of ▁blad der ▁a ffer ent ▁nerv e ▁activity ▁and ▁smooth ▁muscle ▁relax ation ▁of ▁the ▁prostat e ▁and ▁blad der ▁ .
▁it ▁is ▁very ▁important ▁that ▁your ▁child ▁takes ▁vir am une ▁oral ▁suspens ion ▁only ▁once ▁a ▁day ▁for ▁the ▁first ▁14 ▁days ▁( ▁" ▁lead - in ▁" ▁period ▁) ▁ .
▁following ▁short ▁term ▁treatment ▁( ▁media n ▁du ration ▁47 ▁days ▁) ▁ , ▁weight ▁gain ▁ ≥ ▁7 ▁% ▁of ▁base line ▁body ▁weight ▁was ▁very ▁common ▁( ▁22. 2 ▁% ▁) ▁ , ▁ ≥ ▁15 ▁% ▁was ▁common ▁( ▁4.2 ▁% ▁) ▁and ▁ ≥ ▁25 ▁% ▁was ▁un com mon ▁( ▁ 0.8 ▁% ▁) ▁ .
▁further more ▁ , ▁there ▁is ▁evidence ▁of ▁an ▁association ▁between ▁hypo cal ca emia ▁and ▁seconda ry ▁neurologi cal ▁events ▁reported ▁in ▁these ▁cases ▁including ▁; ▁convuls ions ▁ , ▁hypo a es the sia ▁and ▁te tany ▁( ▁see ▁section ▁4.4 ▁) ▁ .
▁patients ▁should ▁be ▁treated ▁with ▁per je ta ▁and ▁tras tuz um ab ▁until ▁disease ▁progression ▁or ▁un mana ge able ▁ toxic ity ▁ .
▁bio ava il ability ▁after ▁oral ▁administration ▁is ▁about ▁60 ▁% ▁ .
▁for ▁more ▁information ▁about ▁treatment ▁with ▁zu tec tra ▁ , ▁read ▁the ▁package ▁le a flet ▁( ▁also ▁part ▁of ▁the ▁e par ▁) ▁or ▁contact ▁your ▁doctor ▁or ▁ pharma ci st ▁ .
▁la mi vu dine ▁and ▁/ ▁or ▁ra lte grav ir ▁( ▁alone ▁or ▁in ▁combination ▁with ▁other ▁art ▁) ▁*
▁in ▁clinic al ▁studies ▁ , ▁mild ▁or ▁moderat e ▁eleva tions ▁of ▁alt ▁and ▁a st ▁have ▁been ▁observe d ▁in ▁patients ▁receiving ▁in flix ima b ▁without ▁progression ▁to ▁severe ▁he pati c ▁injury ▁ .
▁aluminium ▁/ ▁aluminium ▁bli ster ▁strip s ▁in ▁carton s ▁of ▁28 ▁ , ▁56 ▁and ▁98 ▁film - co ated ▁tablets ▁per ▁carton ▁ .
▁ras - as soci ated ▁malign a ncies ▁have ▁been ▁reported ▁in ▁clinic al ▁trial s ▁ , ▁both ▁with ▁another ▁bra f ▁inhibi tor ▁( ▁chronic ▁mye lo mono cy tic ▁leuk a emia ▁and ▁non - ▁cu tane ous ▁s cc ▁of ▁the ▁head ▁and ▁ne ck ▁) ▁as ▁well ▁as ▁with ▁da bra fen ib ▁mono therapy ▁( ▁pan creati c ▁a den oca rci noma ▁ , ▁bile ▁ duct ▁a den oca rci noma ▁) ▁and ▁with ▁da bra fen ib ▁in ▁combination ▁with ▁the ▁ mek ▁inhibi tor ▁ , ▁tram etin ib ▁( ▁colore c tal ▁cancer ▁ , ▁pan creati c ▁cancer ▁) ▁ .
▁cardiovascular ▁complica tions ▁( ▁affect ing ▁the ▁heart ▁and ▁blood ▁ves sels ▁) ▁including ▁heart ▁attack ▁ , ▁con ges tive ▁heart ▁failure ▁ , ▁palp it ations ▁ , ▁blood ▁ves sel ▁di lation ▁ , ▁changes ▁in ▁your ▁puls e ▁rate ▁including ▁we ak ▁/ ▁absent ▁puls e ▁ , ▁heart ▁stop s ▁be ating ▁ , ▁heart ▁and ▁breath ing ▁stop ▁ , ▁blue ▁disco lou ration ▁of ▁skin ▁and ▁/ ▁or ▁mu cou s ▁membran es ▁due ▁to ▁lack ▁of ▁oxygen ▁in ▁the ▁blood ▁( ▁c yan osis ▁)
▁patients ▁with ▁a ▁q t c ▁interval ▁over ▁480 ▁m sec ▁ .
▁er bit ux ▁does ▁not ▁contain ▁any ▁anti micro bi al ▁preserva tive ▁or ▁bacteri o static ▁agent ▁ .
▁if ▁you ▁stop ▁taking ▁hep s era
▁each ▁prolong ed - release ▁tablet ▁contain s ▁1. 05 ▁mg ▁pra mi pe xo le ▁( ▁as ▁1.5 ▁mg ▁pra mi pe xo le ▁di hydro ch lor ide ▁mono hydrat e ▁) ▁ .
▁each ▁a genera se ▁capsule ▁contain s ▁50 ▁mg ▁of ▁amp rena vir ▁ .
▁the ▁first ▁inject ion ▁of ▁ri lona cept ▁regener on ▁should ▁be ▁given ▁under ▁the ▁super vision ▁of ▁a ▁train ed ▁health care ▁professional ▁ .
▁because ▁le flu nom ide ▁med ac ▁is ▁a ▁generic ▁medicine ▁ , ▁studies ▁in ▁patients ▁have ▁been ▁limited ▁to ▁tests ▁to ▁determine ▁that ▁it ▁is ▁bio e qui valent ▁to ▁the ▁reference ▁medicine ▁ , ▁a rava ▁ .
▁comparison ▁of ▁tras tuz um ab ▁ pk ▁data ▁from ▁study ▁m 770 04 ▁in ▁which ▁women ▁with ▁her 2- posi tive ▁mb c ▁were ▁treated ▁con com i tant ly ▁with ▁her cept in ▁ , ▁pac lita xel ▁and ▁do xor ubi cin ▁to ▁tras tuz um ab ▁ pk ▁data ▁in ▁studies ▁where ▁her cept in ▁was ▁ad minister ed ▁as ▁mono therapy ▁( ▁h 06 49 g ▁) ▁or ▁in ▁combination ▁with ▁an thra cycli ne ▁plus ▁ cyclo phos pha mi de ▁or ▁pac lita xel ▁( ▁study ▁h 06 48 g ▁) ▁ , ▁suggest ed ▁no ▁effect ▁of ▁do xor ubi cin ▁and ▁pac lita xel ▁on ▁the ▁ pharma cok ine tics ▁of ▁tras tuz um ab ▁ .
▁however ▁ , ▁the ▁following ▁advers e ▁events ▁occur red ▁more ▁frequently ▁in ▁pa e dia tric ▁patients ▁: ▁di ar r ho e a ▁( ▁41 ▁% ▁) ▁ , ▁post operativ e ▁pain ▁( ▁38 ▁% ▁) ▁ , ▁fe ver ▁( ▁33 ▁% ▁) ▁ , ▁vom i ting ▁( ▁33 ▁% ▁) ▁ , ▁hyper tension ▁( ▁28 ▁% ▁) ▁ , ▁pru ritu s ▁( ▁21 ▁% ▁) ▁and ▁infection s ▁of ▁the ▁upp er ▁respirator y ▁tract ▁( ▁20 ▁% ▁) ▁and ▁urin ary ▁tract ▁( ▁18 ▁% ▁) ▁ .
▁in ▁patients ▁with ▁creati nine ▁clear ance ▁< ▁15 ▁ml ▁/ ▁min ▁ , ▁or ▁in ▁patients ▁under go ing ▁di al ysis ▁ , ▁there ▁is ▁no ▁clinic al ▁experience ▁therefore ▁a pix aban ▁is ▁not ▁recommended ▁( ▁see ▁section s ▁4.2 ▁and ▁5.2 ▁) ▁ .
▁en ta ca pone ▁bind s ▁to ▁human ▁album in ▁ binding ▁site ▁i i ▁which ▁also ▁bind s ▁several ▁other ▁medicinal ▁products ▁ , ▁including ▁dia zep am ▁and ▁ibu profe n ▁ .
▁some ▁of ▁the ▁effects ▁mentioned ▁under ▁section ▁4. 8 ▁" ▁unde sir able ▁effects ▁" ▁may ▁affect ▁the ▁ability ▁to ▁drive ▁or ▁use ▁machines ▁ .
▁in ▁a ▁clinic al ▁trial ▁of ▁147 ▁patients ▁with ▁advanced ▁head ▁and ▁ne ck ▁s quam ous ▁cell ▁car cino ma ▁ , ▁tum our ▁response ▁ , ▁define d ▁as ▁a ▁re duction ▁of ▁a ▁minimum ▁of ▁50 ▁% ▁of ▁the ▁tum our ▁mass ▁for ▁a ▁minimum ▁of ▁four ▁weeks ▁ , ▁was ▁observe d ▁in ▁25 ▁% ▁after ▁a ▁single ▁treatment ▁ .
▁patients ▁who ▁experience ▁advers e ▁reaction s ▁during ▁treatment ▁should ▁wait ▁for ▁these ▁to ▁resolve ▁before ▁driving ▁or ▁operating ▁machines ▁ .
▁it ▁is ▁recommended ▁that ▁in r ▁( ▁international ▁normal ised ▁ratio ▁) ▁be ▁monitor ed ▁ .
▁novos even ▁powder ▁and ▁solve nt ▁vi als ▁should ▁be ▁at ▁room ▁temperature ▁at ▁recon stitu tion ▁ .
▁dis continu ation ▁rates ▁due ▁to ▁advers e ▁events ▁were ▁similar ▁across ▁treatment ▁and ▁sham ▁groups ▁( ▁13 ▁% ▁vs ▁11 ▁% ▁) ▁ .
▁in cre syn c ▁25 ▁mg ▁/ ▁45 ▁mg ▁tablets ▁a log lip tin ▁/ ▁pi og lita zone
▁the ▁ma cula ▁is ▁the ▁portion ▁of ▁retin a ▁responsible ▁for ▁fine ▁vision ▁ .
▁if ▁you ▁take ▁more ▁kin zal kom b ▁than ▁you ▁should
▁very ▁rare ▁ , ▁may ▁affect ▁up ▁to ▁1 ▁in ▁1,000 ▁people
▁ner vous ▁system ▁disorder s ▁un com mon ▁: ▁di zzi ness ▁rare ▁: ▁para es the sia
▁therefore ▁ , ▁rey ata z ▁is ▁contra indica ted ▁with ▁medicinal ▁products ▁that ▁are ▁substrat es ▁of ▁cy p 3 a 4 ▁and ▁have ▁a ▁n arrow ▁ therapeut ic ▁index ▁: ▁a ste mi zole ▁ , ▁ter fen a dine ▁ , ▁ci sa pri de ▁ , ▁pi moz ide ▁ , ▁qui ni dine ▁ , ▁be pri dil ▁ , ▁tri azo lam ▁ , ▁oral ly ▁ad minister ed ▁mida zola m ▁ , ▁and ▁ergo t ▁al kalo ids ▁ , ▁particularly ▁ergo tamine ▁and ▁di hydro er go tamine ▁( ▁see ▁section ▁4.3 ▁) ▁ .
▁a ▁certain ▁type ▁of ▁allergi c ▁reaction ▁called ▁se rum ▁sick ness ▁has ▁been ▁observe d ▁in ▁patients ▁treated ▁with ▁xo la ir ▁ .
▁if ▁you ▁forget ▁to ▁take ▁a trip la
▁however ▁ , ▁mild ▁to ▁moderat e ▁increase s ▁in ▁se rum ▁creati nine ▁concentration s ▁ , ▁hypo phos pha te mia ▁and ▁a ▁decrease ▁in ▁car ni tine ▁concentration s ▁were ▁reported ▁in ▁3 ▁% ▁ , ▁4 ▁% ▁and ▁6 ▁% ▁of ▁patients ▁ , ▁respective ly ▁ , ▁on ▁extend ed ▁treatment ▁ .
▁if ▁possible ▁ , ▁have ▁your ▁medicine ▁and ▁this ▁le a flet ▁with ▁you ▁ .
▁1 ▁pre - fill ed ▁sy ringe ▁+ ▁1 ▁need le
▁in fusion ▁for ▁sub cuta ne ous ▁use ▁for ▁hy q via ▁hy alu ron idas e
▁the ▁benefit ▁of ▁apre pitan t ▁combination ▁ therapy ▁in ▁the ▁full ▁study ▁population ▁was ▁main ly ▁drive n ▁by ▁the ▁results ▁observe d ▁in ▁patients ▁with ▁poor ▁control ▁with ▁the ▁standard ▁regime n ▁such ▁as ▁in ▁women ▁ , ▁even ▁though ▁the ▁results ▁were ▁numer ically ▁better ▁regardless ▁of ▁age ▁ , ▁tum our ▁type ▁or ▁gender ▁ .
▁how ▁to ▁store ▁insulin ▁human ▁win thro p ▁bas al
▁at ▁week ▁96 ▁ , ▁results ▁were ▁consistent ▁with ▁those ▁seen ▁at ▁week ▁48 ▁ .
▁in ▁human ▁the ▁principal ▁ toxic ▁effects ▁were ▁he pato toxic ity ▁and ▁central ▁ner vous ▁system ▁( ▁c ns ▁) ▁effects ▁ .
▁tell ▁your ▁doctor ▁if ▁you ▁are ▁la ctos e ▁intoleran t ▁or ▁intoleran t ▁to ▁other ▁sugar s ▁ .
▁breast - feed ing ▁: ▁there ▁are ▁no ▁laborator y ▁animal ▁or ▁human ▁data ▁available ▁on ▁secret ion ▁of ▁sa quina vir ▁in ▁breast ▁milk ▁ .
▁other ▁information ▁about ▁ec alta
▁the ▁temporar y ▁usual ▁sign s ▁following ▁vaccin ation ▁ , ▁such ▁as ▁increased ▁temperature ▁ , ▁a pathy ▁( ▁list less ness ▁) ▁and ▁digestiv e ▁problems ▁such ▁as ▁abdominal ▁disco m fort ▁may ▁also ▁be ▁seen ▁following ▁vaccin ation ▁ .
▁after ▁the ▁bottle ▁cap ▁is ▁removed ▁ , ▁if ▁the ▁tam per ▁evident ▁snap ▁col lar ▁is ▁loo se ▁ , ▁remove ▁before ▁using ▁the ▁product ▁ .
▁starting ▁your ▁first ▁pack ▁of ▁zo ely
▁ pharma cok ine tic ▁data ▁in ▁el der ly ▁( ▁> ▁65 ▁years ▁) ▁are ▁limited ▁but ▁consistent ▁with ▁ pharma cok ine tics ▁in ▁young er ▁adults ▁ .
▁a ▁drug ▁ utilisation ▁study ▁conduct ed ▁in ▁several ▁ee a ▁countries ▁ai med ▁at ▁descri bing ▁the ▁character istic s ▁of ▁i va bra dine ▁users ▁ , ▁as ▁well ▁as ▁descri bing ▁the ▁pattern s ▁of ▁use ▁of ▁i va bra dine ▁ , ▁and ▁ad her ence ▁to ▁the ▁risk ▁minim isation ▁measure s ▁ .
▁it ▁is ▁given ▁as ▁a ▁12- week ▁course ▁ , ▁with ▁a ▁first ▁dose ▁of ▁ 0.7 ▁mg ▁per ▁kilogram ▁body ▁weight ▁followed ▁by ▁week ly ▁inject ions ▁of ▁1.0 ▁mg ▁/ ▁kg ▁ .
▁by ▁ reducing ▁the ▁production ▁of ▁pro stag land ins ▁ , ▁equi o xx ▁helps ▁reduce ▁the ▁symptoms ▁of ▁ inflammation ▁ , ▁including ▁pain ▁ .
▁the ▁film - co ated ▁tablets ▁are ▁white ▁to ▁off - white ▁ , ▁ oval ▁shape d ▁and ▁embo s sed ▁with ▁the ▁number ▁" ▁60 ▁" ▁on ▁one ▁side ▁and ▁" ▁n ▁" ▁on ▁the ▁other ▁side ▁ .
▁these ▁are ▁deri ved ▁from ▁spontane ous ▁reports ▁for ▁which ▁it ▁is ▁not ▁always ▁possible ▁to ▁reli ably ▁establish ▁fre que ncy ▁or ▁a ▁causa l ▁relationship ▁to ▁exposure ▁to ▁the ▁medicinal ▁product ▁ .
▁the ▁potential ▁for ▁har m ▁to ▁the ▁breast - feed ▁infant ▁is ▁un know n ▁ .
▁10 ▁prolong ed - release ▁tablets ▁: ▁eu ▁/ ▁1 ▁/ ▁08 ▁/ ▁ 469 ▁/ ▁03 8 ▁30 ▁prolong ed - release ▁tablets ▁: ▁eu ▁/ ▁1 ▁/ ▁08 ▁/ ▁ 469 ▁/ ▁03 9 ▁90 ▁prolong ed - release ▁tablets ▁: ▁eu ▁/ ▁1 ▁/ ▁08 ▁/ ▁ 469 ▁/ ▁0 40 ▁100 ▁prolong ed - release ▁tablets ▁: ▁eu ▁/ ▁1 ▁/ ▁08 ▁/ ▁ 469 ▁/ ▁04 1
▁nespo ▁300 ▁μ g ▁darbe po etin ▁alfa ▁i v ▁/ ▁sc
▁advocate ▁spot - on ▁solution ▁for ▁small ▁dog s
▁for ▁the ▁full ▁list ▁of ▁all ▁side ▁effects ▁and ▁restriction s ▁ , ▁see ▁the ▁package ▁le a flet ▁ .
▁4 ▁pre - fill ed ▁sy ring es ▁of ▁1 ▁ml ▁solve nt ▁4 ▁sta in less ▁steel ▁inject ion ▁need les
▁if ▁ , ▁after ▁a ▁care ful ▁individual ▁benefit ▁/ ▁risk ▁evaluation ▁by ▁the ▁pre scribi ng ▁physician ▁ , ▁treatment ▁is ▁de em ed ▁necessary ▁in ▁the ▁ ≥ ▁75 ▁years ▁age ▁group ▁then ▁following ▁a ▁load ing ▁dose ▁of ▁60 ▁mg ▁ , ▁a ▁reduce d ▁maintenance ▁dose ▁of ▁5 mg ▁should ▁be ▁pre scribe d ▁ .
▁use ▁the ▁pe el - off ▁sticker s ▁below ▁to ▁mark ▁the ▁dates ▁on ▁your ▁calendar ▁ .
▁the ▁european ▁commission ▁gran ted ▁a ▁marketing ▁author isation ▁valid ▁throughout ▁the ▁european ▁union ▁for ▁apro vel ▁on ▁27 ▁august ▁1997 ▁ .
▁qui ni dine ▁200 ▁mg ▁s d ▁( ▁in dina vir ▁400 ▁mg ▁s d ▁)
▁patients ▁were ▁treated ▁at ▁dos es ▁of ▁imati ni b ▁of ▁260 ▁mg ▁/ ▁m 2 ▁/ ▁day ▁( ▁n ▁= ▁5 ▁) ▁ , ▁340 ▁mg ▁/ ▁m 2 ▁/ ▁day ▁( ▁n ▁= ▁9 ▁) ▁ , ▁440 ▁mg ▁/ ▁m 2 ▁/ ▁day ▁( ▁n ▁= ▁7 ▁) ▁and ▁5 70 ▁mg ▁/ ▁m 2 ▁/ ▁day ▁( ▁n ▁= ▁5 ▁) ▁ .
▁no ▁dos age ▁adjust ment ▁is ▁required ▁for ▁patients ▁with ▁mild ▁to ▁moderat e ▁renal ▁im pair ment ▁ .
▁insu man ▁bas al ▁can ▁be ▁used ▁during ▁breast - feed ing ▁ .
▁poole d ▁studies ▁consiste d ▁of ▁04 6 ▁( ▁ europe ▁/ ▁austral ia ▁) ▁ , ▁04 7 ▁( ▁north ▁ america ▁[ ▁na ▁] ▁) ▁and ▁07 4 ▁( ▁ europe ▁/ ▁na ▁) ▁ .
▁26. 4 ▁% ▁( ▁20. 9 ▁to ▁3 2.4 ▁)
▁can gre lor ▁has ▁not ▁been ▁evaluat ed ▁in ▁a ▁pa e dia tric ▁population ▁( ▁see ▁section ▁4.2 ▁and ▁section ▁5.1 ▁) ▁ .
▁in ▁patients ▁with ▁severe ▁chronic ▁pain ▁there ▁is ▁a ▁higher ▁incide nce ▁of ▁suicide ▁and ▁suicide ▁attempt s ▁than ▁in ▁the ▁general ▁population ▁ .
▁high ▁blood ▁pressure ▁ , ▁short ness ▁of ▁breath ▁ , ▁di zzi ness ▁ , ▁sleep ▁disturb ances ▁ , ▁ting ling ▁or ▁nu mb ness ▁of ▁the ▁hands ▁or ▁feet ▁ , ▁di ar r ho e a ▁ .
▁in ▁that ▁case ▁ , ▁the ▁need le ▁should ▁be ▁attached ▁without ▁screw ing ▁ .
▁red ness ▁ , ▁swe lling ▁or ▁pain ▁in ▁the ▁mouth ▁or ▁ thro at ▁ , ▁difficult y ▁in ▁speaking ▁ , ▁ho arse ness
▁how ▁to ▁use ▁ema dine ▁( ▁continued ▁)
▁any ▁un used ▁product ▁or ▁was te ▁material ▁should ▁be ▁dispose d ▁of ▁in ▁accordance ▁with ▁local ▁requirements ▁ .
▁talk ▁to ▁your ▁doctor ▁about ▁your ▁risk ▁of ▁developing ▁these ▁conditions ▁ .
▁the ▁effect ▁of ▁anti - sil tu xim ab ▁anti body ▁status ▁was ▁not ▁examine d ▁ , ▁as ▁there ▁were ▁in sufficient ▁numbers ▁of ▁anti - sil tu xim ab ▁anti body ▁positive ▁patients ▁ .
▁avoid ▁direct ▁contact ▁with ▁application ▁area ▁while ▁it ▁is ▁wet ▁ .
▁in ▁the ▁rat ▁fertil ity ▁study ▁ , ▁de x mede tomi dine ▁had ▁no ▁effect ▁on ▁male ▁or ▁female ▁fertil ity ▁ .
▁1 ▁dose ▁of ▁100 ▁micro li tres ▁equal s ▁100 ▁micro gram s ▁fent an yl ▁ .
▁du lo xe tine ▁should ▁not ▁be ▁used ▁in ▁children ▁and ▁adolescents ▁under ▁the ▁age ▁of ▁18 ▁years ▁for ▁the ▁treatment ▁of ▁major ▁ depressiv e ▁disorder ▁because ▁of ▁safety ▁and ▁ef fica cy ▁concern s ▁( ▁see ▁section s ▁4.4 ▁ , ▁4. 8 ▁and ▁5.1 ▁) ▁ .
▁out er ▁wrap per ▁label ▁on ▁multi pack s ▁wrap ped ▁in ▁foi l ▁( ▁including ▁blue ▁box ▁)
▁back ▁ , ▁ne ck ▁and ▁f lank ▁pain
▁he pati c ▁im pair ment ▁( ▁spa f ▁ , ▁d vt ▁/ ▁pe ▁)
▁the ▁potential ▁risk s ▁and ▁benefits ▁of ▁ana gre li de ▁ therapy ▁in ▁a ▁patient ▁with ▁im pair ment ▁of ▁renal ▁function ▁should ▁be ▁assess ed ▁before ▁treatment ▁is ▁commence d ▁( ▁see ▁section s ▁4.2 ▁and ▁4.3 ▁) ▁ .
▁revol ade ▁can ▁cause ▁blood ▁test ▁results ▁that ▁may ▁be ▁sign s ▁of ▁ liver ▁damage ▁- ▁an ▁increase ▁of ▁some ▁ liver ▁enzym es ▁ , ▁especially ▁bilir u bin ▁and ▁alan ine ▁/ ▁as parta te ▁trans ami nas es ▁ .
▁on ▁initiat ion ▁of ▁carb amaz e pine ▁ , ▁the ▁dose ▁of ▁xe pli on ▁should ▁be ▁re - evalua ted ▁and ▁increased ▁if ▁necessary ▁ .
▁your ▁body ▁size ▁( ▁your ▁surface ▁area ▁ , ▁measure d ▁in ▁ square ▁metres ▁( ▁m 2 ▁) ▁)
▁after ▁inject ion ▁of ▁the ▁dose ▁ , ▁disc ard ▁the ▁pen ▁in ▁an ▁appropriate ▁container ▁ .
▁the ▁cy p 2 c 19 ▁* ▁2 ▁and ▁cy p 2 c 19 ▁* ▁3 ▁alle les ▁account ▁for ▁the ▁majority ▁of ▁reduce d ▁function ▁alle les ▁in ▁ca uca sian ▁( ▁85 ▁% ▁) ▁and ▁asian ▁( ▁99 ▁% ▁) ▁poor ▁metabol iser s ▁ .
▁the ▁virus ▁has ▁first ▁been ▁in activa ted ▁so ▁that ▁it ▁does ▁not ▁cause ▁any ▁disease ▁ .
▁talk ▁to ▁your ▁doctor ▁ , ▁ pharma ci st ▁or ▁nurse ▁before ▁using ▁leg anto ▁ .
▁similar ▁results ▁were ▁seen ▁in ▁hi v -1 - infect ed ▁children ▁ .
▁this ▁demonstrat ed ▁that ▁approximately ▁two - thir ds ▁of ▁the ▁weight ▁loss ▁associated ▁with ▁can a gli flo zin ▁was ▁due ▁to ▁loss ▁of ▁fat ▁mass ▁relative ▁to ▁place bo ▁ .
▁ ≥ ▁60 ▁kg ▁to ▁ ≤ ▁100 ▁kg
▁clean ▁the ▁inject ion ▁site ▁with ▁the ▁alcohol ▁s wab ▁ .
▁the ▁ binding ▁a ffin ities ▁of ▁the ▁major ▁circula ting ▁metabol ites ▁of ▁las o fox ife ne ▁were ▁at ▁least ▁31- fold ▁and ▁18- ▁ fold ▁less ▁than ▁those ▁of ▁las o fox ife ne ▁for ▁the ▁estrogen ▁receptor ▁al pha ▁and ▁the ▁estrogen ▁receptor ▁beta ▁ , ▁respective ly ▁ , ▁indicat ing ▁that ▁these ▁metabol ites ▁are ▁un like ly ▁to ▁contribute ▁to ▁the ▁ pharma c ologic ▁activity ▁of ▁las o fox ife ne ▁ .
▁anti - poli o ▁type ▁2 ▁( ▁1 ▁/ ▁8 ▁dilu tion ▁)
▁patients ▁must ▁be ▁monitor ed ▁close ly ▁for ▁infection s ▁including ▁tubercul osis ▁before ▁ , ▁during ▁and ▁after ▁treatment ▁with ▁rem s ima ▁ .
▁during ▁clinic al ▁trial s ▁ , ▁10 ▁% ▁of ▁patients ▁had ▁a ▁creati nine ▁increase ▁from ▁base line ▁greater ▁than ▁30 ▁μ mol ▁/ ▁l ▁with ▁co - ad minister ed ▁feno fi bra te ▁and ▁sim vasta tin ▁versus ▁4.4 ▁% ▁with ▁stati n ▁mono therapy ▁ .
▁appropriate ▁medical ▁support ▁and ▁monitoring ▁measure s ▁should ▁be ▁read ily ▁available ▁when ▁bond enza ▁intra ven ous ▁inject ion ▁is ▁ad minister ed ▁ .
▁rapid ▁heart ▁beat ▁ , ▁irregular ▁heart ▁beat ▁ , ▁blu ish ▁skin
▁patients ▁must ▁be ▁advise d ▁to ▁report ▁worse ning ▁sign s ▁and ▁symptoms ▁of ▁as th ma ▁during ▁ therapeut ic ▁use ▁to ▁their ▁physician ▁ .
▁however ▁ , ▁ex en ati de ▁does ▁not ▁im pair ▁the ▁normal ▁glu ca gon ▁response ▁and ▁other ▁hormone ▁response s ▁to ▁hypo gly ca emia ▁ .
▁change ▁1 ▁grade ▁from ▁base line ▁to ▁grade ▁3 ▁or ▁higher
▁male ▁patients ▁ , ▁who ▁may ▁wish ▁to ▁father ▁a ▁child ▁ , ▁should ▁ask ▁their ▁doctor ▁for ▁family ▁planning ▁advice ▁or ▁treatment ▁ .
▁en te ca vir ▁( ▁0.5 ▁mg ▁or ▁1 ▁mg ▁) ▁n ▁= ▁22
▁maintain ▁or ▁decrease ▁de pending ▁on ▁clinic al ▁status
▁marketing ▁author isation ▁holder ▁act avis ▁group ▁pt c ▁ehf ▁ .
▁the ▁full ▁e par ▁for ▁pi xu vri ▁can ▁be ▁found ▁on ▁the ▁agency ▁' s ▁website ▁: ▁ema . europa . eu ▁/ ▁find ▁medicine ▁/ ▁human ▁medicine s ▁/ ▁european ▁public ▁assessment ▁reports ▁ .
▁immun isation ▁should ▁be ▁carried ▁out ▁by ▁intra mus cular ▁inject ion ▁only ▁ , ▁prefer ably ▁into ▁the ▁del to id ▁muscle ▁ .
▁keep ▁the ▁mouth piece ▁cover ▁closed ▁after ▁remo val ▁of ▁the ▁foi l ▁wrap ▁ .
▁in ▁the ▁dop pler ▁studies ▁ , ▁using ▁sono vu e ▁to ▁measure ▁blood ▁flow ▁in ▁large ▁blood ▁ves sels ▁improve d ▁the ▁quality ▁of ▁the ▁scan ▁when ▁testing ▁the ▁cerebral ▁arteri es ▁( ▁in ▁the ▁head ▁) ▁ , ▁the ▁caro tid s ▁( ▁in ▁the ▁ne ck ▁) ▁and ▁the ▁portal ▁ve in ▁( ▁leading ▁to ▁the ▁ liver ▁) ▁ , ▁but ▁not ▁the ▁renal ▁arteri es ▁( ▁leading ▁to ▁the ▁ki dne ys ▁) ▁ .
▁hyper kala emia ▁: ▁as ▁with ▁other ▁medicinal ▁products ▁that ▁affect ▁the ▁re nin - angi oten sin - al do ster one ▁system ▁ , ▁hyper kala emia ▁may ▁occur ▁during ▁the ▁treatment ▁with ▁apro vel ▁ , ▁especially ▁in ▁the ▁presence ▁of ▁renal ▁im pair ment ▁ , ▁over t ▁protein uria ▁due ▁to ▁diabet ic ▁renal ▁disease ▁ , ▁and ▁/ ▁or ▁heart ▁failure ▁ .
▁this ▁medicinal ▁product ▁contain s ▁50 ▁vol ▁% ▁et han ol ▁an hydro us ▁( ▁alcohol ▁) ▁ , ▁i . e . ▁up ▁to ▁3. 16 ▁g ▁et han ol ▁an hydro us ▁per ▁vi al ▁ , ▁equivalent ▁to ▁80 ▁ml ▁of ▁beer ▁or ▁32 ▁ml ▁wine ▁per ▁vi al ▁ .
▁inci vo ▁is ▁not ▁for ▁use ▁in ▁children ▁or ▁adolescents ▁ , ▁because ▁it ▁has ▁not ▁been ▁ sufficient ly ▁studie d ▁in ▁patients ▁under ▁18 ▁years ▁of ▁age ▁ .
▁however ▁due ▁to ▁pre system ic ▁first ▁pass ▁metabolism ▁ , ▁the ▁absolute ▁bio ava il ability ▁of ▁drone dar one ▁( ▁given ▁with ▁food ▁) ▁is ▁15 ▁% ▁ .
▁the ▁effects ▁of ▁pre ot act ▁on ▁bone ▁ architecture ▁were ▁evaluat ed ▁using ▁quantitat ive ▁com put ed ▁tom ography ▁( ▁q ct ▁) ▁and ▁per i pher al ▁q ct ▁ .
▁other ▁information ▁about ▁stri bild
▁the ▁ef fica cy ▁and ▁safety ▁in ▁this ▁population ▁is ▁not ▁well ▁established ▁ .
▁effects ▁of ▁ nico ti nic ▁acid ▁on ▁other ▁medicinal ▁products
▁this ▁medicinal ▁product ▁should ▁never ▁be ▁mix ed ▁with ▁any ▁other ▁medicinal ▁products ▁ .
▁gra stof il ▁treatment ▁will ▁last ▁for ▁4 ▁to ▁5 ▁days ▁ .
▁in ▁animals ▁ , ▁gli me piri de ▁is ▁ex cre ted ▁in ▁milk ▁ .
▁what ▁is ▁the ▁risk ▁associated ▁with ▁op atan ol ▁?
▁in ▁light ▁of ▁potential ▁risk s ▁with ▁prolong ed ▁ therapy ▁ , ▁pre scribe rs ▁should ▁confirm ▁at ▁subsequent ▁routine ▁reviews ▁that ▁the ▁benefit ▁of ▁pi og lita zone ▁is ▁maintain ed ▁( ▁see ▁section ▁4.4 ▁) ▁ .
▁it ▁is ▁used ▁to ▁treat ▁two ▁conditions ▁:
▁in ▁di al ysis ▁patients ▁with ▁serious ▁ki dne y ▁disease ▁ , ▁about ▁40 ▁% ▁of ▁the ▁patients ▁taking ▁mim para ▁had ▁p th ▁levels ▁below ▁250 ▁micro gram s ▁/ ▁l ▁at ▁the ▁end ▁of ▁the ▁study ▁ , ▁compared ▁with ▁about ▁6 ▁% ▁of ▁those ▁taking ▁place bo ▁ .
▁in ▁both ▁studies ▁ , ▁a ▁total ▁of ▁ 347 ▁patients ▁were ▁random ized ▁and ▁received ▁o zur dex ▁and ▁350 ▁patients ▁received ▁sham ▁ .
▁fre que ncies ▁are ▁define d ▁as ▁: ▁very ▁common ▁( ▁1 ▁/ ▁10 ▁) ▁ , ▁common ▁( ▁1 ▁/ ▁100 ▁ , ▁< ▁1 ▁/ ▁10 ▁) ▁ , ▁un com mon ▁( ▁1 ▁/ ▁1,000 ▁ , ▁< ▁1 ▁/ ▁100 ▁) ▁ , ▁rare ▁( ▁ ≥ ▁1 ▁/ ▁10,000 ▁ , ▁< ▁1 ▁/ ▁1000 ▁) ▁and ▁very ▁rare ▁( ▁< ▁1 ▁/ ▁10,000 ▁including ▁isola ted ▁reports ▁) ▁ .
▁carton ▁( ▁with ▁blue ▁box ▁) ▁for ▁unit ▁pack
▁you ▁may ▁have ▁early ▁sign s ▁of ▁severe ▁ja w ▁problems ▁( ▁nec rosi s ▁( ▁dead ▁bone ▁tissu e ▁) ▁in ▁the ▁ja w ▁bone ▁) ▁it ching ▁ , ▁swe lling ▁of ▁your ▁face ▁ , ▁lips ▁ , ▁ton gue ▁and ▁ thro at ▁ , ▁with ▁difficult y ▁breath ing ▁ .
▁carton ▁ , ▁pack ▁size ▁of ▁1 ▁ , ▁2 ▁ , ▁3 ▁ , ▁4 ▁ , ▁6 ▁ , ▁9 ▁ , ▁12 ▁ , ▁21 ▁and ▁42 ▁pipe ttes
▁the ▁activity ▁ad minister ed ▁must ▁be ▁such ▁that ▁the ▁result ing ▁dose ▁is ▁as ▁low ▁as ▁reason ably ▁a chi ev able ▁bear ing ▁in ▁mind ▁the ▁need ▁to ▁obtain ▁the ▁intended ▁diagnostic ▁result ▁ .
▁the ▁usual ▁starting ▁dose ▁is ▁one ▁150 ▁mg ▁tablet ▁once ▁daily ▁ .
▁vi read ▁can ▁cause ▁di zzi ness ▁ .
▁the ▁ 662 ▁en roll ed ▁patients ▁had ▁a ▁media n ▁age ▁of ▁51 ▁years ▁( ▁range ▁: ▁21 ▁to ▁70 ▁) ▁; ▁70 ▁% ▁of ▁the ▁patients ▁were ▁male ▁; ▁26 ▁% ▁had ▁a ▁body ▁mass ▁index ▁ ≥ ▁30 ▁kg ▁/ ▁m 2 ▁; ▁5 ▁% ▁were ▁black ▁; ▁11 ▁% ▁were ▁his pa nic ▁or ▁latino ▁; ▁89 ▁% ▁had ▁base line ▁h c v ▁ rna ▁levels ▁> ▁800 , 000 ▁iu ▁/ ▁ml ▁; ▁22 ▁% ▁had ▁ brid ging ▁fibro sis ▁; ▁26 ▁% ▁had ▁cir r ho sis ▁; ▁54 ▁% ▁had ▁h c v ▁geno type ▁1 a ▁; ▁and ▁46 ▁% ▁had ▁h c v ▁geno type ▁1 b ▁ .
▁in ▁children ▁we igh ing ▁less ▁than ▁35 ▁kg ▁ , ▁it ▁is ▁20 ▁mg ▁ , ▁given ▁as ▁two ▁10 ▁mg ▁dos es ▁ .
▁increased ▁blood ▁sugar ▁protein ▁in ▁the ▁urin e
▁this ▁will ▁allow ▁quick ▁ identification ▁of ▁new ▁safety ▁information ▁ .
▁indeed ▁ , ▁the ▁available ▁clinic al ▁data ▁are ▁very ▁limited ▁and ▁pre clu de ▁any ▁reliable ▁conclusion ▁in ▁the ▁field ▁ .
▁hypo gly ca emia ▁( ▁when ▁used ▁with ▁su ▁or ▁insulin ▁) ▁b
▁sign s ▁of ▁matern al ▁and ▁fet al ▁ toxic ity ▁were ▁seen ▁in ▁rat s ▁and ▁rabbi ts ▁( ▁reduce d ▁fet al ▁weight s ▁ , ▁de lay s ▁in ▁oss ification ▁[ ▁rat s ▁] ▁ , ▁reduce d ▁litt er ▁size ▁and ▁number ▁of ▁live ▁fet uses ▁[ ▁rabbi ts ▁] ▁) ▁ , ▁but ▁not ▁ter ato geni city ▁ .
▁in ▁one ▁clinic al ▁study ▁( ▁ni nos ▁) ▁ , ▁treatment ▁groups ▁were ▁similar ▁with ▁respect ▁to ▁the ▁incide nce ▁and ▁sever ity ▁of ▁in trac rani al ▁ha e mor r hage ▁ , ▁grade ▁i v ▁ha e mor r hage ▁ , ▁per i ven tri cular ▁leuk om ala cia ▁ , ▁cerebral ▁in far ction ▁ , ▁se iz ures ▁requiri ng ▁antico n vul sant ▁ therapy ▁ , ▁pulmonar y ▁ha e mor r hage ▁ , ▁or ▁gastro inte stin al ▁ha e mor r hage ▁ .
▁if ▁you ▁have ▁any ▁side ▁effects ▁ , ▁including ▁any ▁side ▁effects ▁not ▁listed ▁in ▁this ▁le a flet ▁ , ▁talk ▁to ▁your ▁doctor ▁or ▁ pharma ci st ▁ .
▁ pharma co therapeut ic ▁group ▁: ▁influenza ▁vaccin es ▁ , ▁influenza ▁live ▁att en u ated ▁; ▁at c ▁code ▁: ▁j 07 bb 03
▁via ▁san ▁marti no ▁12 ▁i -2012 2 ▁mil an
▁panto pra zole ▁: ▁co - administration ▁of ▁panto pra zole ▁( ▁80 ▁mg ▁od ▁) ▁did ▁not ▁alter ▁the ▁ pharma cok ine tics ▁of ▁ cina cal cet ▁ .
▁10 ▁% ▁p ▁= ▁0.0 05
▁tell ▁your ▁doctor ▁or ▁get ▁emergency ▁medical ▁help ▁straight ▁away ▁if ▁you ▁notice ▁any ▁of ▁the ▁following ▁sign s ▁ .
▁if ▁a ▁dose ▁is ▁missed ▁ , ▁the ▁patient ▁should ▁not ▁take ▁an ▁additional ▁dose ▁ , ▁but ▁should ▁take ▁the ▁next ▁usual ▁pre scribe d ▁dose ▁ .
▁si li con ▁ dioxid e ▁magnesium ▁stea rate ▁ .
▁simul ect ▁is ▁contra indica ted ▁in ▁pre gna ncy ▁and ▁lac tation ▁( ▁see ▁section ▁4.3 ▁) ▁ .
▁do ▁not ▁breast - feed ▁if ▁you ▁are ▁taking ▁envia ge ▁ .
▁per ▁dose ▁of ▁1 ▁ml ▁:
▁in ▁dog s ▁with ▁non - ▁res ect able ▁mast ▁cell ▁tu mo urs ▁ , ▁grade ▁2 ▁or ▁3 ▁ , ▁express ing ▁a ▁mutat ed ▁ty ros ine ▁kina se ▁c - kit ▁receptor ▁ , ▁treatment ▁with ▁masiv et ▁showed ▁a ▁significantly ▁longer ▁time - to - tum our ▁progression ▁( ▁ tt p ▁) ▁with ▁a ▁media n ▁of ▁24 1 ▁days ▁as ▁compared ▁to ▁83 ▁days ▁for ▁place bo ▁ .
▁no ▁adjust ment ▁of ▁the ▁initial ▁dose ▁is ▁required ▁for ▁patients ▁with ▁mild ▁to ▁moderat e ▁renal ▁im pair ment ▁( ▁estima ted ▁glo mer ular ▁filtr ation ▁rate ▁( ▁g fr ▁) ▁89 -60 ▁ml ▁/ ▁min ▁/ ▁1. 73 ▁m 2 ▁and ▁59 -30 ▁ml ▁/ ▁min ▁/ ▁1. 73 ▁m 2 ▁ , ▁respective ly ▁) ▁( ▁see ▁section s ▁4.4 ▁and ▁5.2 ▁) ▁ .
▁ pharma co therapeut ic ▁group ▁: ▁cy to toxic ▁agents ▁( ▁an thra cycli nes ▁and ▁related ▁substance s ▁) ▁ , ▁at c ▁code ▁: ▁l 01 db 01 ▁ .
▁in ▁sal iva ▁ve ctor ▁d na ▁was ▁still ▁detect able ▁up ▁to ▁12 ▁weeks ▁; ▁in ▁urin e ▁up ▁to ▁10 ▁weeks ▁and ▁in ▁sem en ▁up ▁to ▁26 ▁weeks ▁ .
▁precau tions ▁to ▁be ▁taken ▁before ▁handling ▁or ▁ad minister ing ▁the ▁product ▁: ▁see ▁section ▁ 6.6 ▁ .
▁if ▁you ▁have ▁taken ▁or ▁are ▁planning ▁to ▁take ▁cialis ▁ , ▁avoid ▁excessive ▁drink ing ▁( ▁blood ▁alcohol ▁level ▁of ▁0.0 8 ▁% ▁or ▁greater ▁) ▁ , ▁since ▁this ▁may ▁increase ▁the ▁risk ▁of ▁di zzi ness ▁when ▁standing ▁up ▁ .
▁sir tur o ▁is ▁a ▁type ▁of ▁antibiotic ▁ .
▁patients ▁treated ▁with ▁mab ther a ▁must ▁be ▁given ▁the ▁patient ▁alert ▁card ▁with ▁each ▁in fusion ▁ .
▁the ▁' ▁class ▁' ▁reflect s ▁the ▁serious ness ▁of ▁the ▁disease ▁: ▁' ▁class ▁i ii ▁' ▁involve s ▁marked ▁limitation ▁of ▁physical ▁activity ▁ .
▁the ▁use ▁of ▁clo pido gre l ▁in ▁cure ▁was ▁associated ▁with ▁a ▁decrease ▁in ▁the ▁need ▁of ▁ thro mbol y tic ▁ therapy ▁( ▁ rrr ▁= ▁4 3.3 ▁% ▁; ▁ci ▁: ▁24. 3 ▁% ▁ , ▁5 7.5 ▁% ▁) ▁and ▁g pi ib ▁/ ▁i i ia ▁inhibi tors ▁( ▁ rrr ▁= ▁18. 2 ▁% ▁; ▁ci ▁: ▁6.5 ▁% ▁ , ▁28. 3 ▁% ▁) ▁ .
▁in ▁healthy ▁person s ▁ , ▁the ▁minimum ▁effective ▁oral ▁dose ▁is ▁approximately ▁ 0.6 ▁mg ▁ .
▁what ▁is ▁the ▁risk ▁associated ▁with ▁ar zer ra ▁?
▁this ▁loss ▁of ▁body ▁fat ▁has ▁been ▁shown ▁to ▁be ▁not ▁fully ▁rever sible ▁after ▁dis continu ation ▁of ▁stavu dine ▁ .
▁you ▁should ▁not ▁start ▁breast - feed ing ▁until ▁at ▁least ▁5 ▁days ▁after ▁the ▁last ▁dose ▁of ▁e ffen tora ▁ .
▁in ▁subject s ▁with ▁moderat e ▁renal ▁im pair ment ▁ , ▁er y thro my cin ▁led ▁to ▁a ▁2.0 ▁ fold ▁increase ▁in ▁mean ▁ri varo xa ban ▁au c ▁and ▁1.6 ▁ fold ▁increase ▁in ▁cr max ▁when ▁compared ▁to ▁subject s ▁with ▁normal ▁renal ▁function ▁ .
▁this ▁condition ▁ , ▁known ▁as ▁severe ▁neutro p enia ▁or ▁a gran ulo cy tos is ▁ , ▁has ▁occur red ▁in ▁1 ▁to ▁2 ▁out ▁of ▁100 ▁people ▁who ▁have ▁taken ▁fer ri prox ▁in ▁clinic al ▁studies ▁ .
▁m n ▁results ▁against ▁a ▁/ ▁vietnam ▁/ ▁11 94 ▁/ ▁2004 ▁indicate ▁a ▁ser o protec tion ▁and ▁ser o con version ▁rate ▁rang ing ▁from ▁of ▁57 ▁% ▁( ▁50- 64 ▁) ▁to ▁79 ▁% ▁( ▁68 - 87 ▁) ▁and ▁55 ▁% ▁( ▁48 - 62 ▁) ▁to ▁58 ▁% ▁( ▁47 - 69 ▁) ▁respective ly ▁ .
▁the ▁other ▁study ▁compared ▁gli vec ▁with ▁place bo ▁( ▁a ▁dum my ▁treatment ▁) ▁in ▁7 13 ▁patients ▁whose ▁cancer ▁had ▁been ▁removed ▁with ▁surgery ▁ .
▁place bo - corre cted ▁treatment ▁effects ▁with ▁m pap ▁were ▁- 2. 7 ▁mm h g ▁( ▁p ▁= ▁0.0 4 ▁) ▁ , ▁- 3.0 ▁mm ▁h g ▁( ▁p ▁= ▁ 0.01 ▁) ▁and ▁- 5.1 ▁mm ▁h g ▁( ▁p ▁< ▁0.0 001 ▁) ▁for ▁sil den a fil ▁20 ▁mg ▁ , ▁40 ▁mg ▁and ▁80 ▁mg ▁tid ▁respective ly ▁ .
▁e po etin ▁alfa ▁should ▁be ▁used ▁with ▁cau tion ▁in ▁patients ▁with ▁epi le psy ▁ , ▁history ▁of ▁se iz ures ▁ , ▁or ▁medical ▁conditions ▁associated ▁with ▁a ▁pred is position ▁to ▁se iz ure ▁activity ▁such ▁as ▁c ns ▁infection s ▁and ▁brain ▁metas tas es ▁ .
▁insulin ▁human ▁win thro p ▁rapid ▁is ▁inject ed ▁sub cuta ne ously ▁15 ▁to ▁20 ▁minutes ▁before ▁a ▁meal ▁ .
▁what ▁benefit ▁has ▁op ta flu ▁shown ▁during ▁the ▁studies ▁?
▁the ▁ pharma cok ine tic ▁interaction s ▁between ▁amp rena vir ▁and ▁low ▁dos es ▁of ▁rito na vir ▁or ▁other ▁prote ase ▁inhibi tors ▁have ▁not ▁yet ▁been ▁evaluat ed ▁in ▁children ▁ .
▁it ▁is ▁recommended ▁to ▁start ▁ce tu xim ab ▁ therapy ▁one ▁week ▁before ▁radi ation ▁ therapy ▁and ▁to ▁continue ▁ce tu xim ab ▁ therapy ▁until ▁the ▁end ▁of ▁the ▁radi ation ▁ therapy ▁period ▁ .
▁treatment ▁with ▁riba vir in ▁bio partner s ▁should ▁be ▁started ▁and ▁monitor ed ▁by ▁a ▁doctor ▁who ▁has ▁experience ▁in ▁the ▁management ▁of ▁long - term ▁hepatitis ▁c . ▁the ▁dose ▁of ▁riba vir in ▁bio partner s ▁is ▁based ▁on ▁the ▁patient ▁' s ▁body ▁weight ▁ , ▁and ▁range s ▁from ▁three ▁to ▁seven ▁tablets ▁a ▁day ▁ .
▁re - administration ▁of ▁gly bera ▁after ▁this ▁first ▁treatment ▁session ▁is ▁not ▁recommended ▁ .
▁hypo gly ca emia ▁( ▁in ▁combination ▁with ▁met form in ▁alone ▁)
▁therefore ▁ , ▁con com i tant ▁use ▁should ▁be ▁under tak en ▁with ▁cau tion ▁( ▁see ▁section ▁4.4 ▁) ▁ .
▁what ▁you ▁need ▁to ▁know ▁before ▁you ▁use ▁forta cin ▁do ▁not ▁use ▁forta cin
▁cy to toxic ▁agents ▁: ▁thi az ides ▁ , ▁including ▁hydro ch lor o thi azi de ▁ , ▁may ▁reduce ▁the ▁renal ▁ex cre tion ▁of ▁cy to toxic ▁agents ▁( ▁e . g . ▁ cyclo phos pha mi de ▁ , ▁met ho tre xa te ▁) ▁and ▁potentia te ▁their ▁mye los up press ive ▁effects ▁ .
▁what ▁to via z ▁looks ▁like ▁and ▁content s ▁of ▁the ▁pack
▁the ▁use ▁of ▁mito tane ▁in ▁patients ▁with ▁severe ▁he pati c ▁im pair ment ▁is ▁not ▁recommended ▁ .
▁py re xia ▁ , ▁influ enz ▁a - like ▁illness ▁* ▁* ▁ , ▁oed ema ▁per i pher al ▁ , ▁as th enia ▁ , ▁thi rst
▁the ▁risk ▁for ▁developing ▁an ▁allergi c ▁reaction ▁is ▁very ▁small ▁ , ▁but ▁your ▁doctor ▁or ▁nurse ▁needs ▁to ▁be ▁aware ▁of ▁your ▁aller gy ▁when ▁decidi ng ▁if ▁you ▁or ▁your ▁child ▁should ▁receive ▁be x s ero ▁ .
▁reproduc tion ▁is ▁author ised ▁provided ▁the ▁source ▁is ▁acknowledge d . ▁gas tric ▁a den oca rci noma ▁( ▁a ▁type ▁of ▁stomach ▁cancer ▁) ▁in ▁patients ▁who ▁have ▁not ▁yet ▁received ▁any ▁treatment ▁for ▁their ▁cancer ▁ .
▁patients ▁with ▁active ▁tubercul osis ▁and ▁other ▁severe ▁infection s ▁ .
▁at ▁the ▁start ▁of ▁ therapy ▁it ▁is ▁recommended ▁that ▁a ▁doctor ▁or ▁a ▁nurse ▁give ▁you ▁the ▁inject ion ▁and ▁train ▁you ▁with ▁the ▁nu tropi na q ▁pen ▁ .
▁after ▁104 ▁weeks ▁of ▁treatment ▁ , ▁can a gli flo zin ▁did ▁not ▁advers ely ▁affect ▁bone ▁mineral ▁den s ity ▁ .
▁kin ▁ul cer ▁; ▁sc ab ▁; ▁excess ▁hair ▁growth ▁( ▁hyper tri chos is ▁) ▁; ▁red ness ▁and ▁swe lling ▁of ▁palm s ▁of ▁hands ▁or ▁sole s ▁of ▁feet ▁( ▁hand - foot ▁syndrome ▁) ▁; ▁excess ▁sweat ing ▁( ▁hyper hid rosi s ▁) ▁; ▁skin ▁reaction ▁( ▁dermatit is ▁) ▁;
▁eli quis ▁has ▁no ▁or ▁negli gi ble ▁influence ▁on ▁the ▁ability ▁to ▁drive ▁and ▁use ▁machines ▁ .
▁this ▁medicinal ▁product ▁must ▁not ▁be ▁mix ed ▁with ▁other ▁medicinal ▁products ▁than ▁ huma log ▁ .
▁no ▁data ▁are ▁available ▁on ▁the ▁administration ▁of ▁t m z ▁in ▁patients ▁with ▁severe ▁he pati c ▁im pair ment ▁( ▁child ▁' s ▁class ▁c ▁) ▁or ▁with ▁renal ▁im pair ment ▁ .
▁if ▁the ▁d rip ▁sting s ▁or ▁hurt s ▁while ▁you ▁are ▁receiving ▁a ▁dose ▁of ▁cael y x ▁ , ▁tell ▁your ▁doctor ▁immediately ▁ .
▁what ▁teva gra s tim ▁is ▁and ▁what ▁it ▁is ▁used ▁for ▁what ▁teva gra s tim ▁is
▁these ▁immun os up press ants ▁are ▁not ▁anticipat ed ▁to ▁impact ▁exposure ▁of ▁efa vir enz ▁ .
▁each ▁capsule ▁contain s ▁100 ▁mg ▁of ▁ata zana vir ▁( ▁as ▁sul pha te ▁) ▁ .
▁the ▁presence ▁of ▁a ▁mutat ed ▁ty ros ine ▁kina se ▁c - kit ▁receptor ▁must ▁be ▁confirm ed ▁prior ▁to ▁treatment ▁( ▁see ▁also ▁section ▁5.1 ▁) ▁ .
▁when ▁given ▁in ▁combination ▁with ▁ci s plat in ▁( ▁ci s plat in ▁day ▁1 ▁ , ▁to pote can ▁days ▁1 ▁to ▁5 ▁) ▁ , ▁the ▁clear ance ▁of ▁to pote can ▁was ▁reduce d ▁on ▁day ▁5 ▁compared ▁to ▁day ▁1 ▁( ▁19. 1 ▁l ▁/ ▁h ▁/ ▁m 2 ▁compared ▁to ▁21. 3 ▁l ▁/ ▁h ▁/ ▁m 2 ▁[ ▁n ▁= ▁9 ▁] ▁) ▁( ▁see ▁section ▁4.5 ▁) ▁ .
▁there ▁are ▁no ▁reliable ▁data ▁on ▁the ▁use ▁of ▁stay ve er ▁in ▁pregnant ▁women ▁ .
▁your ▁dose ▁will ▁be ▁adjust ed ▁de pending ▁on ▁the ▁level ▁of ▁rap am une ▁in ▁your ▁blood ▁ .
▁the ▁total ▁clear ance ▁( ▁mean ▁ ± ▁s d ▁) ▁is ▁approximately ▁58 ▁ ± ▁5 ▁l ▁/ ▁h ▁after ▁an ▁intra ven ous ▁administration ▁with ▁renal ▁clear ance ▁account ing ▁for ▁about ▁22 ▁% ▁of ▁this ▁ .
▁in ▁all ▁patients ▁cardiac ▁function ▁should ▁be ▁monitor ed ▁during ▁treatment ▁( ▁e . g . ▁every ▁12 ▁weeks ▁) ▁ .
▁all ▁patients ▁received ▁a ▁total ▁dose ▁of ▁ci s plat in ▁of ▁480 ▁mg ▁/ ▁m 2 ▁as ▁part ▁of ▁their ▁in duction ▁( ▁neo ad ju vant ▁) ▁and ▁/ ▁or ▁maintenance ▁( ▁ad ju vant ▁) ▁che mo therapy ▁regime n ▁ .
▁< ▁60 ▁ml ▁/ ▁min ▁/ ▁1. 73 ▁m 2 ▁ , ▁can a gli flo zin ▁provided ▁clinic ally ▁meaning ful ▁re duction ▁in ▁h ba 1 c ▁compared ▁to ▁place bo ▁ , ▁with ▁- 0.4 7 ▁% ▁for ▁can a gli flo zin ▁100 ▁mg ▁and ▁- 0.5 2 ▁% ▁for ▁can a gli flo zin ▁300 ▁mg ▁ .
▁the ▁maximum ▁dose ▁of ▁600 ▁mg ▁per ▁day ▁may ▁be ▁achieve d ▁after ▁an ▁additional ▁week ▁ .
▁the ▁following ▁symptoms ▁may ▁occur ▁in ▁new born ▁babi es ▁ , ▁of ▁mother s ▁that ▁have ▁used ▁o laza x ▁in ▁the ▁last ▁tri mester ▁( ▁last ▁three ▁months ▁of ▁their ▁pre gna ncy ▁) ▁: ▁shak ing ▁ , ▁muscle ▁sti ff ness ▁and ▁/ ▁or ▁we ak ness ▁ , ▁sleep ines s ▁ , ▁agita tion ▁ , ▁breath ing ▁problems ▁ , ▁and ▁difficult y ▁in ▁feed ing ▁ .
▁what ▁e var rest ▁looks ▁like ▁and ▁content s ▁of ▁the ▁pack
▁accident al ▁in gestion ▁can ▁be ▁le thal ▁for ▁children ▁ .
▁un com mon ▁: ▁renal ▁im pair ment ▁including ▁a cute ▁renal ▁failure
▁the ▁dos es ▁of ▁glu stin ▁may ▁need ▁to ▁be ▁adjust ed ▁when ▁given ▁with ▁some ▁other ▁medicine s ▁such ▁as ▁gem fi bro zil ▁( ▁used ▁to ▁lower ▁cholesterol ▁) ▁or ▁rif ampi cin ▁( ▁an ▁antibiotic ▁used ▁to ▁treat ▁tubercul osis ▁) ▁ .
▁en bre l ▁is ▁suppli ed ▁as ▁a ▁pre - fill ed ▁sy ringe ▁contain ing ▁a ▁clear ▁ , ▁colour less ▁or ▁pale ▁yellow ▁solution ▁for ▁inject ion ▁( ▁solution ▁for ▁inject ion ▁) ▁ .
▁within ▁each ▁fre que ncy ▁group ing ▁ , ▁advers e ▁reaction s ▁are ▁presente d ▁in ▁order ▁of ▁de cre as ing ▁serious ness ▁ .
▁given ▁the ▁possibility ▁of ▁extra vas ation ▁ , ▁it ▁is ▁ad vis able ▁to ▁close ly ▁monitor ▁the ▁in fusion ▁site ▁for ▁possible ▁infiltra tion ▁during ▁administration ▁of ▁the ▁medicinal ▁product ▁ .
▁these ▁occur red ▁in ▁3.4 ▁% ▁of ▁japanese ▁subject s ▁on ▁roti go tine ▁compared ▁to ▁1.9 ▁% ▁on ▁place bo ▁in ▁double - blind ▁par kin son ▁' s ▁disease ▁and ▁r ls ▁studies ▁ .
▁cel sen tri ▁contain s ▁a ▁medicine ▁called ▁mara vi roc ▁ .
▁how ▁to ▁store ▁tol ura
▁gla xo smith k line ▁( ▁cy pru s ▁) ▁l t d ▁τη λ ▁: ▁+ ▁ 357 ▁22 ▁39 ▁70 ▁00 ▁g sk cy pru s ▁@ ▁g sk . com
▁in ▁r vo ▁ , ▁anti - co agu lant ▁ therapy ▁was ▁used ▁in ▁2 ▁% ▁of ▁patients ▁receiving ▁o zur dex ▁; ▁there ▁were ▁no ▁reports ▁of ▁ha e mor r hagi c ▁advers e ▁events ▁in ▁these ▁patients ▁ .
▁interrupt ▁le nali domi de ▁treatment ▁and ▁conduct ▁the ▁c bc ▁at ▁least ▁every ▁7 ▁days ▁resume ▁le nali domi de ▁at ▁next ▁lower ▁level ▁( ▁dose ▁level ▁-2 ▁ , ▁- 3 ▁ , ▁- 4 ▁or ▁- 5 ▁) ▁ .
▁it ▁may ▁be ▁given ▁with ▁or ▁without ▁food ▁ .
▁as ▁with ▁other ▁anti thro mbo tic ▁drugs ▁ , ▁the ▁most ▁common ▁side ▁effect ▁with ▁re flu dan ▁( ▁seen ▁in ▁more ▁than ▁1 ▁patient ▁in ▁10 ▁) ▁is ▁ble ed ing ▁ .
▁e darbi ▁20 ▁mg ▁tablets ▁e darbi ▁40 ▁mg ▁tablets ▁e darbi ▁80 ▁mg ▁tablets ▁az ils ar tan ▁medo xo mil
▁how ▁to ▁take ▁your ▁dose
▁some ▁patients ▁who ▁received ▁som a vert ▁developed ▁anti - g row th ▁hormone ▁anti bo dies ▁( ▁protein s ▁that ▁are ▁produced ▁in ▁response ▁to ▁som a vert ▁) ▁ , ▁but ▁the ▁clinic al ▁importance ▁of ▁this ▁side ▁effect ▁is ▁not ▁known ▁ .
▁the ▁hydrat ion ▁status ▁of ▁patients ▁must ▁be ▁assess ed ▁prior ▁to ▁and ▁following ▁administration ▁of ▁zo le dro nic ▁acid ▁act avis ▁to ▁ensure ▁that ▁they ▁are ▁adequat ely ▁hydrat ed ▁ .
▁matern al ▁anti bo dies ▁may ▁interfere ▁with ▁vaccin ation ▁ .
▁detailed ▁information ▁on ▁this ▁medicinal ▁product ▁is ▁available ▁on ▁the ▁website ▁of ▁the ▁european ▁medicine s ▁agency ▁http ▁: ▁/ ▁/ ▁www . ema . europa . eu ▁/ ▁ .
▁what ▁is ▁ultra tar d ▁used ▁for ▁?
▁cases ▁of ▁radi ation ▁recall ▁and ▁radi ation ▁sensi t ization ▁have ▁been ▁reported ▁in ▁patients ▁treated ▁with ▁radi ation ▁either ▁prior ▁ , ▁during ▁ , ▁or ▁subsequent ▁to ▁ve mura fen ib ▁treatment ▁ .
▁non - clin ical ▁data ▁reveal ▁no ▁special ▁risk ▁for ▁humans ▁based ▁on ▁convention al ▁studies ▁of ▁safety ▁ pharma c ology ▁and ▁ toxic ity ▁ .
▁vision ▁problems ▁: ▁when ▁you ▁first ▁start ▁your ▁insulin ▁treatment ▁ , ▁it ▁may ▁disturb ▁your ▁vision ▁ , ▁but ▁the ▁disturb ance ▁is ▁usually ▁temporar y ▁ .
▁meta cre sol ▁man ni tol ▁glaci al ▁a ce tic ▁acid ▁so dium ▁ac etate ▁tri hydrat e ▁water ▁for ▁inject ions
▁4 ▁pre - fill ed ▁pens ▁( ▁clear click ▁) ▁contain ing ▁powder ▁and ▁solve nt ▁for ▁solution ▁for ▁inject ion ▁ , ▁4 ▁need les ▁( ▁" ▁push - on ▁need le ▁" ▁) ▁ ,
▁the ▁dose ▁of ▁lo ju xta ▁should ▁be ▁ad minister ed ▁12 ▁hours ▁apart ▁from ▁any ▁other ▁we ak ▁cy p 3 a 4 ▁inhibi tor ▁ .
▁the ▁dose ▁must ▁be ▁strict ly ▁a dhe red ▁to ▁ , ▁especially ▁the ▁14- day s ▁lead - in ▁period ▁( ▁see ▁section ▁4.2 ▁) ▁ .
▁au c ▁ ↓ ▁0 . 86 ▁( ▁ 0.7 6-0 . 97 ▁)
▁dos age ▁ , ▁route ▁and ▁method ▁of ▁administration
▁p 1.5 ▁/ ▁r ▁riba vir in ▁( ▁800 ▁mg ▁) ▁+ ▁pe g inter fer on ▁alfa -2 b ▁( ▁1.5 ▁micro gram s ▁/ ▁kg ▁)
▁how ▁to ▁take ▁spe dra
▁an ▁additional ▁study ▁compared ▁cim zia ▁given ▁alone ▁with ▁place bo ▁in ▁218 ▁patients ▁whose ▁response ▁to ▁other ▁medicine s ▁such ▁as ▁met ho tre xa te ▁had ▁been ▁in adequa te ▁ .
▁the ▁estima te ▁terminal ▁elimina tion ▁half - life ▁of ▁da c liz um ab ▁range d ▁from ▁270 ▁to ▁9 19 ▁hours ▁( ▁average ▁480 ▁hours ▁) ▁in ▁renal ▁all ograf t ▁patients ▁and ▁is ▁equivalent ▁to ▁that ▁reported ▁for ▁human ▁i gg ▁which ▁range d ▁from ▁4 32 ▁to ▁ 552 ▁hours ▁( ▁average ▁480 ▁hours ▁) ▁ .
▁what ▁you ▁need ▁to ▁know ▁before ▁you ▁take ▁com tan
▁if ▁you ▁forget ▁to ▁take ▁xen ical
▁continue ▁to ▁test ▁the ▁patient ▁every ▁month ▁for ▁auto im mu ne ▁conditions ▁ , ▁until ▁4 ▁years ▁after ▁last ▁in fusion ▁ .
▁the ▁clinic al ▁ef fica cy ▁of ▁es bri et ▁has ▁been ▁studie d ▁in ▁four ▁phase ▁3 ▁ , ▁multi centre ▁ , ▁random ised ▁ , ▁double - blind ▁ , ▁place bo - control led ▁studies ▁in ▁patients ▁with ▁i pf ▁ .
▁any ▁un used ▁medicine ▁or ▁was te ▁material ▁should ▁be ▁dispose d ▁of ▁in ▁accordance ▁with ▁local ▁requirements ▁ .
▁effective ▁contra cep tive ▁measure s ▁must ▁be ▁taken ▁by ▁women ▁of ▁child - be aring ▁potential ▁ .
▁the ▁first ▁dose ▁can ▁be ▁ad minister ed ▁at ▁6 ▁weeks ▁of ▁age ▁ .
▁each ▁pre - fill ed ▁sy ringe ▁of ▁0.1 65 ▁ml ▁solution ▁contain s ▁1. 65 ▁mg ▁of ▁ rani biz um ab ▁( ▁10 ▁mg ▁/ ▁ml ▁) ▁ .
▁close ▁clinic al ▁sur ve illa nce ▁is ▁recommended ▁when ▁da biga tran ▁et ex ila te ▁is ▁combine d ▁with ▁qui ni dine ▁and ▁particularly ▁in ▁the ▁occur r ence ▁of ▁ble ed ing ▁ , ▁not ably ▁in ▁patients ▁having ▁a ▁mild ▁to ▁moderat e ▁renal ▁im pair ment ▁ .
▁tubercul osis ▁can ▁develop ▁during ▁ therapy ▁even ▁if ▁your ▁child ▁has ▁received ▁prevent ative ▁treatment ▁for ▁tubercul osis ▁ .
▁in ▁the ▁population ▁ pharma cok ine tic ▁analysis ▁of ▁data ▁from ▁clinic al ▁studies ▁in ▁patients ▁with ▁meta static ▁melan oma ▁ , ▁pre - exist ing ▁mild ▁and ▁moderat e ▁renal ▁im pair ment ▁did ▁not ▁influence ▁the ▁clear ance ▁of ▁i pili mum ab ▁ .
▁in ▁very ▁rare ▁cases ▁ , ▁application ▁site ▁reaction s ▁such ▁as ▁transit ory ▁scratch ing ▁ , ▁er y thema ▁ , ▁a lo pecia ▁or ▁dermatit is ▁at ▁the ▁application ▁site ▁may ▁occur ▁ .
▁the ▁effect ▁of ▁calci to nin ▁may ▁be ▁monitor ed ▁by ▁measure ment ▁of ▁suitable ▁marker s ▁of ▁bone ▁remodel ing ▁ , ▁such ▁as ▁se rum ▁al ka line
▁exposure ▁to ▁bo ce pre vir ▁in ▁nur sing ▁human ▁infants ▁is ▁estima ted ▁to ▁be ▁less ▁than ▁1 ▁% ▁of ▁the ▁dose ▁ .
▁after ▁a ▁single ▁oral ▁dose ▁of ▁100 ▁mg ▁ , ▁the ▁mean ▁maximum ▁total ▁plasma ▁concentration ▁of ▁sil den a fil ▁is ▁approximately ▁440 ▁ng ▁/ ▁ml ▁( ▁cv ▁40 ▁% ▁) ▁ .
▁if ▁it ▁is ▁used ▁during ▁pre gna ncy ▁ , ▁the ▁patient ▁must ▁be ▁informe d ▁of ▁the ▁potential ▁risk ▁to ▁the ▁fo etus ▁ .
▁diabet ic ▁ma cular ▁oed ema ▁is ▁a ▁swe lling ▁of ▁the ▁light - sensitiv e ▁layer ▁at ▁the ▁back ▁of ▁the ▁eye ▁called ▁the ▁ma cula ▁ .
▁what ▁her cept in ▁is ▁and ▁what ▁it ▁is ▁used ▁for
▁all ▁of ▁the ▁studies ▁la sted ▁six ▁months ▁and ▁compared ▁the ▁effects ▁of ▁ri va stig mine ▁he xal ▁with ▁those ▁of ▁place bo ▁( ▁a ▁dum my ▁treatment ▁) ▁ .
▁how ▁to ▁store ▁z y delig
▁73 ▁% ▁of ▁the ▁cu tane ous ▁reaction s ▁were ▁rever sible ▁within ▁21 ▁days ▁ .
▁for ▁con com i tant ▁use ▁of ▁rasa gi line ▁with ▁select ive ▁serotonin ▁re up take ▁inhibi tors ▁( ▁s s ris ▁) ▁/ ▁select ive ▁serotonin - ▁no re pine ph rine ▁re up take ▁inhibi tors ▁( ▁s n ris ▁) ▁in ▁clinic al ▁trial s ▁ , ▁see ▁section ▁4. 8 ▁ .
▁rif ampi cin ▁reduce s ▁plasma ▁levels ▁of ▁ra lte grav ir ▁; ▁the ▁impact ▁on ▁the ▁ef fica cy ▁of ▁ra lte grav ir ▁is ▁un know n ▁ .
▁if ▁the ▁woman ▁does ▁not ▁want ▁to ▁change ▁her ▁normal ▁tablet - tak ing ▁schedule ▁ , ▁she ▁has ▁to ▁take ▁the ▁extra ▁white ▁tablet ▁( ▁s ▁) ▁from ▁another ▁pack ▁ .
▁they ▁should ▁consult ▁a ▁physician ▁if ▁they ▁develop ▁sign s ▁or ▁symptoms ▁of ▁heart ▁failure ▁;
▁to pote can ▁plus ▁ci s plat in ▁had ▁a ▁statistic ally ▁significant ▁benefit ▁in ▁overall ▁survival ▁relative ▁to ▁ci s plat in ▁mono therapy ▁after ▁adjust ing ▁for ▁inter im ▁analyse s ▁( ▁log - rank ▁p ▁= ▁0.0 33 ▁) ▁ .
▁its ▁exact ▁mechanism ▁of ▁action ▁is ▁un know n ▁ , ▁but ▁it ▁ attache s ▁to ▁several ▁receptor s ▁on ▁the ▁surface ▁of ▁nerv e ▁cell s ▁in ▁the ▁brain ▁ .
▁if ▁you ▁have ▁sick le ▁cell ▁disease ▁ , ▁make ▁sure ▁that ▁you ▁tell ▁your ▁doctor ▁before ▁you ▁start ▁taking ▁ratio gra s tim ▁ .
▁no ▁formal ▁distribution ▁studies ▁have ▁been ▁perform ed ▁ .
▁if ▁in hal ation ▁with ▁venta vis ▁10 ▁micro gram ▁/ ▁ml ▁is ▁well ▁to ler ated ▁ , ▁the ▁dose ▁should ▁be ▁increased ▁by ▁using ▁venta vis ▁20 ▁micro gram ▁/ ▁ml ▁ .
▁co - administration ▁of ▁pa zo pan ib ▁with ▁a ▁cy p 3 a 4 ▁ , ▁p - gp ▁ , ▁and ▁ bc rp ▁inhibi tor ▁ , ▁such ▁as ▁la pati ni b ▁ , ▁will ▁result ▁in ▁an ▁increase ▁in ▁plasma ▁pa zo pan ib ▁concentration s ▁ .
▁it ▁was ▁not ▁possible ▁to ▁detect ▁stavu dine ▁in ▁cerebro spin al ▁fluid ▁until ▁at ▁least ▁2 ▁hours ▁after ▁oral ▁administration ▁ .
▁increased ▁bone ▁mar row ▁reti cul in ▁fibre s
▁lead ▁pot ▁( ▁without ▁blue ▁box ▁)
▁in ▁patients ▁ , ▁over dos e ▁more ▁than ▁twice ▁the ▁recommended ▁dose ▁has ▁been ▁associated ▁with ▁the ▁a cute ▁ons et ▁of ▁symptom a tic ▁hypo tension ▁and ▁ thro mbo cy top enia ▁with ▁fatal ▁outcome s ▁ .
▁there ▁have ▁been ▁reports ▁of ▁serious ▁hyper sensitiv ity ▁reaction s ▁including ▁ana phy la ctic ▁reaction ▁ , ▁ang io ede ma ▁ , ▁allergi c ▁bron chos pas m ▁ , ▁skin ▁ rash ▁and ▁ur tica ria ▁associated ▁with ▁darbe po etin ▁alfa ▁ .
▁you ▁should ▁not ▁take ▁si mpon i ▁with ▁medicine s ▁contain ing ▁the ▁active ▁substance ▁anak in ra ▁or ▁a bata cept ▁ .
▁withdraw al ▁period ▁: ▁7 ▁days ▁ .
▁what ▁measure s ▁are ▁being ▁taken ▁to ▁ensure ▁the ▁safe ▁use ▁of ▁bre tari s ▁genu air ▁?
